<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>[Committee name]</title></head><body><div><p style="font-size:12pt; line-height:200%; margin:0pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="line-height:28pt; margin:14pt 0pt 9pt"><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:20pt">Science and Technology</span><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:20pt"> </span><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:20pt">Committee</span></p><p style="line-height:28pt; margin:14pt 0pt 9pt"><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:18pt">Oral evidence:</span><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:18pt"> </span><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:18pt">Antimicrobial resistance (AMR), HC</span><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:18pt">&#xa0;</span><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:18pt">848</span><br /><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:18pt">Wednesday 8 January 2014</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">Ordered by the House of Commons to be published on </span><span style="font-family:Garamond; font-size:12pt">8 January</span><span style="font-family:Garamond; font-size:12pt"> 201</span><span style="font-family:Garamond; font-size:12pt">4</span><span style="font-family:Garamond; font-size:12pt">.</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">Written evidence from witnesses:</span></p><p style="margin:0pt 0pt 12pt 21.3pt; text-align:justify; text-indent:-0.8pt"><span style="font-family:Garamond; font-size:12pt">–</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><a href="http://data.parliament.uk/writtenevidence/WrittenEvidence.svc/EvidencePdf/3415"><span style="color:#0000ff; font-family:Garamond; font-size:12pt; text-decoration:underline">Public Health England</span></a></p><p style="margin:0pt 0pt 12pt 21.3pt; text-align:justify; text-indent:-0.8pt"><span style="font-family:Garamond; font-size:12pt">–</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><a href="http://data.parliament.uk/writtenevidence/WrittenEvidence.svc/EvidencePdf/3537"><span style="color:#0000ff; font-family:Garamond; font-size:12pt; text-decoration:underline">Royal College of Physicians</span></a></p><p style="margin:0pt 0pt 12pt 21.3pt; text-align:justify; text-indent:-0.8pt"><span style="font-family:Garamond; font-size:12pt">–</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><a href="http://data.parliament.uk/writtenevidence/WrittenEvidence.svc/EvidencePdf/3430"><span style="color:#0000ff; font-family:Garamond; font-size:12pt; text-decoration:underline">Imperial College London</span></a></p><p style="margin:0pt 0pt 12pt 21.3pt; text-align:justify; text-indent:-0.8pt"><span style="font-family:Garamond; font-size:12pt">–</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><a href="http://data.parliament.uk/writtenevidence/WrittenEvidence.svc/EvidencePdf/3486"><span style="color:#0000ff; font-family:Garamond; font-size:12pt; text-decoration:underline">Novolytics</span></a></p><p style="margin:0pt 0pt 12pt 21.3pt; text-align:justify; text-indent:-0.8pt"><span style="font-family:Garamond; font-size:12pt">–</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><a href="http://data.parliament.uk/writtenevidence/WrittenEvidence.svc/EvidencePdf/3223"><span style="color:#0000ff; font-family:Garamond; font-size:12pt; text-decoration:underline">Novartis</span></a></p><p style="margin:0pt 0pt 12pt 21.3pt; text-align:justify; text-indent:-0.8pt"><span style="font-family:Garamond; font-size:12pt">–</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><a href="http://data.parliament.uk/writtenevidence/WrittenEvidence.svc/EvidencePdf/3412"><span style="color:#0000ff; font-family:Garamond; font-size:12pt; text-decoration:underline">University of Southampton Medical School</span></a></p><p style="margin:0pt 0pt 12pt 21.3pt; text-align:justify; text-indent:-0.8pt"><span style="font-family:Garamond; font-size:12pt">–</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><a href="http://data.parliament.uk/writtenevidence/WrittenEvidence.svc/EvidencePdf/3433"><span style="color:#0000ff; font-family:Garamond; font-size:12pt; text-decoration:underline">British In Vitro Diagnostics Association (BIVDA)</span></a></p><p style="margin:0pt 0pt 12pt; text-align:justify"><a name="bkChairMemberFirstPage"></a><a name="bkMembersFirstPage"></a><a name="bkMembersFirstPageEnd"></a><a href="http://www.parliamentlive.tv/Main/Player.aspx?meetingId=14550"><span style="color:#0000ff; font-family:Garamond; font-size:12pt; text-decoration:underline">Watch the meeting</span></a></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">Members present: </span><span style="font-family:Garamond; font-size:12pt">Andrew Miller (Chair); Jim Dowd; Stephen Metcalfe; David Morris; Stephen Mosley; Pamela Nash; David </span><span style="font-family:Garamond; font-size:12pt">Tredinnick</span><span style="font-family:Garamond; font-size:12pt"> </span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt; text-align:center"><span style="font-family:Garamond; font-size:12pt">Questions </span><span style="font-family:Garamond; font-size:12pt">39</span><span style="font-family:Garamond; font-size:12pt">-</span><span style="font-family:Garamond; font-size:12pt">111</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><a name="bkWitnessesFirstPage"></a><span style="font-family:Garamond; font-size:12pt">Witnesses: </span><span style="font-family:Garamond; font-size:12pt; font-weight:bold">Professor Anthony </span><span style="font-family:Garamond; font-size:12pt; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">, Director of Public Health Strategy, Public Health England, </span><span style="font-family:Garamond; font-size:12pt; font-weight:bold">Dr Michael Moore</span><span style="font-family:Garamond; font-size:12pt">, National Clinical Champion for Antimicrobial Stewardship, Royal College of General Practitioners, </span><span style="font-family:Garamond; font-size:12pt; font-weight:bold">Professor Alison Holmes</span><span style="font-family:Garamond; font-size:12pt">, Director of Infection Prevention and Control, National Centre for Infection Prevention and Management, Imperial College London, and </span><span style="font-family:Garamond; font-size:12pt; font-weight:bold">Dr Susan Hopkins</span><span style="font-family:Garamond; font-size:12pt">, Chair, Healthcare Associated Infections Working Group, Royal Colle</span><span style="font-family:Garamond; font-size:12pt">ge of Physicians, gave evidence. </span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q39 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Welcome </span><span style="font-family:Garamond; font-size:12pt">to </span><span style="font-family:Garamond; font-size:12pt">everyone here this morning. Thank you very much for coming. The subject of our inquiry has </span><span style="font-family:Garamond; font-size:12pt">coincidentally</span><span style="font-family:Garamond; font-size:12pt"> captured some media</span><span style="font-family:Garamond; font-size:12pt"> attention, with a piece on </span><span style="font-family:Garamond; font-size:12pt">regional BBC news the night before last</span><span style="font-family:Garamond; font-size:12pt"> and</span><span style="font-family:Garamond; font-size:12pt"> on the BBC </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">Inside Out</span><span style="font-family:Garamond; font-size:12pt">” programme on TB</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">i</span><span style="font-family:Garamond; font-size:12pt">n London</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and today the Wellcome Trust on Radio 4 </span><span style="font-family:Garamond; font-size:12pt">was </span><span style="font-family:Garamond; font-size:12pt">talking about antimicrobial</span><span style="font-family:Garamond; font-size:12pt"> resistance as well. F</span><span style="font-family:Garamond; font-size:12pt">rom discussions we have had with Dame Sally Davies</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> we realise that t</span><span style="font-family:Garamond; font-size:12pt">his is an area of some </span><span style="font-family:Garamond; font-size:12pt">concern, so w</span><span style="font-family:Garamond; font-size:12pt">e want to cover a </span><span style="font-family:Garamond; font-size:12pt">number of aspects </span><span style="font-family:Garamond; font-size:12pt">this morning</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">J</span><span style="font-family:Garamond; font-size:12pt">ust for the record</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> I would be grateful if the four of you would introduce yourselves very briefly.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I am Professor Anthony </span><span style="font-family:Garamond; font-size:12pt">Kessel</span><span style="font-family:Garamond; font-size:12pt">. I am director of public health strategy and the responsible officer at Public Health </span><span style="font-family:Garamond; font-size:12pt">England</span><span style="font-family:Garamond; font-size:12pt">. I also have a chair at</span><span style="font-family:Garamond; font-size:12pt"> the London School of</span><span style="font-family:Garamond; font-size:12pt"> Hygiene and</span><span style="font-family:Garamond; font-size:12pt"> Tropical Medicine.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I am Michael Moore</span><span style="font-family:Garamond; font-size:12pt">. I am a general practitioner. </span><span style="font-family:Garamond; font-size:12pt">I have been a GP in </span><span style="font-family:Garamond; font-size:12pt">Salisbury</span><span style="font-family:Garamond; font-size:12pt"> for 26 years. I al</span><span style="font-family:Garamond; font-size:12pt">so hold a research post at the U</span><span style="font-family:Garamond; font-size:12pt">niversity of Southampton. I am here today as I am representing the Royal College of General Practitioners. I am their national clinical champion for antimicrobial stewardship.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: I am Alison Holmes. I am </span><span style="font-family:Garamond; font-size:12pt">professor of i</span><span style="font-family:Garamond; font-size:12pt">nfectious diseases at Imperial C</span><span style="font-family:Garamond; font-size:12pt">ollege London</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and I am also a director of infection prevention and control within the NHS.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">My name is Susan Hopkins and I am a consultant in infectious diseases and </span><span style="font-family:Garamond; font-size:12pt">microbiology at the Royal Free H</span><span style="font-family:Garamond; font-size:12pt">ospital in London. I also work with Public Health </span><span style="font-family:Garamond; font-size:12pt">England</span><span style="font-family:Garamond; font-size:12pt"> as a healthcare epidemiologist. I am here today representing the Royal College of Physicians as chair of their HCAI working group.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q40 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair: </span><span style="font-family:Garamond; font-size:12pt">Thank you very much. First of all</span><span style="font-family:Garamond; font-size:12pt">, a straightforward question: w</span><span style="font-family:Garamond; font-size:12pt">ho is currently accountable for ensuring adherence to the Department of Health policies for reducing antimicrobial resistance? </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: At an NHS level—</span><span style="font-family:Garamond; font-size:12pt">from the p</span><span style="font-family:Garamond; font-size:12pt">oint of view within the NHS—</span><span style="font-family:Garamond; font-size:12pt">the Health and Social Care Act 2008</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> updated in 2011</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> clearly gives responsibility for health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">associated</span><span style="font-family:Garamond; font-size:12pt"> infections, antimicrobial resistance and antimicrobial stewardship to the chief responsible officer, the chief executive of those organisations. There is also a personal responsibility within </span><span style="font-family:Garamond; font-size:12pt">the</span><span style="font-family:Garamond; font-size:12pt"> Health and Social Care Act for everyone working in health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care to prevent infection spreading from one patient to the other and to make sure that they use antibiotics as prudently as possible.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Within acute care and acute hospitals, the structure is such that the chief executive is responsible for the delivery of that</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but there is a director of infec</span><span style="font-family:Garamond; font-size:12pt">tion prevention and control who</span><span style="font-family:Garamond; font-size:12pt"> reports directly to the chief executive</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> with the responsibility of addressing infection prevention and antibiotic stewardship within that trust.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q41 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">We hear of clinician</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">focused</span><span style="font-family:Garamond; font-size:12pt"> initiatives like </span><span style="font-family:Garamond; font-size:12pt">“Start Smart—Then F</span><span style="font-family:Garamond; font-size:12pt">ocus</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt">. How effective are initiatives like that in dealing with issues like antimicrobial resistance?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">We welcome </span><span style="font-family:Garamond; font-size:12pt">such </span><span style="font-family:Garamond; font-size:12pt">initiatives</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt">. I particularly welcome initiatives such as that</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because it actually focuses on the principles of good prescribing rather than the kind of technical expertise of which drug, what type of organism</span><span style="font-family:Garamond; font-size:12pt">; </span><span style="font-family:Garamond; font-size:12pt">it </span><span style="font-family:Garamond; font-size:12pt">actually </span><span style="font-family:Garamond; font-size:12pt">focuses on safe and best practice</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which means that it is much more amenable to all of t</span><span style="font-family:Garamond; font-size:12pt">hose involved in </span><span style="font-family:Garamond; font-size:12pt">prescribing</span><span style="font-family:Garamond; font-size:12pt"> antibiotics,</span><span style="font-family:Garamond; font-size:12pt"> administering antibiotics or caring for patients on antibiotics. That type of approach is extremely welcome, but we must remi</span><span style="font-family:Garamond; font-size:12pt">nd ourselves that it is not a policy;</span><span style="font-family:Garamond; font-size:12pt"> it is a guideline</span><span style="font-family:Garamond; font-size:12pt">. I</span><span style="font-family:Garamond; font-size:12pt">t is a framework that can be adopted to promote best practice within acute care. I </span><span style="font-family:Garamond; font-size:12pt">welcome the fact that it emphasises best practice and p</span><span style="font-family:Garamond; font-size:12pt">rinciples of good prescribing. </span><span style="font-family:Garamond; font-size:12pt">We have used it locally to promote multi</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">professional</span><span style="font-family:Garamond; font-size:12pt"> engagement, so it is not just for doctors who prescribe; it is for nurses who look after</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and </span><span style="font-family:Garamond; font-size:12pt">it is </span><span style="font-family:Garamond; font-size:12pt">for pharmacists who are involved in the managing of drugs. </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">t has been a useful external reinforcement. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: O</span><span style="font-family:Garamond; font-size:12pt">ne of the key things is ensuring that we get the best agent to the patient up</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">front to reduce morbidity and mortality from sepsis, so we often start broadly. One of the key things in </span><span style="font-family:Garamond; font-size:12pt">“Start Smart—Then F</span><span style="font-family:Garamond; font-size:12pt">ocus</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt"> is focusing down after two to three days of treatment into a n</span><span style="font-family:Garamond; font-size:12pt">arrow agent that has less </span><span style="font-family:Garamond; font-size:12pt">impact on both the microbiology in the individual patient </span><span style="font-family:Garamond; font-size:12pt">and</span><span style="font-family:Garamond; font-size:12pt"> the microbiology in the environment of the hospital that can then </span><span style="font-family:Garamond; font-size:12pt">lead to</span><span style="font-family:Garamond; font-size:12pt"> onward transmission events within hospitals. One of the things about </span><span style="font-family:Garamond; font-size:12pt">“Start S</span><span style="font-family:Garamond; font-size:12pt">mart</span><span style="font-family:Garamond; font-size:12pt">—Then F</span><span style="font-family:Garamond; font-size:12pt">ocus</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt"> is that it focuses the need for good microbiology and diagnostics up</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">front and requires people to think about</span><span style="font-family:Garamond; font-size:12pt"> what they need at the start. It requires</span><span style="font-family:Garamond; font-size:12pt"> education and train</span><span style="font-family:Garamond; font-size:12pt">ing of individuals to know </span><span style="font-family:Garamond; font-size:12pt">the right tests to do when a</span><span style="font-family:Garamond; font-size:12pt">n unwell</span><span style="font-family:Garamond; font-size:12pt"> pa</span><span style="font-family:Garamond; font-size:12pt">tient comes into hospital</span><span style="font-family:Garamond; font-size:12pt">. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">It is altering the message slightly, which I think is really important. This is not all about control of antibiotics; it is access to effective antibiotics</span><span style="font-family:Garamond; font-size:12pt">, so </span><span style="font-family:Garamond; font-size:12pt">starting sma</span><span style="font-family:Garamond; font-size:12pt">rt is a critical component</span><span style="font-family:Garamond; font-size:12pt">. What we need, though, is teeth around these things. This is a </span><span style="font-family:Garamond; font-size:12pt">very useful </span><span style="font-family:Garamond; font-size:12pt">guideline</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt">but it would be useful to have a little bit more regulation</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> I am speaking for acute trusts</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and my collea</span><span style="font-family:Garamond; font-size:12pt">gue can talk about primary care,</span><span style="font-family:Garamond; font-size:12pt"> but in terms of acute trusts it would be quite useful if we started to look at process indicators and best practice</span><span style="font-family:Garamond; font-size:12pt">, and got a </span><span style="font-family:Garamond; font-size:12pt">bit more teeth around what is good pra</span><span style="font-family:Garamond; font-size:12pt">ctice. A</span><span style="font-family:Garamond; font-size:12pt">t the end of </span><span style="font-family:Garamond; font-size:12pt">“Start Smart” there i</span><span style="font-family:Garamond; font-size:12pt">s a variety of guidelines, but it would be useful if we could tell trusts that they need to deliver on this.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q42 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> I</span><span style="font-family:Garamond; font-size:12pt">s the message the same</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">i</span><span style="font-family:Garamond; font-size:12pt">n primary care?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">It is complicated in primary care because you are talking about individual practitioners who are self</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">employed</span><span style="font-family:Garamond; font-size:12pt">. T</span><span style="font-family:Garamond; font-size:12pt">hey sit in their office</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and they are the people controlling the prescription pad, as it were. They are much more distant from these kinds of </span><span style="font-family:Garamond; font-size:12pt">initiatives and regulation. I</span><span style="font-family:Garamond; font-size:12pt">t is much more difficult to influence them. We have obviously made attempts with the </span><span style="font-family:Garamond; font-size:12pt">TARGET</span><span style="font-family:Garamond; font-size:12pt"> website, which is a collection of educational tools for GPs to teach them about more rational prescribing, but we cannot force people to do these things and we cannot force them to change. It is much more difficult to influence individual GPs</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and at the moment there are not</span><span style="font-family:Garamond; font-size:12pt"> any regulatory approaches that</span><span style="font-family:Garamond; font-size:12pt"> do that.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q43 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> Have </span><span style="font-family:Garamond; font-size:12pt">the new structures that have been e</span><span style="font-family:Garamond; font-size:12pt">stablished in the NHS </span><span style="font-family:Garamond; font-size:12pt">helped or hindered this process?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: I</span><span style="font-family:Garamond; font-size:12pt">t has disrupted continuity and it is less clear now </span><span style="font-family:Garamond; font-size:12pt">on </span><span style="font-family:Garamond; font-size:12pt">the mechanisms for influence than it was before. I am sure things will sort themselves out with time, but when there were PCTs there were prescribing advisers within the</span><span style="font-family:Garamond; font-size:12pt">m</span><span style="font-family:Garamond; font-size:12pt"> and they communicated with the GPs in their patch, whereas </span><span style="font-family:Garamond; font-size:12pt">now </span><span style="font-family:Garamond; font-size:12pt">they have b</span><span style="font-family:Garamond; font-size:12pt">een made homeless; they are </span><span style="font-family:Garamond; font-size:12pt">finding themselves, I think, back in Public Health England. A big organisational change is disruptive, so I do not think at the moment we are quite clear how to influence GPs. They are contracted through the area teams, which is NHS England work</span><span style="font-family:Garamond; font-size:12pt">ing through the area teams. </span><span style="font-family:Garamond; font-size:12pt">I anticipate that in time they will be looking at things like antimicrobial stewardship</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but at the moment that is not at the top of their priority list.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q44 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Who has the responsibility overall to pull that together?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I guess that resides with NHS England</span><span style="font-family:Garamond; font-size:12pt">, which then contract </span><span style="font-family:Garamond; font-size:12pt">GPs through the area teams.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q45 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Tredinnick</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Do you think that current undergraduate medical courses focus enough on antimicrobial resistance</span><span style="font-family:Garamond; font-size:12pt">, and,</span><span style="font-family:Garamond; font-size:12pt"> if not, what should be done about it, please?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The</span><span style="font-family:Garamond; font-size:12pt"> first thing to say is that </span><span style="font-family:Garamond; font-size:12pt">undergraduate medical courses are at the moment both regulated and have standards applied by the General Medical Council. I reviewed the curricula for those courses recently</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and what the GMC says is that they should have some training in microbiology, and microbiology obviously includes looking at micro</span><span style="font-family:Garamond; font-size:12pt">-</span><span style="font-family:Garamond; font-size:12pt">organisms and resistance. It also mentions that it is important to understand the principles of infection prevention and control</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and antibiotic prescribing. </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e know that there is variability in the </span><span style="font-family:Garamond; font-size:12pt">number </span><span style="font-family:Garamond; font-size:12pt">of hours of training that are given to medical students across the country. It is an area that has had various amounts of attention</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> depending on the s</span><span style="font-family:Garamond; font-size:12pt">kills that the university set. </span><span style="font-family:Garamond; font-size:12pt">Potentially there is an opportunity now with the AMR strategy to bring this to the fore, both with the General Medical Council and with Health Education England</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">and </span><span style="font-family:Garamond; font-size:12pt">talk to them about strengthening that area of their curriculum. Obviously every area of the curriculum fights for its support and i</span><span style="font-family:Garamond; font-size:12pt">ts necessary niche, but </span><span style="font-family:Garamond; font-size:12pt">it i</span><span style="font-family:Garamond; font-size:12pt">s an area that cross</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">cuts</span><span style="font-family:Garamond; font-size:12pt"> all</span><span style="font-family:Garamond; font-size:12pt"> the delivery of medicine</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">in that</span><span style="font-family:Garamond; font-size:12pt"> we know that every individual who works as a doctor will prescribe an antibiotic du</span><span style="font-family:Garamond; font-size:12pt">ring their day</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">to</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">day life. I</span><span style="font-family:Garamond; font-size:12pt">t could be </span><span style="font-family:Garamond; font-size:12pt">strengthened, but it is </span><span style="font-family:Garamond; font-size:12pt">in the curriculum at </span><span style="font-family:Garamond; font-size:12pt">present</span><span style="font-family:Garamond; font-size:12pt">.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q46 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Tredinnick</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Who </span><span style="font-family:Garamond; font-size:12pt">d</span><span style="font-family:Garamond; font-size:12pt">o you think should be responsible for the curriculum content of medical degrees?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The General Medical Council is a very good place to start with the curriculum content</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> as they are responsible for doctors and for their revalidation in the future. Health Education England</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s new role of delivering an effective work</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">force has to start to develop what it wants undergraduate curricula to look like across the board for health work</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">force delivery. </span><span style="font-family:Garamond; font-size:12pt">The GMC set the standards and review</span><span style="font-family:Garamond; font-size:12pt"> the universities</span><span style="font-family:Garamond; font-size:12pt">—attend universities and review whether</span><span style="font-family:Garamond; font-size:12pt"> they are meeting the minimum standards that are required</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">but the question is whether those standards need to be enhanced at the moment to make sure that we bring this</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> as an area of patient safety</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">across the board and improve i</span><span style="font-family:Garamond; font-size:12pt">t for undergraduate health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q47 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Tredinnick</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Much of the Government</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s antimicrobial resistance strategy, perhaps naturally</span><span style="font-family:Garamond; font-size:12pt">, focused on increasing supply—</span><span style="font-family:Garamond; font-size:12pt">looking at new ways of finding antibiotics and looking at encouraging</span><span style="font-family:Garamond; font-size:12pt"> drug companies to produce them.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">ould you agree that we should be looking at reducing demand much more and looking at some of the other options that are currently available, perhaps not tested as much as other drugs, such as acupuncture, herbal medicine and possi</span><span style="font-family:Garamond; font-size:12pt">bly hom</span><span style="font-family:Garamond; font-size:12pt">eopathic medicine, which is used widely outside this country? What do you think </span><span style="font-family:Garamond; font-size:12pt">about reducing demand through looking at other options</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and should more research money be spent on these topics?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: One of the good opportunities in</span><span style="font-family:Garamond; font-size:12pt"> the new strategy is co</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">ordination around professional education and public awareness. That goes not just for doctors, both undergraduate and postgraduate</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">we have only talked about undergraduate medicine here</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">but across other health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care professionals who are all involved in antimicro</span><span style="font-family:Garamond; font-size:12pt">bial resistance and play a part.</span><span style="font-family:Garamond; font-size:12pt"> Public Health England will play a big role in </span><span style="font-family:Garamond; font-size:12pt">the </span><span style="font-family:Garamond; font-size:12pt">co</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">ordination of that improved professional education. In relation to your question about other ways of reducing demand, I think, yes, one of those includes greater public awareness</span><span style="font-family:Garamond; font-size:12pt">, so that the public—patients—</span><span style="font-family:Garamond; font-size:12pt">make </span><span style="font-family:Garamond; font-size:12pt">fewer</span><span style="font-family:Garamond; font-size:12pt"> unnecessary demands, or inappropriate demands, for antibiotics. </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">t is important in terms of what is prov</span><span style="font-family:Garamond; font-size:12pt">ided that it is evidence based—</span><span style="font-family:Garamond; font-size:12pt">that you are providing treatment or interventions that are evidence based. Some of the things that are encouraged in the strategy around alternatives to antibiotics include vaccines against bacteria and more work on diagnostics that can assist </span><span style="font-family:Garamond; font-size:12pt">in </span><span style="font-family:Garamond; font-size:12pt">appropriate prescribing and those kinds of things.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Could I pick up on the education questions and expand </span><span style="font-family:Garamond; font-size:12pt">on what my colleague was saying?</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">he GMC is responsible</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but the universities can deliver that in a </span><span style="font-family:Garamond; font-size:12pt">variety</span><span style="font-family:Garamond; font-size:12pt"> of ways</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and some UKCRC</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">funded</span><span style="font-family:Garamond; font-size:12pt"> work has just demonstrated the enormous variability in the education provided in our medical schools, from a range of five hours to over 240 hours in </span><span style="font-family:Garamond; font-size:12pt">this domain. I</span><span style="font-family:Garamond; font-size:12pt">t is there, </span><span style="font-family:Garamond; font-size:12pt">but </span><span style="font-family:Garamond; font-size:12pt">there is a huge amount of variability</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and this </span><span style="font-family:Garamond; font-size:12pt">is</span><span style="font-family:Garamond; font-size:12pt"> looking at antibi</span><span style="font-family:Garamond; font-size:12pt">otic safety and antibiotic use </span><span style="font-family:Garamond; font-size:12pt">as a kind of core aspect of training that</span><span style="font-family:Garamond; font-size:12pt"> maybe goes across </span><span style="font-family:Garamond; font-size:12pt">all people involved in health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care. We are talking about medical students here, but we should also be talking about our pharmacists and nurses as well</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> perhaps having some kind of core principles</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and then, on top of that, different types of education depending on the profession a</span><span style="font-family:Garamond; font-size:12pt">nd the type of development the </span><span style="font-family:Garamond; font-size:12pt">individual needs. There is enormous variability, but we can do a lot more </span><span style="font-family:Garamond; font-size:12pt">to</span><span style="font-family:Garamond; font-size:12pt"> improve it</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and look at innovation and how we teach as well.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I </span><span style="font-family:Garamond; font-size:12pt">want</span><span style="font-family:Garamond; font-size:12pt"> to come back to the alternative treatments for symptoms. Most antibiotics in this country are prescribed in primary care</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">80% is the estimated amount</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">and most of those are for respiratory tract infections</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which are self</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">limiting. It has been shown that antibiotics make very little difference to th</span><span style="font-family:Garamond; font-size:12pt">e outcome from those infections. P</span><span style="font-family:Garamond; font-size:12pt">eople still go </span><span style="font-family:Garamond; font-size:12pt">to see their doctor </span><span style="font-family:Garamond; font-size:12pt">because they </span><span style="font-family:Garamond; font-size:12pt">are very uncomfortable and </span><span style="font-family:Garamond; font-size:12pt">have distressing symptoms</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which last two or three weeks</span><span style="font-family:Garamond; font-size:12pt">, and a</span><span style="font-family:Garamond; font-size:12pt">t the moment the </span><span style="font-family:Garamond; font-size:12pt">doctor’s </span><span style="font-family:Garamond; font-size:12pt">dominant strategy is to issue </span><span style="font-family:Garamond; font-size:12pt">a prescription. Around 80% to </span><span style="font-family:Garamond; font-size:12pt">90% of the time</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> a prescription for antibiotics is still issued. </span><span style="font-family:Garamond; font-size:12pt">O</span><span style="font-family:Garamond; font-size:12pt">bviously there are alternative things that we have looked at</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> li</span><span style="font-family:Garamond; font-size:12pt">ke using delayed prescriptions, </span><span style="font-family:Garamond; font-size:12pt">but another potential strategy is to offer somethi</span><span style="font-family:Garamond; font-size:12pt">ng for symptom relief. T</span><span style="font-family:Garamond; font-size:12pt">here is an urgent need to look for alternative ways of providing symptom relief. People go to their do</span><span style="font-family:Garamond; font-size:12pt">ctor with symptoms and they anticipate</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">getting </span><span style="font-family:Garamond; font-size:12pt">something to help them. At the moment there is not much in the cupboard and people go to antibiotics, although we really are pretty sure that t</span><span style="font-family:Garamond; font-size:12pt">hey do not make any difference—</span><span style="font-family:Garamond; font-size:12pt">or </span><span style="font-family:Garamond; font-size:12pt">very little difference—</span><span style="font-family:Garamond; font-size:12pt">to the duration of symptoms.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q48 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Jim Dowd:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Just to make sure I understood it correctly, the most common use of them, you said, is for respiratory infections.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Yes. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q49 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Jim Dowd:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Everybody knows, apparently, that they do not work, so who is prescribing them?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">They are being prescribed by GPs in their surgeries.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q50 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Jim Dowd:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Are they not aware of what everybody else knows?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">It is a complicated interaction and at the mo</span><span style="font-family:Garamond; font-size:12pt">ment there are few alternatives.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">You might </span><span style="font-family:Garamond; font-size:12pt">say, </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">Why do</span><span style="font-family:Garamond; font-size:12pt">n’t people just</span><span style="font-family:Garamond; font-size:12pt"> stop prescribing them?</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt">, but that does not happen</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so we have to find other ways of helping that hap</span><span style="font-family:Garamond; font-size:12pt">pen. You can do it by saying, “T</span><span style="font-family:Garamond; font-size:12pt">here is a d</span><span style="font-family:Garamond; font-size:12pt">ifferent way. Wait a few days. W</span><span style="font-family:Garamond; font-size:12pt">e a</span><span style="font-family:Garamond; font-size:12pt">re using a delayed prescription.” W</span><span style="font-family:Garamond; font-size:12pt">e can use near</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">patient</span><span style="font-family:Garamond; font-size:12pt"> tests</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which per</span><span style="font-family:Garamond; font-size:12pt">haps focus on the people who </span><span style="font-family:Garamond; font-size:12pt">need antibiotics</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and we can find alternative symptom r</span><span style="font-family:Garamond; font-size:12pt">elievers. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">One of the things people worry about </span><span style="font-family:Garamond; font-size:12pt">is complications;</span><span style="font-family:Garamond; font-size:12pt"> I think there wa</span><span style="font-family:Garamond; font-size:12pt">s something in the paper today about </span><span style="font-family:Garamond; font-size:12pt">somebody who did not get antibiotics and then died as a result of pneumonia. </span><span style="font-family:Garamond; font-size:12pt">When people</span><span style="font-family:Garamond; font-size:12pt"> go to the doctor</span><span style="font-family:Garamond; font-size:12pt"> with a bad cough,</span><span style="font-family:Garamond; font-size:12pt"> feeling pretty terrible</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">they are worried</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">they </span><span style="font-family:Garamond; font-size:12pt">are </span><span style="font-family:Garamond; font-size:12pt">going to get pneumonia. The doctor really does not know if they are going to get pneumonia or not. It is the same if you have a very bad sore throat: are you going to get an abscess in your throat? </span><span style="font-family:Garamond; font-size:12pt">O</span><span style="font-family:Garamond; font-size:12pt">ne of the drivers of that continued prescribing is being risk averse, worryin</span><span style="font-family:Garamond; font-size:12pt">g about potential complications, so, “</span><span style="font-family:Garamond; font-size:12pt">I will give you these antibiotics because I do not want you to get one of those bad complications.</span><span style="font-family:Garamond; font-size:12pt">” W</span><span style="font-family:Garamond; font-size:12pt">e need to get much more sophisticated about sp</span><span style="font-family:Garamond; font-size:12pt">otting the people who really </span><span style="font-family:Garamond; font-size:12pt">need the antibiotics and the majority who simply do not need them. </span><span style="font-family:Garamond; font-size:12pt">A</span><span style="font-family:Garamond; font-size:12pt">nother focus for research </span><span style="font-family:Garamond; font-size:12pt">is </span><span style="font-family:Garamond; font-size:12pt">to try and do that, but it is difficult. It is not as easy as you might think to spot those people.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: It is appropriate versus </span><span style="font-family:Garamond; font-size:12pt">inappropriate antibiotic prescribing</span><span style="font-family:Garamond; font-size:12pt">; </span><span style="font-family:Garamond; font-size:12pt">we talk about this a lot. It is very easy in retrospect to describe inappropriate prescribing</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because you have seen how the patient</span><span style="font-family:Garamond; font-size:12pt"> has gone over a few days. I</span><span style="font-family:Garamond; font-size:12pt">n a way, managing antibiotics in hospital comes under that measure</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because we monitor the patient daily for a few days. That is why </span><span style="font-family:Garamond; font-size:12pt">“Start Smart—Then F</span><span style="font-family:Garamond; font-size:12pt">ocus</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt"> works</span><span style="font-family:Garamond; font-size:12pt">;</span><span style="font-family:Garamond; font-size:12pt"> at two days</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> you can make that intervention. Where the majority of antibiotics are prescribed</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> in general practice</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> you have a 10</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">minute interaction</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> you will not see the patient again and they can potentially get much worse. It is about understanding</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> first of all</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which patients are likely to get worse and, </span><span style="font-family:Garamond; font-size:12pt">secondly</span><span style="font-family:Garamond; font-size:12pt">, delivering strategies that are acceptable to patients. Patient acceptability is quite important in all of this as well</span><span style="font-family:Garamond; font-size:12pt">. The aspect</span><span style="font-family:Garamond; font-size:12pt"> where we need research</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt">ou</span><span style="font-family:Garamond; font-size:12pt">tside of development of new drugs, is </span><span style="font-family:Garamond; font-size:12pt">point</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">of</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">care</span><span style="font-family:Garamond; font-size:12pt"> tests that are acceptable to patients that will help us diagnose a virus from a bacteria</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because you cannot do that simply by looking at a patient. We know that 80</span><span style="font-family:Garamond; font-size:12pt">% to </span><span style="font-family:Garamond; font-size:12pt">90% are viruses, but we do not know the 10</span><span style="font-family:Garamond; font-size:12pt">% to </span><span style="font-family:Garamond; font-size:12pt">20% that are not</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> when the patient is in front of us.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q51 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Jim Dowd:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Is part of it to retain the confidence of the patient? They</span><span style="font-family:Garamond; font-size:12pt"> expect to get a prescription and </span><span style="font-family:Garamond; font-size:12pt">they get a prescription</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> even though it is medically dubious.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Not all of them are expecting a prescription. In fact, one of the things you can do is to explore the expectations of the patient</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and we have shown that training in communication skills is one way of reduc</span><span style="font-family:Garamond; font-size:12pt">ing antibiotic prescribing. T</span><span style="font-family:Garamond; font-size:12pt">here are ways of dealing with that but you have to get people to pick up and implement these things at practice level. </span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">We are going to come back to this theme in a moment.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q52 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Tredinnick</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Briefly</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> just to go back to my suggestion that we should be looking at other options m</span><span style="font-family:Garamond; font-size:12pt">ore thoroughly, according to a</span><span style="font-family:Garamond; font-size:12pt"> briefing we have received, </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">P</span><span style="font-family:Garamond; font-size:12pt">rimary</span><span style="font-family:Garamond; font-size:12pt"> C</span><span style="font-family:Garamond; font-size:12pt">are</span><span style="font-family:Garamond; font-size:12pt"> R</span><span style="font-family:Garamond; font-size:12pt">esearch</span><span style="font-family:Garamond; font-size:12pt"> P</span><span style="font-family:Garamond; font-size:12pt">rojects on</span><span style="font-family:Garamond; font-size:12pt"> H</span><span style="font-family:Garamond; font-size:12pt">erbal</span><span style="font-family:Garamond; font-size:12pt"> M</span><span style="font-family:Garamond; font-size:12pt">edicine in</span><span style="font-family:Garamond; font-size:12pt"> I</span><span style="font-family:Garamond; font-size:12pt">nfectious</span><span style="font-family:Garamond; font-size:12pt"> D</span><span style="font-family:Garamond; font-size:12pt">isease</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt"> already </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">A number of research projects with implications for AMR, particularly around herbal treatment, are in progress at the National School for Primary Care Research.</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt"> These include one on a herb called </span><span style="font-family:Garamond; font-size:12pt">Uva</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">ursi</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">for</span><span style="font-family:Garamond; font-size:12pt"> acute urinary tract infection and another relating to </span><span style="font-family:Garamond; font-size:12pt">probiotics</span><span style="font-family:Garamond; font-size:12pt"> and vitamin D and infections. Do you not think</span><span style="font-family:Garamond; font-size:12pt"> this is the big clue </span><span style="font-family:Garamond; font-size:12pt">that we should be spending more money on looking at remedies that have been with us for thousands of years</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> rather than spending so much money looking at new treatments? They are staring us in the face</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so why do</span><span style="font-family:Garamond; font-size:12pt">n’t we </span><span style="font-family:Garamond; font-size:12pt">do more research on treatments that have been available for thousands of years?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I am the chief investigator of the </span><span style="font-family:Garamond; font-size:12pt">Uva</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">ursi</span><span style="font-family:Garamond; font-size:12pt"> study, so you are </span><span style="font-family:Garamond; font-size:12pt">trying to convince</span><span style="font-family:Garamond; font-size:12pt"> the wrong person really. I lead that research. </span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Tredinnick</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">So you are very much</span><span style="font-family:Garamond; font-size:12pt"> involved</span><span style="font-family:Garamond; font-size:12pt">, well recently obviously</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt"> </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Yes.</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Tredinnick</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Thank you very much. </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q53 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Before we move</span><span style="font-family:Garamond; font-size:12pt"> on, can I </span><span style="font-family:Garamond; font-size:12pt">ask how involved is Health Education England in respect of the medical curric</span><span style="font-family:Garamond; font-size:12pt">ulum as far as AMR is concerned, a</span><span style="font-family:Garamond; font-size:12pt">nd</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> at the opposite end of the spectrum</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> are doctors coming into the NHS from other countries sufficiently well versed in dealing with our approach to AMR?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I will take the second </span><span style="font-family:Garamond; font-size:12pt">part </span><span style="font-family:Garamond; font-size:12pt">first</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> as it is easier in my day</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">to</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">day job to understand what we do. When doctors come into the UK</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> they register with the General Medical Council showing that they have standard competencies to achieve that registration. Once they are within the system</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> every doctor starting within the NHS system in health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">in </span><span style="font-family:Garamond; font-size:12pt">hospit</span><span style="font-family:Garamond; font-size:12pt">als or in a training programme—</span><span style="font-family:Garamond; font-size:12pt">that includes GP training programmes or any train</span><span style="font-family:Garamond; font-size:12pt">ing programme within hospitals—has</span><span style="font-family:Garamond; font-size:12pt"> a minimum</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> mandatory day that they have to cover</span><span style="font-family:Garamond; font-size:12pt">; i</span><span style="font-family:Garamond; font-size:12pt">t includes infection prevention and control</span><span style="font-family:Garamond; font-size:12pt"> and</span><span style="font-family:Garamond; font-size:12pt"> antimicrobial stewardship as a basic minimum on the day they start. The curricula for all hospital doctors </span><span style="font-family:Garamond; font-size:12pt">all </span><span style="font-family:Garamond; font-size:12pt">include basic requirements on microbiology infection control and antimicrobials stewardship</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and it is required that they have this knowledge and awareness as they are progressing t</span><span style="font-family:Garamond; font-size:12pt">hrough the system. All the post</span><span style="font-family:Garamond; font-size:12pt">graduate </span><span style="font-family:Garamond; font-size:12pt">exams have some aspect of this</span><span style="font-family:Garamond; font-size:12pt">. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">Could it be strengthened? Of course. I am speaking as an infectious diseases physician; I obviously believe it should have gr</span><span style="font-family:Garamond; font-size:12pt">eat priority on all the post</span><span style="font-family:Garamond; font-size:12pt">graduate curricula</span><span style="font-family:Garamond; font-size:12pt">. W</span><span style="font-family:Garamond; font-size:12pt">e push for that as the Royal College of Physicians</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> a</span><span style="font-family:Garamond; font-size:12pt">nd have pushed to strengthen i</span><span style="font-family:Garamond; font-size:12pt">t throughout all of the curricula at the Royal Colleg</span><span style="font-family:Garamond; font-size:12pt">e of Physicians. It is there;</span><span style="font-family:Garamond; font-size:12pt"> it is present. I would never say it </span><span style="font-family:Garamond; font-size:12pt">was</span><span style="font-family:Garamond; font-size:12pt"> enough</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but that is coming from the area that I am in. </span><span style="font-family:Garamond; font-size:12pt">Now</span><span style="font-family:Garamond; font-size:12pt"> is an opportunity to make sure that we have raised awareness again with people who are not specialists in this area</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> to ensure that they understand why they should not prescribe, what are the unnecessary consequences and, in particular, to think about it as </span><span style="font-family:Garamond; font-size:12pt">a whole-</span><span style="font-family:Garamond; font-size:12pt">population approach</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">rather </span><span style="font-family:Garamond; font-size:12pt">than </span><span style="font-family:Garamond; font-size:12pt">just the individual sitting in front of them. As doctors, we very much think about the individual in </span><span style="font-family:Garamond; font-size:12pt">front of us</span><span style="font-family:Garamond; font-size:12pt">; </span><span style="font-family:Garamond; font-size:12pt">antimicrobial resistance really focuses us to think about the population and the impact </span><span style="font-family:Garamond; font-size:12pt">a</span><span style="font-family:Garamond; font-size:12pt"> prescription may ha</span><span style="font-family:Garamond; font-size:12pt">ve on somebody down the line. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">With respect to Health Education England, as a new organisation they have been very much focusing on postgraduate training across </span><span style="font-family:Garamond; font-size:12pt">the health care work force,</span><span style="font-family:Garamond; font-size:12pt"> as their remit is the NHS work</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">force. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hey are there to help</span><span style="font-family:Garamond; font-size:12pt"> to develop </span><span style="font-family:Garamond; font-size:12pt">the undergraduate curricula</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and I look forward to their impact in this area.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The education of professionals is complex and </span><span style="font-family:Garamond; font-size:12pt">multifactorial</span><span style="font-family:Garamond; font-size:12pt">. On top of </span><span style="font-family:Garamond; font-size:12pt">the </span><span style="font-family:Garamond; font-size:12pt">educational packages for doctors, nurses, pharmacists and others involved, there are</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">and the new strategy has provided</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">a range of other educational material</span><span style="font-family:Garamond; font-size:12pt">s</span><span style="font-family:Garamond; font-size:12pt"> being developed already</span><span style="font-family:Garamond; font-size:12pt">. I</span><span style="font-family:Garamond; font-size:12pt">n Public Health England</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> we are preparing prescribing quality guidelines for primary and secondary care. NICE</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt">the National Institute for Health and </span><span style="font-family:Garamond; font-size:12pt">Care</span><span style="font-family:Garamond; font-size:12pt"> Excellence</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt">along with Public Health </span><span style="font-family:Garamond; font-size:12pt">England</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> are already preparing new good practice guidance, clinical guidance and public healt</span><span style="font-family:Garamond; font-size:12pt">h guidance—three sets of guidance—on</span><span style="font-family:Garamond; font-size:12pt"> antimi</span><span style="font-family:Garamond; font-size:12pt">crobial resistance. T</span><span style="font-family:Garamond; font-size:12pt">he strategy has enabled us to ramp up the priority attention that has been given to antimicrobial resistance</span><span style="font-family:Garamond; font-size:12pt">, and </span><span style="font-family:Garamond; font-size:12pt">provides us w</span><span style="font-family:Garamond; font-size:12pt">ith an excellent opportunity. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">In terms of Health </span><span style="font-family:Garamond; font-size:12pt">Education England and its role on </span><span style="font-family:Garamond; font-size:12pt">the professional educat</span><span style="font-family:Garamond; font-size:12pt">ion strand of the new strategy, </span><span style="font-family:Garamond; font-size:12pt">the overall co</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">ordination is falling to Public Health </span><span style="font-family:Garamond; font-size:12pt">England</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> I am the policy lead for Public Health </span><span style="font-family:Garamond; font-size:12pt">England</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so </span><span style="font-family:Garamond; font-size:12pt">I chair the co</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">ordination group, and</span><span style="font-family:Garamond; font-size:12pt"> Health Education England </span><span style="font-family:Garamond; font-size:12pt">is</span><span style="font-family:Garamond; font-size:12pt"> on that group. Just </span><span style="font-family:Garamond; font-size:12pt">as</span><span style="font-family:Garamond; font-size:12pt"> the strategy is only relatively new</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">a few months</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">Health Education England and indeed ourselves are relatively new</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so we are settling down</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but we</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> Public Health England</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> are absolutely dependent on working with partners like Health Education England to e</span><span style="font-family:Garamond; font-size:12pt">nsure further improvements in</span><span style="font-family:Garamond; font-size:12pt"> prescribing education.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Could I expand on the perspective from the acute NHS trust side of things? Echoing what Susan says, acute hospitals have a framework</span><span style="font-family:Garamond; font-size:12pt">, so i</span><span style="font-family:Garamond; font-size:12pt">t does not matter w</span><span style="font-family:Garamond; font-size:12pt">here doctors join them from;</span><span style="font-family:Garamond; font-size:12pt"> they should have an infrastructure and a framework that actually supports, encourages and drives good prescribing around the principles of good prescribing. The other thing is that prescribers and doctors are not doing this in iso</span><span style="font-family:Garamond; font-size:12pt">lation. </span><span style="font-family:Garamond; font-size:12pt">There is a mu</span><span style="font-family:Garamond; font-size:12pt">ltidisciplinary programme for</span><span style="font-family:Garamond; font-size:12pt"> how we look after antibiotics, monitor </span><span style="font-family:Garamond; font-size:12pt">them and</span><span style="font-family:Garamond; font-size:12pt"> ensure that best practice is there. </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">f the systems are there</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">the trusts should have these systems in place</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">it really should not matter where doctors come from.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q54 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Dr Moore, you talked about the distance between initiatives and GPs. Is one way of narrowing that distance through the use of continued professional development</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">CPD</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">and how much control is there over what is studied as part of your continuous professional development</span><span style="font-family:Garamond; font-size:12pt">?</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">C</span><span style="font-family:Garamond; font-size:12pt">ould antimicrobial resis</span><span style="font-family:Garamond; font-size:12pt">tance form a greater part of i</span><span style="font-family:Garamond; font-size:12pt">t?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: That is the way forward. </span><span style="font-family:Garamond; font-size:12pt">GPs are mandated to continue professional education. They have an annual appraisal process at which their educational attainments are discussed with an appraiser, but at the moment they are independent contractors and they choose, or choose with their appraiser, what their development needs are. I do not think at the moment that antimicrobial resistance and rational prescribing are high on the agenda. There are lots of other new thi</span><span style="font-family:Garamond; font-size:12pt">ngs, huge pressures and </span><span style="font-family:Garamond; font-size:12pt">a massive curriculum for GPs to try and keep up with</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and they are probably pretty comfortable with their day</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">to</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">day stuff. They have been in practice for 20 </span><span style="font-family:Garamond; font-size:12pt">years prescribing antibiotics; </span><span style="font-family:Garamond; font-size:12pt">people do not come back because they </span><span style="font-family:Garamond; font-size:12pt">get better.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hey are not really thinking about looking in a critical way at their prescribing practice and </span><span style="font-family:Garamond; font-size:12pt">doing educational activities. </span><span style="font-family:Garamond; font-size:12pt">O</span><span style="font-family:Garamond; font-size:12pt">ne of the difficulties</span><span style="font-family:Garamond; font-size:12pt"> is </span><span style="font-family:Garamond; font-size:12pt">that there will be </span><span style="font-family:Garamond; font-size:12pt">100</span><span style="font-family:Garamond; font-size:12pt"> other things </span><span style="font-family:Garamond; font-size:12pt">GPs will be </span><span style="font-family:Garamond; font-size:12pt">asked to look at</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and they will not be critically looking at their </span><span style="font-family:Garamond; font-size:12pt">antibiotic prescribing. </span><span style="font-family:Garamond; font-size:12pt">Dame Sally Davies</span><span style="font-family:Garamond; font-size:12pt">’s</span><span style="font-family:Garamond; font-size:12pt"> annual report highlighting antimicrobial resistance is really helpful and the strategy is helpful, but these are words on paper in Government offices and they do not </span><span style="font-family:Garamond; font-size:12pt">really filter down </span><span style="font-family:Garamond; font-size:12pt">to the man or woman behind the desk with the prescribing pad.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q55 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> How do you change that—b</span><span style="font-family:Garamond; font-size:12pt">y the assessor making it more of a priority? </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: The mechanism for change would be </span><span style="font-family:Garamond; font-size:12pt">somehow </span><span style="font-family:Garamond; font-size:12pt">to </span><span style="font-family:Garamond; font-size:12pt">raise the priority level so that it is discussed in the ap</span><span style="font-family:Garamond; font-size:12pt">praisal process and people </span><span style="font-family:Garamond; font-size:12pt">take up educational initiatives.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q56 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Who is responsible for raising that priority?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I do not know the mechanism, but you have someone </span><span style="font-family:Garamond; font-size:12pt">here </span><span style="font-family:Garamond; font-size:12pt">who knows the answer to that.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: O</span><span style="font-family:Garamond; font-size:12pt">ne of the points being made is </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">we have, I believe, an ambitious and very important strategy, but we must not underestimate the enormity of the challenge of implementing </span><span style="font-family:Garamond; font-size:12pt">it,</span><span style="font-family:Garamond; font-size:12pt"> and making the changes required nationally and internationally for what is a very significant problem. </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">hat Dr Moore has also highlighted is the gap between the strategy and its ambitions and the greater opportunity with implementation </span><span style="font-family:Garamond; font-size:12pt">at ground level. </span><span style="font-family:Garamond; font-size:12pt">I echo some of that as a former GP </span><span style="font-family:Garamond; font-size:12pt">mys</span><span style="font-family:Garamond; font-size:12pt">elf. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">he new system of revalidat</span><span style="font-family:Garamond; font-size:12pt">ion</span><span style="font-family:Garamond; font-size:12pt"> for doctors in this country that the General Medical Council introduced earlier this year</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">which </span><span style="font-family:Garamond; font-size:12pt">in </span><span style="font-family:Garamond; font-size:12pt">the responsible officer part of my role I am responsib</span><span style="font-family:Garamond; font-size:12pt">le for in Public Health England—</span><span style="font-family:Garamond; font-size:12pt">provide</span><span style="font-family:Garamond; font-size:12pt">s </span><span style="font-family:Garamond; font-size:12pt">a really good opportunity</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">to strengthen the appraisal process. A significant part of that</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">I am already seeing it through in the new style of appraisals that are required annually for every consultant, specialist and GP</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">is greater attention to continue</span><span style="font-family:Garamond; font-size:12pt">d professional development. But,</span><span style="font-family:Garamond; font-size:12pt"> to my knowledge at the moment, there is not a way of specifying, </span><span style="font-family:Garamond; font-size:12pt">whichever specialty you are in—</span><span style="font-family:Garamond; font-size:12pt">public health ph</span><span style="font-family:Garamond; font-size:12pt">ysician or general practitioner—</span><span style="font-family:Garamond; font-size:12pt">what should be in the CPD, what you should be doing. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hat is an opportunity. The </span><span style="font-family:Garamond; font-size:12pt">Royal C</span><span style="font-family:Garamond; font-size:12pt">olleges and the Faculty of Public Health have a part</span><span style="font-family:Garamond; font-size:12pt"> to play in that, and I think i</span><span style="font-family:Garamond; font-size:12pt">t is an interesting idea.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q57 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">By mandating it, by making it obligatory.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Of influencing, yes.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q58 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> R</span><span style="font-family:Garamond; font-size:12pt">evalidation, the appraisal system as it stands at the moment, will be different depending on who is carrying out that appraisal. It does not contain the same</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt"> </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Yes and no. The appraisal process, whichever specialty of medic</span><span style="font-family:Garamond; font-size:12pt">ine you are in—</span><span style="font-family:Garamond; font-size:12pt">whether you are a microbiologist, a general practitioner or </span><span style="font-family:Garamond; font-size:12pt">a public health physician—</span><span style="font-family:Garamond; font-size:12pt">covers the same domains of medical practice and areas of importance</span><span style="font-family:Garamond; font-size:12pt">. </span><span style="font-family:Garamond; font-size:12pt">When you go into the details of it with your appraiser, you will focus on the area</span><span style="font-family:Garamond; font-size:12pt"> relevant to your specialty. </span><span style="font-family:Garamond; font-size:12pt">A</span><span style="font-family:Garamond; font-size:12pt">ntimicrobial resistance is obviously important whether you are a paediatrician, a public health physician, </span><span style="font-family:Garamond; font-size:12pt">or </span><span style="font-family:Garamond; font-size:12pt">a GP and so forth.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: T</span><span style="font-family:Garamond; font-size:12pt">here are enormous opportunities to use the appraisal and revalidation process</span><span style="font-family:Garamond; font-size:12pt">es</span><span style="font-family:Garamond; font-size:12pt">. </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e are </span><span style="font-family:Garamond; font-size:12pt">talking just about medics here, </span><span style="font-family:Garamond; font-size:12pt">but </span><span style="font-family:Garamond; font-size:12pt">I think </span><span style="font-family:Garamond; font-size:12pt">we can look at </span><span style="font-family:Garamond; font-size:12pt">the roles of all health professionals</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">in </span><span style="font-family:Garamond; font-size:12pt">this</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">O</span><span style="font-family:Garamond; font-size:12pt">ne opportunity is also framing this in terms of patient safety and the quality of care. </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">t does not need to be a technical</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> s</span><span style="font-family:Garamond; font-size:12pt">eparate little bit of expertise. I</span><span style="font-family:Garamond; font-size:12pt">t can be about the overall delivery of quality of care and patient safety</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and you can frame that bit of the appraisal to fit in addressing antimicrobial resistance as an aspect of patient safety and quality of care</span><span style="font-family:Garamond; font-size:12pt">. Y</span><span style="font-family:Garamond; font-size:12pt">ou can use that</span><span style="font-family:Garamond; font-size:12pt">, and </span><span style="font-family:Garamond; font-size:12pt">I think t</span><span style="font-family:Garamond; font-size:12pt">here are enormous opportunities.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">n fact</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> that addresses one of the issues about stakeholder engagement, which is not just all about stakeholder engagement with the public</span><span style="font-family:Garamond; font-size:12pt">, but </span><span style="font-family:Garamond; font-size:12pt">stakeholder engagement with other health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care professionals</span><span style="font-family:Garamond; font-size:12pt">. T</span><span style="font-family:Garamond; font-size:12pt">he appraisal and CPD mechanism may be a great opportunity.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q59 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Thank you for that. I take it, therefore, from your answers that there is at the moment no effective way of monitoring the use of ant</span><span style="font-family:Garamond; font-size:12pt">imicrobials within GP practices.</span><span style="font-family:Garamond; font-size:12pt"> There is no national monitoring going on.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">To some extent</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> there has been a policy to reduce the presc</span><span style="font-family:Garamond; font-size:12pt">ribing of some antibiotics that</span><span style="font-family:Garamond; font-size:12pt"> are associated with </span><span style="font-family:Garamond; font-size:12pt">C. </span><span style="font-family:Garamond; font-size:12pt">diff infections</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">quinolones</span><span style="font-family:Garamond; font-size:12pt"> and </span><span style="font-family:Garamond; font-size:12pt">cephalosporins</span><span style="font-family:Garamond; font-size:12pt">. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hose things have been m</span><span style="font-family:Garamond; font-size:12pt">onitored and fed back to practic</span><span style="font-family:Garamond; font-size:12pt">es and there has been quite a dramatic change in </span><span style="font-family:Garamond; font-size:12pt">the </span><span style="font-family:Garamond; font-size:12pt">prescribing </span><span style="font-family:Garamond; font-size:12pt">of those antibiotics </span><span style="font-family:Garamond; font-size:12pt">in primary care. </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">t is possible to specifically focus on an antibiotic and to deliver that through the quality mechanisms for primary care</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and to implement change</span><span style="font-family:Garamond; font-size:12pt">. I</span><span style="font-family:Garamond; font-size:12pt">t is not entirely true that there is no mechanism. It is simply that general antimicrobial stewardship has not been part of one of those approaches.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q60 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> It works on individual specified drugs at the moment, rather than taking a wider view of use generally.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Yes.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q61 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">With the examples you used </span><span style="font-family:Garamond; font-size:12pt">for</span><span style="font-family:Garamond; font-size:12pt"> C. diff, were </span><span style="font-family:Garamond; font-size:12pt">there </span><span style="font-family:Garamond; font-size:12pt">or are there any consequences if you discovered that someone was continually overprescribing that particular antimicrobial?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The feedb</span><span style="font-family:Garamond; font-size:12pt">ack takes the form of a traffic-</span><span style="font-family:Garamond; font-size:12pt">light chart</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and you are green, amber or red. I guess it is up to your professional standards</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> if you are persistently showing red on the traffic light</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> to change your behaviour or not, but there are n</span><span style="font-family:Garamond; font-size:12pt">ot any sanctions for people who</span><span style="font-family:Garamond; font-size:12pt"> do not change their behaviour.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q62 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Do you think there should be?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: T</span><span style="font-family:Garamond; font-size:12pt">he new mechanisms with CCGs are an opportunity</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because they are slightly more grounded in practice</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and I think that there will be greater pressures brought to bear as </span><span style="font-family:Garamond; font-size:12pt">a result of being in a CCG rather than a PCT</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> I am not a great fan of regulatory big</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">stick</span><span style="font-family:Garamond; font-size:12pt"> approaches</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but there may be a case for some kind of sanction for people </span><span style="font-family:Garamond; font-size:12pt">who</span><span style="font-family:Garamond; font-size:12pt"> persistently do that. </span><span style="font-family:Garamond; font-size:12pt">P</span><span style="font-family:Garamond; font-size:12pt">eople will always say</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">I did it in this instance</span><span style="font-family:Garamond; font-size:12pt">,”</span><span style="font-family:Garamond; font-size:12pt"> and you do not know</span><span style="font-family:Garamond; font-size:12pt"> what the drivers are; </span><span style="font-family:Garamond; font-size:12pt">you are not the clinician in the consultation</span><span style="font-family:Garamond; font-size:12pt">, and</span><span style="font-family:Garamond; font-size:12pt"> I think it is a mistake to have absolutes.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: I</span><span style="font-family:Garamond; font-size:12pt">t is a complex picture that you get in primary care</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">the same goes for secondary care</span><span style="font-family:Garamond; font-size:12pt">, to get a picture for us—</span><span style="font-family:Garamond; font-size:12pt">on the amount of antimicrobial resistance</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e will want to look at antibiotic prescribing</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but also antibiotic usage</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which might not be the same as prescribing</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">A</span><span style="font-family:Garamond; font-size:12pt">lso the real end result, th</span><span style="font-family:Garamond; font-size:12pt">e amount of resistance </span><span style="font-family:Garamond; font-size:12pt">in infections in primary care</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which will be different from secondary care</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> is equally important. Again, we do not have at the moment all those surveillance systems set up optimally, but the strategy provides us with the opportunity to work towards those</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and we are. My experience has been that, thankfully, in this country we are not at a standing start in terms of our general surveillance systems for health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">associated</span><span style="font-family:Garamond; font-size:12pt"> infectio</span><span style="font-family:Garamond; font-size:12pt">ns and antimicrobial resistance. W</span><span style="font-family:Garamond; font-size:12pt">e have one of the best sets of systems in the world</span><span style="font-family:Garamond; font-size:12pt">, and my experience, </span><span style="font-family:Garamond; font-size:12pt">travelling to other countries, is </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">often we are the envy. But we are thinking about ways that we can share good practice. I was recently with the chief medical officer at the World Innovation Summit for Health conference. We were talking about ways that different countries could share their good practices, fo</span><span style="font-family:Garamond; font-size:12pt">r instance around surveillance—</span><span style="font-family:Garamond; font-size:12pt">both high i</span><span style="font-family:Garamond; font-size:12pt">ncome and low income countries—</span><span style="font-family:Garamond; font-size:12pt">which is I think something we have to do.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: I want to raise an</span><span style="font-family:Garamond; font-size:12pt"> issue about the critical role of pharmacists</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">ith some of the changes</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> it is not quite so clear what their roles are now in primary care. Within secondary care</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> the role of our pharmacists is absolutely critical in working in a multidisciplinary way to address this issue</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">looking at prescribing, </span><span style="font-family:Garamond; font-size:12pt">monitoring prescribing</span><span style="font-family:Garamond; font-size:12pt"> and </span><span style="font-family:Garamond; font-size:12pt">being involved in the f</span><span style="font-family:Garamond; font-size:12pt">eedback within the organisation</span><span style="font-family:Garamond; font-size:12pt"> so </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">prescribing can be performance</span><span style="font-family:Garamond; font-size:12pt">-</span><span style="font-family:Garamond; font-size:12pt">monitored at the level </span><span style="font-family:Garamond; font-size:12pt">of directorate, division, unit and</span><span style="font-family:Garamond; font-size:12pt"> individual</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e completely rely on our pharmacists to work with us in this</span><span style="font-family:Garamond; font-size:12pt">, and with the changes that</span><span style="font-family:Garamond; font-size:12pt"> will become clear in primary care. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">The other thing that is going to be important </span><span style="font-family:Garamond; font-size:12pt">for us </span><span style="font-family:Garamond; font-size:12pt">is that we address this as a whole health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care economy</span><span style="font-family:Garamond; font-size:12pt">, so that</span><span style="font-family:Garamond; font-size:12pt"> we are not addressing it in acute care and primary care but really bring</span><span style="font-family:Garamond; font-size:12pt">ing</span><span style="font-family:Garamond; font-size:12pt"> it together</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">t is completely artific</span><span style="font-family:Garamond; font-size:12pt">ial and </span><span style="font-family:Garamond; font-size:12pt">nonsense to do it </span><span style="font-family:Garamond; font-size:12pt">completely </span><span style="font-family:Garamond; font-size:12pt">separately.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q63 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Pamela Nash:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Dr Moore, you mentioned the horror story of someone contracting pneumonia after not being prescribed antibiotics</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and we know about the effect resistance is having on TB</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt">here in </span><span style="font-family:Garamond; font-size:12pt">London</span><span style="font-family:Garamond; font-size:12pt">, and gonorrhoea—</span><span style="font-family:Garamond; font-size:12pt">the two that we talk about. Are there other examples? Are these just horror stori</span><span style="font-family:Garamond; font-size:12pt">es? I am thinking of my family. </span><span style="font-family:Garamond; font-size:12pt">I am sure everyone in this room was </span><span style="font-family:Garamond; font-size:12pt">either </span><span style="font-family:Garamond; font-size:12pt">ill or had a family member who was ill over the Christmas break</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and many were running to the doctor. As a result of this inquiry, I spent a lot of time persuading my family members that they did not need to go to the doctor, and</span><span style="font-family:Garamond; font-size:12pt"> I even had a pharmacist</span><span style="font-family:Garamond; font-size:12pt"> trying to tell me to go to the doctor and get an antibiotic. </span><span style="font-family:Garamond; font-size:12pt">A</span><span style="font-family:Garamond; font-size:12pt">re these horror stories</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> or could you give us a better understanding of what the dangers are of not prescribing antibiotics?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: I</span><span style="font-family:Garamond; font-size:12pt">f you compare areas with high and low antibiotic prescribing in England</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">the evidence shows </span><span style="font-family:Garamond; font-size:12pt">that if you move to a lower prescribing area there are more episodes of infection </span><span style="font-family:Garamond; font-size:12pt">such as</span><span style="font-family:Garamond; font-size:12pt"> quinsy, which is a throat infection </span><span style="font-family:Garamond; font-size:12pt">that</span><span style="font-family:Garamond; font-size:12pt"> is a complication of a sore throat. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hey are very rare complications</span><span style="font-family:Garamond; font-size:12pt">, but if you prescribe less </span><span style="font-family:Garamond; font-size:12pt">you will se</span><span style="font-family:Garamond; font-size:12pt">e more of those complications. </span><span style="font-family:Garamond; font-size:12pt">The same applies to prescribing for chesty coughs or bronchitis. If you do less </span><span style="font-family:Garamond; font-size:12pt">prescribing, there will be a few more cases of pn</span><span style="font-family:Garamond; font-size:12pt">eumonia seen as a result. T</span><span style="font-family:Garamond; font-size:12pt">hose complications are rare and are usually treatable rather than untrea</span><span style="font-family:Garamond; font-size:12pt">table. I</span><span style="font-family:Garamond; font-size:12pt">f you move to </span><span style="font-family:Garamond; font-size:12pt">a lower prescribing environment, </span><span style="font-family:Garamond; font-size:12pt">y</span><span style="font-family:Garamond; font-size:12pt">ou will see, as a result</span><span style="font-family:Garamond; font-size:12pt">, a small increase in more serious infections</span><span style="font-family:Garamond; font-size:12pt">. T</span><span style="font-family:Garamond; font-size:12pt">hat will be a k</span><span style="font-family:Garamond; font-size:12pt">ind of consequence</span><span style="font-family:Garamond; font-size:12pt"> of that public health strategy. The positive side is that you are going to reduce antimicrobial resistance in the future</span><span style="font-family:Garamond; font-size:12pt">, and t</span><span style="font-family:Garamond; font-size:12pt">he future we might be looking at in 20 years</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt"> time is that</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> if you develop pneumonia</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> you will have an untreatable infection</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and that may be fatal</span><span style="font-family:Garamond; font-size:12pt">. T</span><span style="font-family:Garamond; font-size:12pt">here is a kind of a pay</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">off</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">but it</span><span style="font-family:Garamond; font-size:12pt"> is a difficult place to be</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> to say, </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">If we do this globally now, there will be a few more cases of pneumonia and serious infections</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but in the future we will have antibiotics which still work</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">f we just prescribe indiscriminately now, we will prevent a few of those infections</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but in the future we</span><span style="font-family:Garamond; font-size:12pt"> won’t</span><span style="font-family:Garamond; font-size:12pt"> be able to treat people.</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e need to be honest about that in the public debate about antibiotic prescribing</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and we need to be smarter about spotting</span><span style="font-family:Garamond; font-size:12pt"> the people who really need </span><span style="font-family:Garamond; font-size:12pt">antibiotics.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q64 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Pamela Nash:</span><span style="font-family:Garamond; font-size:12pt"> S</span><span style="font-family:Garamond; font-size:12pt">o</span><span style="font-family:Garamond; font-size:12pt"> so</span><span style="font-family:Garamond; font-size:12pt">me of this could be mitigated with better</span><span style="font-family:Garamond; font-size:12pt"> or alternative treatments.</span><span style="font-family:Garamond; font-size:12pt"> </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">There are various approaches to doing that</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and one of them, as I mentioned before, is the delayed prescription</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> where you say to somebody, </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">You do not need an antibiotic now, but</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> if you do not get better in four or five days</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt"> time, you do not have to come back and see me but you can take this prescription at that point.</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt"> That reduces prescribing in sore throats, say, from 90% down to about 40%. </span><span style="font-family:Garamond; font-size:12pt">Y</span><span style="font-family:Garamond; font-size:12pt">ou get much less antibiotic uptake by using that. You ne</span><span style="font-family:Garamond; font-size:12pt">ed to use strategies where you have what we call a </span><span style="font-family:Garamond; font-size:12pt">safety ne</span><span style="font-family:Garamond; font-size:12pt">t,</span><span style="font-family:Garamond; font-size:12pt"> which is </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">you say to people, </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">You do not need an antibiotic now, but these are the things that you need to look out for and I would want you to re</span><span style="font-family:Garamond; font-size:12pt">-</span><span style="font-family:Garamond; font-size:12pt">consult for.</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt"> In other words, if people are deteriorating or getting worse</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> they </span><span style="font-family:Garamond; font-size:12pt">should </span><span style="font-family:Garamond; font-size:12pt">seek further medical advice. Another strategy is to use near</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">patient</span><span style="font-family:Garamond; font-size:12pt"> tests</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">F</span><span style="font-family:Garamond; font-size:12pt">or instance, in people </span><span style="font-family:Garamond; font-size:12pt">who present </span><span style="font-family:Garamond; font-size:12pt">with chest infections, there i</span><span style="font-family:Garamond; font-size:12pt">s a near</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">patient</span><span style="font-family:Garamond; font-size:12pt"> test available that</span><span style="font-family:Garamond; font-size:12pt"> moderately increases your ability to detect or determine who does and does not need antibiotics, although the</span><span style="font-family:Garamond; font-size:12pt">re is a grey area in the middle; p</span><span style="font-family:Garamond; font-size:12pt">eople with very high scores almost certainly do need antibiotics and people with very low scores almos</span><span style="font-family:Garamond; font-size:12pt">t certainly do not, but there are</span><span style="font-family:Garamond; font-size:12pt"> still a number of pe</span><span style="font-family:Garamond; font-size:12pt">ople in the middle, o</span><span style="font-family:Garamond; font-size:12pt">n whom you are uncertain. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e can get smarter and </span><span style="font-family:Garamond; font-size:12pt">we can </span><span style="font-family:Garamond; font-size:12pt">use delayed prescribing, we can use effective safety net advice and we can use near</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">patient</span><span style="font-family:Garamond; font-size:12pt"> tests. </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">ith all of these things complications are rare but they are serious</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and that is one of t</span><span style="font-family:Garamond; font-size:12pt">he things that worries</span><span style="font-family:Garamond; font-size:12pt"> the prescriber and the patient </span><span style="font-family:Garamond; font-size:12pt">with</span><span style="font-family:Garamond; font-size:12pt"> bad symptoms </span><span style="font-family:Garamond; font-size:12pt">who is </span><span style="font-family:Garamond; font-size:12pt">seeing the doctor.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: M</span><span style="font-family:Garamond; font-size:12pt">oving fro</span><span style="font-family:Garamond; font-size:12pt">m primary care into acute care—</span><span style="font-family:Garamond; font-size:12pt">I am sure</span><span style="font-family:Garamond; font-size:12pt"> Susan will support me on this—</span><span style="font-family:Garamond; font-size:12pt">this is not something way in the future; it is something we are seeing now. </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">t is really important that we start shifting the public debate away from MRSA </span><span style="font-family:Garamond; font-size:12pt">bacter</span><span style="font-family:Garamond; font-size:12pt">a</span><span style="font-family:Garamond; font-size:12pt">emias</span><span style="font-family:Garamond; font-size:12pt"> and </span><span style="font-family:Garamond; font-size:12pt">C.difficile</span><span style="font-family:Garamond; font-size:12pt"> to looking at how we address antimicrobial resistance in our hospitals</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt">particularly the rise in </span><span style="font-family:Garamond; font-size:12pt">E.c</span><span style="font-family:Garamond; font-size:12pt">oli</span><span style="font-family:Garamond; font-size:12pt"> infections and some of the</span><span style="font-family:Garamond; font-size:12pt"> other gram negative infections and the resistance rate</span><span style="font-family:Garamond; font-size:12pt">s</span><span style="font-family:Garamond; font-size:12pt">. </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e need to </span><span style="font-family:Garamond; font-size:12pt">shift</span><span style="font-family:Garamond; font-size:12pt"> that so that we can actually start addressing this within our health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care services and have a whole</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">systems</span><span style="font-family:Garamond; font-size:12pt"> approach </span><span style="font-family:Garamond; font-size:12pt">a</span><span style="font-family:Garamond; font-size:12pt">rou</span><span style="font-family:Garamond; font-size:12pt">nd it, but we really </span><span style="font-family:Garamond; font-size:12pt">need to move from looking at those two to looking at antimicrobial resistance in a more comprehensive way.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">That is absolutely right. Working in public health, we are constantly having to weigh up </span><span style="font-family:Garamond; font-size:12pt">that balance </span><span style="font-family:Garamond; font-size:12pt">between what might be in the population</span><span style="font-family:Garamond; font-size:12pt">’s</span><span style="font-family:Garamond; font-size:12pt"> health</span><span style="font-family:Garamond; font-size:12pt"> interests—</span><span style="font-family:Garamond; font-size:12pt">nationally </span><span style="font-family:Garamond; font-size:12pt">but also the global population—</span><span style="font-family:Garamond; font-size:12pt">which is undoubtedly to reduce antimicrobial resistance, which will involve reducing antibiotic prescribing and certainly reducing </span><span style="font-family:Garamond; font-size:12pt">inappr</span><span style="font-family:Garamond; font-size:12pt">opriate antibiotic prescribing, </span><span style="font-family:Garamond; font-size:12pt">against the individual person</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s interests. Arguably, on an individual person basis, actually not receiving an antibiotic which is of no use to you is probably a good thing anyway, but there will be cases where that does not happen, albeit thankfully rare. The near</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">point</span><span style="font-family:Garamond; font-size:12pt"> diagnostics </span><span style="font-family:Garamond; font-size:12pt">that could tell you in the doctor</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s surgery whether the infection the patient next to you </span><span style="font-family:Garamond; font-size:12pt">has </span><span style="font-family:Garamond; font-size:12pt">is viral and will not benefit from an antibiotic</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> or </span><span style="font-family:Garamond; font-size:12pt">is </span><span style="font-family:Garamond; font-size:12pt">bacterial and will</span><span style="font-family:Garamond; font-size:12pt">, will</span><span style="font-family:Garamond; font-size:12pt"> be i</span><span style="font-family:Garamond; font-size:12pt">nvaluable, hence the importance—</span><span style="font-family:Garamond; font-size:12pt">it is mentioned, I think, in the </span><span style="font-family:Garamond; font-size:12pt">strategy and in our submission—</span><span style="font-family:Garamond; font-size:12pt">of more research around that.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q65 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> I</span><span style="font-family:Garamond; font-size:12pt">n a hospital environment is there not a tension between the clinical desire to deal with every patient as an individual and the big corporate view that</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">We must n</span><span style="font-family:Garamond; font-size:12pt">ot have our statistics look bad”</span><span style="font-family:Garamond; font-size:12pt">?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">That is spot on. That is why we need these processes, structures and leadership within trusts to understand the</span><span style="font-family:Garamond; font-size:12pt"> risks and that tension, but i</span><span style="font-family:Garamond; font-size:12pt">t is also why</span><span style="font-family:Garamond; font-size:12pt">—as we were discussing earlier—</span><span style="font-family:Garamond; font-size:12pt">we should not be talking just about antibiotic control. It is about access to effective antibiotics, so we need to make sure that our sick patients get antibiotics im</span><span style="font-family:Garamond; font-size:12pt">mediately when they need them. </span><span style="font-family:Garamond; font-size:12pt">There can be no blocks to that. But then we have the opportunity to review, step down, narrow the spectrum, stop, IV to oral, all those things, and they need to be part of the process. Earlier on</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> we were talking about the risk at the individual level in terms of antibiotic resistance and the risk at the societal level of antibiotic resistance.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">The other issue for us within hospita</span><span style="font-family:Garamond; font-size:12pt">ls of course is </span><span style="font-family:Garamond; font-size:12pt">C.difficile</span><span style="font-family:Garamond; font-size:12pt">—antibiotics driving </span><span style="font-family:Garamond; font-size:12pt">C.diff</span><span style="font-family:Garamond; font-size:12pt">—and </span><span style="font-family:Garamond; font-size:12pt">the risk</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">benefit</span><span style="font-family:Garamond; font-size:12pt">. W</span><span style="font-family:Garamond; font-size:12pt">e have a variety of ways of making sure that we minimise the amount of antibiotics we expose people to. B</span><span style="font-family:Garamond; font-size:12pt">ut you are absolutely right; that is a tension and i</span><span style="font-family:Garamond; font-size:12pt">t is managed every day in complex patients. It is something that has to be thought through. </span><span style="font-family:Garamond; font-size:12pt">Y</span><span style="font-family:Garamond; font-size:12pt">ou cannot walk away and think, </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">Actually, what I</span><span style="font-family:Garamond; font-size:12pt">’ll</span><span style="font-family:Garamond; font-size:12pt"> do is just leave this person on </span><span style="font-family:Garamond; font-size:12pt">so many antibiotics that I </span><span style="font-family:Garamond; font-size:12pt">cover everything. It does</span><span style="font-family:Garamond; font-size:12pt">n’t</span><span style="font-family:Garamond; font-size:12pt"> matter that we</span><span style="font-family:Garamond; font-size:12pt">’ll</span><span style="font-family:Garamond; font-size:12pt"> drive resistance, give the patien</span><span style="font-family:Garamond; font-size:12pt">t </span><span style="font-family:Garamond; font-size:12pt">C.diff</span><span style="font-family:Garamond; font-size:12pt"> and when they next have an infection we w</span><span style="font-family:Garamond; font-size:12pt">on’t</span><span style="font-family:Garamond; font-size:12pt"> be able to treat it.</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Y</span><span style="font-family:Garamond; font-size:12pt">ou have to weigh </span><span style="font-family:Garamond; font-size:12pt">up all of that </span><span style="font-family:Garamond; font-size:12pt">at the time you are treating the patient</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> with the possible collateral damage you will do to that patient then and in the future</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> as well as </span><span style="font-family:Garamond; font-size:12pt">to </span><span style="font-family:Garamond; font-size:12pt">the society and people around the</span><span style="font-family:Garamond; font-size:12pt">m.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: T</span><span style="font-family:Garamond; font-size:12pt">here is an important role for pharmacists, nurses and infection specialist</span><span style="font-family:Garamond; font-size:12pt">s in hospitals. You help</span><span style="font-family:Garamond; font-size:12pt"> to arbitrate the individual clinician who is responsible for the patient into lo</span><span style="font-family:Garamond; font-size:12pt">oking at the big picture and </span><span style="font-family:Garamond; font-size:12pt">basically say, </span><span style="font-family:Garamond; font-size:12pt">“Y</span><span style="font-family:Garamond; font-size:12pt">es, I understand that you have treated this patient aggressively</span><span style="font-family:Garamond; font-size:12pt">, but now it’</span><span style="font-family:Garamond; font-size:12pt">s two days later, they are doing fine</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and we could do this.</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">It is about being able to have </span><span style="font-family:Garamond; font-size:12pt">structures in a hospital that help to bring down antimicrobial prescribing into the narrower spectrum that will treat the patient effectively</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> using the</span><span style="font-family:Garamond; font-size:12pt"> epidemiology that we know </span><span style="font-family:Garamond; font-size:12pt">is occurring in the hospital and the best for the patient. </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">t</span><span style="font-family:Garamond; font-size:12pt"> is about having those external-</span><span style="font-family:Garamond; font-size:12pt">internal pe</span><span style="font-family:Garamond; font-size:12pt">ople, if you like, who do not, potentially,</span><span style="font-family:Garamond; font-size:12pt"> have the same doctor</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">patient</span><span style="font-family:Garamond; font-size:12pt"> relationship but are looking a</span><span style="font-family:Garamond; font-size:12pt">t the best for that patient and </span><span style="font-family:Garamond; font-size:12pt">also the best for the population.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q66 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Pamela Nash:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">In the evidence that we have received so far, and indeed you mentioned it this </span><span style="font-family:Garamond; font-size:12pt">morning, there is variation </span><span style="font-family:Garamond; font-size:12pt">across England in terms of doctors prescribing antibiotics. Could you give us an idea of how much</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">what is the ra</span><span style="font-family:Garamond; font-size:12pt">nge of that variation—and,</span><span style="font-family:Garamond; font-size:12pt"> if any of you know</span><span style="font-family:Garamond; font-size:12pt">, whether</span><span style="font-family:Garamond; font-size:12pt"> that variation exists across the United Kingdom as well, not just England?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I will take a little bit of this, if that is okay. I have recently taken over the oversight group looking at the English surveillance programme for ant</span><span style="font-family:Garamond; font-size:12pt">imicrobial use and resistance. </span><span style="font-family:Garamond; font-size:12pt">As part of that, we have been gathering information at a CCG level from primary care and also from hospitals, but as a larger grouping of hospitals together, to understand what is happening in ecological levels across the country. </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e can see </span><span style="font-family:Garamond; font-size:12pt">that</span><span style="font-family:Garamond; font-size:12pt"> there is about a fivefold variation in prescribing across practices. Some of that can be explained by the age structure of the populations</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but some of it cannot. What we are looking at is trying to understand this information better: what particular antibiotics are being prescribed across the country? Is it related to deprivation? </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">here is some evidence that the more deprived populations have higher prescribing levels</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and that may be related to their co</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">mo</span><span style="font-family:Garamond; font-size:12pt">rbidities</span><span style="font-family:Garamond; font-size:12pt"> and smoking and so on. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e </span><span style="font-family:Garamond; font-size:12pt">also </span><span style="font-family:Garamond; font-size:12pt">know that we can help drive down prescribing if we are</span><span style="font-family:Garamond; font-size:12pt"> open and transparent about the</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">data. We need to understand it at Public Health England </span><span style="font-family:Garamond; font-size:12pt">and</span><span style="font-family:Garamond; font-size:12pt"> at</span><span style="font-family:Garamond; font-size:12pt"> prescribing levels across the country</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and then we need to feed that back</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> to explain to people, </span><span style="font-family:Garamond; font-size:12pt">“I</span><span style="font-family:Garamond; font-size:12pt">f one practice can do this</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> can we look and see what that practice is doing to drive down prescriptions?</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt"> Very much part of our aim at Public Health England is to </span><span style="font-family:Garamond; font-size:12pt">be open and transparent in</span><span style="font-family:Garamond; font-size:12pt"> looking at antimicrobial prescribing data across CCGs and across hospitals over the next year</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and the AMR strategy is helping to drive that.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: T</span><span style="font-family:Garamond; font-size:12pt">he funding that has been made available to look at some of these interesting aspects</span><span style="font-family:Garamond; font-size:12pt"> in the strategy—</span><span style="font-family:Garamond; font-size:12pt">particularly </span><span style="font-family:Garamond; font-size:12pt">to </span><span style="font-family:Garamond; font-size:12pt">develop applied </span><span style="font-family:Garamond; font-size:12pt">research—</span><span style="font-family:Garamond; font-size:12pt">will drive some of the research and address some of these important questions. The creation of health protection research units in this area will also help</span><span style="font-family:Garamond; font-size:12pt"> to</span><span style="font-family:Garamond; font-size:12pt"> address some of these questions.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: It is a</span><span style="font-family:Garamond; font-size:12pt">cross different countries</span><span style="font-family:Garamond; font-size:12pt">. W</span><span style="font-family:Garamond; font-size:12pt">e are obviously not the only country that sees this kind of variation in practice</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> Public Health England</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s c</span><span style="font-family:Garamond; font-size:12pt">ounterpart in America, the CDC—</span><span style="font-family:Garamond; font-size:12pt">the </span><span style="font-family:Garamond; font-size:12pt">Centers</span><span style="font-family:Garamond; font-size:12pt"> for Dis</span><span style="font-family:Garamond; font-size:12pt">ease Control and Prevention—</span><span style="font-family:Garamond; font-size:12pt">produced their report on antimicrobial resistance late last year, </span><span style="font-family:Garamond; font-size:12pt">in </span><span style="font-family:Garamond; font-size:12pt">autumn 2013, and one of the quite striking maps shows almost double the problem of antimicrobial resistance antibio</span><span style="font-family:Garamond; font-size:12pt">tic prescribing </span><span style="font-family:Garamond; font-size:12pt">between states in south</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">east United States and the west coast and California. There are various reasons discus</span><span style="font-family:Garamond; font-size:12pt">sed, but again you see </span><span style="font-family:Garamond; font-size:12pt">a variation in practice and in seriousness</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which reminds us that the factors that influence prescribing and antimicrobial r</span><span style="font-family:Garamond; font-size:12pt">esistance are complex. T</span><span style="font-family:Garamond; font-size:12pt">hey are professional factors about doctors and their prescr</span><span style="font-family:Garamond; font-size:12pt">ibing and lots of other factors, </span><span style="font-family:Garamond; font-size:12pt">but also public awareness. I think we touched on it in the previous qu</span><span style="font-family:Garamond; font-size:12pt">estion. I believe there is </span><span style="font-family:Garamond; font-size:12pt">a responsibility on </span><span style="font-family:Garamond; font-size:12pt">the </span><span style="font-family:Garamond; font-size:12pt">public around demands for antibiotics</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and we experience this in the general practice room where you have a very short consultation and can be pressed on receiving an antibiotic. That is a real ground</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">level</span><span style="font-family:Garamond; font-size:12pt"> issue, hence </span><span style="font-family:Garamond; font-size:12pt">again the importance </span><span style="font-family:Garamond; font-size:12pt">in the strategy of greater improving </span><span style="font-family:Garamond; font-size:12pt">of </span><span style="font-family:Garamond; font-size:12pt">awareness and understanding among the public of antimicrobial resistance.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q67 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Pamela Nash:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Professor, you just touched on my next point. We have discussed the variation in prescrip</span><span style="font-family:Garamond; font-size:12pt">tion and the fact that in </span><span style="font-family:Garamond; font-size:12pt">areas with more prescription there is some increased infection, but the Society of Biology has given us evidence that resistance is still increasing across the country</span><span style="font-family:Garamond; font-size:12pt">. I</span><span style="font-family:Garamond; font-size:12pt">s there variation in resistance</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and do we have enough information yet to say that </span><span style="font-family:Garamond; font-size:12pt">in </span><span style="font-family:Garamond; font-size:12pt">areas where prescribing antibiotics has been curtailed resistance </span><span style="font-family:Garamond; font-size:12pt">is </span><span style="font-family:Garamond; font-size:12pt">receding</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> or is it still continuing to rise at the same rate?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The first thing to say is that</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> predominantly in the </span><span style="font-family:Garamond; font-size:12pt">UK</span><span style="font-family:Garamond; font-size:12pt"> and in </span><span style="font-family:Garamond; font-size:12pt">England</span><span style="font-family:Garamond; font-size:12pt"> over the last 10 years, </span><span style="font-family:Garamond; font-size:12pt">we have monitored bacter</span><span style="font-family:Garamond; font-size:12pt">a</span><span style="font-family:Garamond; font-size:12pt">emi</span><span style="font-family:Garamond; font-size:12pt">a surveillance, which is the tip of the iceberg, and </span><span style="font-family:Garamond; font-size:12pt">b</span><span style="font-family:Garamond; font-size:12pt">acter</span><span style="font-family:Garamond; font-size:12pt">a</span><span style="font-family:Garamond; font-size:12pt">emias</span><span style="font-family:Garamond; font-size:12pt"> do not occur in primary care. By and large, if somebody is sick with a blood culture infection or sepsis, the</span><span style="font-family:Garamond; font-size:12pt">y are in hospital. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">M</span><span style="font-family:Garamond; font-size:12pt">ore recently</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> over the last couple of years</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">we have </span><span style="font-family:Garamond; font-size:12pt">developed a surveillance system to look at all microbiology samples from microbiology laboratories</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and we have now almost achieved a 60% uptake of laboratories across the country reporting centrally to Public Health </span><span style="font-family:Garamond; font-size:12pt">England</span><span style="font-family:Garamond; font-size:12pt">. That is from samples such as urine, which are a really good marker for what is happening in the community</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and sputum samples as well. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hat is the surveillance system that will help give us the early warning signals. In some areas, such as the west midlands</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> 100% of the laboratory data </span><span style="font-family:Garamond; font-size:12pt">are </span><span style="font-family:Garamond; font-size:12pt">being reported, so we know exactly what is ha</span><span style="font-family:Garamond; font-size:12pt">ppening in that. In other areas,</span><span style="font-family:Garamond; font-size:12pt"> there are resources being put in by Publi</span><span style="font-family:Garamond; font-size:12pt">c Health </span><span style="font-family:Garamond; font-size:12pt">England</span><span style="font-family:Garamond; font-size:12pt"> to improve </span><span style="font-family:Garamond; font-size:12pt">surveillance</span><span style="font-family:Garamond; font-size:12pt">.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">U</span><span style="font-family:Garamond; font-size:12pt">ntil we have robust surveillance systems collecting laboratory data</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> we do not know where our gaps are. Our priority over the next year is to improve that</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> to make sure </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">60% of lab</span><span style="font-family:Garamond; font-size:12pt">s</span><span style="font-family:Garamond; font-size:12pt"> are reporting</span><span style="font-family:Garamond; font-size:12pt"> and</span><span style="font-family:Garamond; font-size:12pt"> to get that to 70% to 80%</span><span style="font-family:Garamond; font-size:12pt">, so that we know we have </span><span style="font-family:Garamond; font-size:12pt">good coverage and that we have developed our early warning systems. But with that</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> we need hospitals and laboratories to work with us to make sure that they can give us the data</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e need hospital laboratory systems to be updated to modern IT so that they can transmit the message</span><span style="font-family:Garamond; font-size:12pt"> to us</span><span style="font-family:Garamond; font-size:12pt">. </span><span style="font-family:Garamond; font-size:12pt">We cannot have outdated systems; i</span><span style="font-family:Garamond; font-size:12pt">f we have old IT systems</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> they will not communi</span><span style="font-family:Garamond; font-size:12pt">cate with more modern ones. I</span><span style="font-family:Garamond; font-size:12pt">t is everyone working together</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">Public Health England can develop a surveillance sy</span><span style="font-family:Garamond; font-size:12pt">stem. H</span><span style="font-family:Garamond; font-size:12pt">ospitals need to help us engage with that so </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">we know what is happening at the ground level.</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Pamela Nash:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Thank you. That is important.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">In primary care there is not a history of sampling. </span><span style="font-family:Garamond; font-size:12pt">For</span><span style="font-family:Garamond; font-size:12pt"> most people who come</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> we do not take microbiological samples. When you do take samples</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> it is when there are complicated cases, </span><span style="font-family:Garamond; font-size:12pt">where </span><span style="font-family:Garamond; font-size:12pt">people have </span><span style="font-family:Garamond; font-size:12pt">had a course of antibiotics, </span><span style="font-family:Garamond; font-size:12pt">the infection has not improved and they have come back with a urine in</span><span style="font-family:Garamond; font-size:12pt">fection, say, for a third time, </span><span style="font-family:Garamond; font-size:12pt">and you send a sample off at that stage. </span><span style="font-family:Garamond; font-size:12pt">The routine samples that</span><span style="font-family:Garamond; font-size:12pt"> come from primary care are not representative of the global picture. One of the </span><span style="font-family:Garamond; font-size:12pt">missing </span><span style="font-family:Garamond; font-size:12pt">pieces of the jigsaw is a systematic sampling of all routine cases</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and </span><span style="font-family:Garamond; font-size:12pt">I think that is something </span><span style="font-family:Garamond; font-size:12pt">we could develop for the future so that you used a number of sites across the UK to routinely sample everybody who presented with particular conditions</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which would give you a much better idea of the rates of antibiotic resistance in the bacteria isolated in the general population, whereas at the m</span><span style="font-family:Garamond; font-size:12pt">oment your sample is from </span><span style="font-family:Garamond; font-size:12pt">complicated cases</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so you will not get a true picture of the ant</span><span style="font-family:Garamond; font-size:12pt">imicrobial resistance. T</span><span style="font-family:Garamond; font-size:12pt">ha</span><span style="font-family:Garamond; font-size:12pt">t is a gap that could be filled.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: M</span><span style="font-family:Garamond; font-size:12pt">easuring the amount of antimicrobial resistance in primary and secondary care</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">is complex. There are definitely gaps</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and Dr Moor</span><span style="font-family:Garamond; font-size:12pt">e has highlighted one. F</span><span style="font-family:Garamond; font-size:12pt">rom an already good start in terms of our surveillance in this country, I am confident, because we </span><span style="font-family:Garamond; font-size:12pt">have already made a significant</span><span style="font-family:Garamond; font-size:12pt"> start in Public Hea</span><span style="font-family:Garamond; font-size:12pt">lth England, that in </span><span style="font-family:Garamond; font-size:12pt">a r</span><span style="font-family:Garamond; font-size:12pt">elatively short period of time—a few years—</span><span style="font-family:Garamond; font-size:12pt">we will have even stronger systems in place. They will not necessarily have answered all the questions, and this particular one may take longer, but </span><span style="font-family:Garamond; font-size:12pt">there will be </span><span style="font-family:Garamond; font-size:12pt">even stronger surveillance systems</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so we can speak even more clearly about the amount of the problem in this country. I do not know about the Society of Biology</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s re</span><span style="font-family:Garamond; font-size:12pt">port, but if you could share i</span><span style="font-family:Garamond; font-size:12pt">t with us we could respond in a written manner to the Committee because I do not know what they are referring to.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q68 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Pamela Nash:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I think there is someone in the room who might be able to do that. Just before I move on to my last point, Professor </span><span style="font-family:Garamond; font-size:12pt">Kessel</span><span style="font-family:Garamond; font-size:12pt">, you mentioned the </span><span style="font-family:Garamond; font-size:12pt">US</span><span style="font-family:Garamond; font-size:12pt">. T</span><span style="font-family:Garamond; font-size:12pt">here was evidence that</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">where </span><span style="font-family:Garamond; font-size:12pt">there was a variation in areas where antibiotics, the prescription, had been curtailed</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> there was a reduction in resistance. Is that correct?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">There is almost a twofold difference between states in the amount of the problem of antimicrobial resistance and prescribing practice between states in the south</span><span style="font-family:Garamond; font-size:12pt">-</span><span style="font-family:Garamond; font-size:12pt">east.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q69 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Pamela Nash:</span><span style="font-family:Garamond; font-size:12pt"> But those </span><span style="font-family:Garamond; font-size:12pt">two</span><span style="font-family:Garamond; font-size:12pt"> figures </span><span style="font-family:Garamond; font-size:12pt">correla</span><span style="font-family:Garamond; font-size:12pt">te. The data where resistance exists correlate</span><span style="font-family:Garamond; font-size:12pt"> with prescribing.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">That is right. I have that here </span><span style="font-family:Garamond; font-size:12pt">i</span><span style="font-family:Garamond; font-size:12pt">n my pile of supporting material</span><span style="font-family:Garamond; font-size:12pt">, and I am happy to share i</span><span style="font-family:Garamond; font-size:12pt">t or send the report through afterwards. It came out as the CDC</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s publication came out in the autumn </span><span style="font-family:Garamond; font-size:12pt">of </span><span style="font-family:Garamond; font-size:12pt">last year.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q70 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Pamela Nash:</span><span style="font-family:Garamond; font-size:12pt"> My final point </span><span style="font-family:Garamond; font-size:12pt">cover</span><span style="font-family:Garamond; font-size:12pt">s</span><span style="font-family:Garamond; font-size:12pt"> the fact that there is variation across the world, as we have touched on, in antibiotics</span><span style="font-family:Garamond; font-size:12pt">; </span><span style="font-family:Garamond; font-size:12pt">indeed</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> in many countries we can buy them over the counter.</span><span style="font-family:Garamond; font-size:12pt"> How will that affect us</span><span style="font-family:Garamond; font-size:12pt"> in the United Kingdom</span><span style="font-family:Garamond; font-size:12pt">, and how significantly will i</span><span style="font-family:Garamond; font-size:12pt">t undermine our efforts here in the UK?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The scope of the problem internationally is absolutely huge. </span><span style="font-family:Garamond; font-size:12pt">It is not only our own strategy; o</span><span style="font-family:Garamond; font-size:12pt">ne of the things</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">the work of the chief medical officer over the last three or f</span><span style="font-family:Garamond; font-size:12pt">our years has done, </span><span style="font-family:Garamond; font-size:12pt">wh</span><span style="font-family:Garamond; font-size:12pt">ich has been hugely influential,</span><span style="font-family:Garamond; font-size:12pt"> has been to dramatically raise the profile of antimicrobial resistance as an issue internationally. Last year at the World Health Assembly</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which I attended</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> there was a session on AMR that there had not been before. There is planned to be a new resolution at the World Health Assembly next May. There is a whole range of other international activities going on. We are doing a lot of work with Public Health England</span><span style="font-family:Garamond; font-size:12pt"> and </span><span style="font-family:Garamond; font-size:12pt">the CMO and her team with the Commonwealth about twinning countries</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">higher income, lower income countries</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">around laboratory and antimicrobial resistance issu</span><span style="font-family:Garamond; font-size:12pt">es. There is a huge amount of attention that</span><span style="font-family:Garamond; font-size:12pt"> did not exist to the degree it </span><span style="font-family:Garamond; font-size:12pt">does</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">now </span><span style="font-family:Garamond; font-size:12pt">just three or four years </span><span style="font-family:Garamond; font-size:12pt">ago, </span><span style="font-family:Garamond; font-size:12pt">even when I started at the Health Protection Agency. That attention internationally was not there.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q71 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">On the BBC programme on regional television the night before last that I referred</span><span style="font-family:Garamond; font-size:12pt"> to in my introductory remarks,</span><span style="font-family:Garamond; font-size:12pt"> a clinician was arguing in favour of screening for the resistant form of TB from certain populations. Do you think that is a serious proposition</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">people moving into the country from particular countries</span><span style="font-family:Garamond; font-size:12pt">?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I might ask a colleague on that. I realise I did not quite answ</span><span style="font-family:Garamond; font-size:12pt">er your question about over-the-</span><span style="font-family:Garamond; font-size:12pt">c</span><span style="font-family:Garamond; font-size:12pt">ounter medicines; we know that i</span><span style="font-family:Garamond; font-size:12pt">t is a significant</span><span style="font-family:Garamond; font-size:12pt"> issue in a number of countries—s</span><span style="font-family:Garamond; font-size:12pt">ome of the high popul</span><span style="font-family:Garamond; font-size:12pt">ation, lower resource countries.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">n </span><span style="font-family:Garamond; font-size:12pt">India</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> they have been doi</span><span style="font-family:Garamond; font-size:12pt">ng a lot of work to change over-the-</span><span style="font-family:Garamond; font-size:12pt">counter provision of medicines</span><span style="font-family:Garamond; font-size:12pt">, but of course i</span><span style="font-family:Garamond; font-size:12pt">t is a problem. If you can just go and get an antibiotic over the counter, it may well be an antibiotic that is not necessary. One of the huge challenges there is </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">in those kinds of </span><span style="font-family:Garamond; font-size:12pt">settings that might be your only way to get a valuable treatment. So the work that needs to be done has to be done in conjunction with improving primary care infrastructure and so forth, but there is a huge amount of work going on </span><span style="font-family:Garamond; font-size:12pt">internationally to raise that in</span><span style="font-family:Garamond; font-size:12pt"> the agenda, which is incredibly valuable. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Could I just say one other thing about over the counter</span><span style="font-family:Garamond; font-size:12pt">, and then talk about screening, b</span><span style="font-family:Garamond; font-size:12pt">ut bring it to the scr</span><span style="font-family:Garamond; font-size:12pt">eening of antibiotic resistance</span><span style="font-family:Garamond; font-size:12pt"> particularly in bact</span><span style="font-family:Garamond; font-size:12pt">erial infections rather than TB?</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">F</span><span style="font-family:Garamond; font-size:12pt">irst</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> in the </span><span style="font-family:Garamond; font-size:12pt">UK</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> we have v</span><span style="font-family:Garamond; font-size:12pt">ery tight regulation about over- the-</span><span style="font-family:Garamond; font-size:12pt">counter prescribing</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but your question was </span><span style="font-family:Garamond; font-size:12pt">on the impact of over-the-</span><span style="font-family:Garamond; font-size:12pt">counter prescribing around the wor</span><span style="font-family:Garamond; font-size:12pt">ld when it is a global problem. W</span><span style="font-family:Garamond; font-size:12pt">e are</span><span style="font-family:Garamond; font-size:12pt"> talking locally and nationally</span><span style="font-family:Garamond; font-size:12pt"> but it is a global problem. There has been a huge amount of work done on this, particularly in </span><span style="font-family:Garamond; font-size:12pt">India</span><span style="font-family:Garamond; font-size:12pt"> with the Chennai D</span><span style="font-family:Garamond; font-size:12pt">eclaration. Their first proposal for antibiotic control was </span><span style="font-family:Garamond; font-size:12pt">unpragmatic</span><span style="font-family:Garamond; font-size:12pt"> and not deliverable</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because of the is</span><span style="font-family:Garamond; font-size:12pt">sue about tight control of over-the-</span><span style="font-family:Garamond; font-size:12pt">counter antibiotics. When we actually talk about access to antibiotics, that might be the only place people can access antibiotics</span><span style="font-family:Garamond; font-size:12pt">, s</span><span style="font-family:Garamond; font-size:12pt">o the more pragmatic approach was a step</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">wise</span><span style="font-family:Garamond; font-size:12pt"> progression of the antibiotics that had to be regulated and the ones that were still over the counter</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and that has now been introduced. I think it was introduced in August. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">he work in Ind</span><span style="font-family:Garamond; font-size:12pt">ia has been quite extraordinary.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">n terms of the question about screening</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt">we are particularly concerned about severe antibiotic resistance being brought in</span><span style="font-family:Garamond; font-size:12pt">;</span><span style="font-family:Garamond; font-size:12pt"> indeed there is a document that has been released</span><span style="font-family:Garamond; font-size:12pt"> recently </span><span style="font-family:Garamond; font-size:12pt">advising hospitals what best to do about screening. We are ve</span><span style="font-family:Garamond; font-size:12pt">ry conscious of the issue </span><span style="font-family:Garamond; font-size:12pt">when patients come in from intensive care units from other places, from hospitals from other places, or even </span><span style="font-family:Garamond; font-size:12pt">when they are just </span><span style="font-family:Garamond; font-size:12pt">involved in health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care in other places</span><span style="font-family:Garamond; font-size:12pt">, and the need to screen </span><span style="font-family:Garamond; font-size:12pt">is being recommended, but Susan may want to say a bit more about the policy.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Yes. Public Health </span><span style="font-family:Garamond; font-size:12pt">England</span><span style="font-family:Garamond; font-size:12pt"> has generated screen</span><span style="font-family:Garamond; font-size:12pt">ing guidelines for </span><span style="font-family:Garamond; font-size:12pt">carbapenem</span><span style="font-family:Garamond; font-size:12pt"> resistance</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which is really important for people coming from overseas</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt">seeking health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care </span><span style="font-family:Garamond; font-size:12pt">here, </span><span style="font-family:Garamond; font-size:12pt">or after having health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care abroad </span><span style="font-family:Garamond; font-size:12pt">in</span><span style="font-family:Garamond; font-size:12pt"> one form or another</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Those </span><span style="font-family:Garamond; font-size:12pt">are the patients </span><span style="font-family:Garamond; font-size:12pt">who </span><span style="font-family:Garamond; font-size:12pt">can transmit</span><span style="font-family:Garamond; font-size:12pt"> and cause an epidemic of multi</span><span style="font-family:Garamond; font-size:12pt">drug resistant bacteria within a hospital setting</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and that is where we have been focusing </span><span style="font-family:Garamond; font-size:12pt">a </span><span style="font-family:Garamond; font-size:12pt">lot of our attention</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because obviously that would be a new transmission event and a very dangerous form of in</span><span style="font-family:Garamond; font-size:12pt">fection—gram negative infections—</span><span style="font-family:Garamond; font-size:12pt">within hospitals</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> rapidly developing resistance to, essentially, all first, second and third</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">line</span><span style="font-family:Garamond; font-size:12pt"> available </span><span style="font-family:Garamond; font-size:12pt">antibiotics, leaving us with old and</span><span style="font-family:Garamond; font-size:12pt"> poor available drugs. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">You also mentioned TB. </span><span style="font-family:Garamond; font-size:12pt">I think tuberculosis has had a long history in </span><span style="font-family:Garamond; font-size:12pt">the UK of slow, simmering rates,</span><span style="font-family:Garamond; font-size:12pt"> and higher rates in London where there are higher populations from overseas, so we have about 3,500 cases </span><span style="font-family:Garamond; font-size:12pt">a year </span><span style="font-family:Garamond; font-size:12pt">in London</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and about </span><span style="font-family:Garamond; font-size:12pt">1.5% to 1.7% of those are multi</span><span style="font-family:Garamond; font-size:12pt">drug resistant, so resistant to two of our major first</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">line</span><span style="font-family:Garamond; font-size:12pt"> drugs. That has not changed that much over</span><span style="font-family:Garamond; font-size:12pt"> the last 10 years actually; </span><span style="font-family:Garamond; font-size:12pt">we have had a slow, steady rate</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> between 1% and 2%</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> of drug resistance. It is important that we ensure that patients with symptoms are screened as necessary</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Port health screening </span><span style="font-family:Garamond; font-size:12pt">is organised for individuals who have symptoms of TB coming </span><span style="font-family:Garamond; font-size:12pt">in</span><span style="font-family:Garamond; font-size:12pt">to the </span><span style="font-family:Garamond; font-size:12pt">UK, and there is a questionnaire for those from </span><span style="font-family:Garamond; font-size:12pt">countries that are</span><span style="font-family:Garamond; font-size:12pt"> high risk.</span><span style="font-family:Garamond; font-size:12pt"> It is important that we have good microbiology services</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so that if people present</span><span style="font-family:Garamond; font-size:12pt"> we diagnose multi</span><span style="font-family:Garamond; font-size:12pt">drug resistant TB fast and accurately</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hat is available through Public Health England</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s tuberculos</span><span style="font-family:Garamond; font-size:12pt">is national reference lab</span><span style="font-family:Garamond; font-size:12pt"> to any laboratory in the country</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so any laboratory can request that test for a fast turnaround on any patient </span><span style="font-family:Garamond; font-size:12pt">with </span><span style="font-family:Garamond; font-size:12pt">suspected</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">tuberculosis.</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">We are running a tad behind time, so can colleagues speed things up a bit?</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q72 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David Morris:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I think a lot of what you have already said has probably answered </span><span style="font-family:Garamond; font-size:12pt">this, but, in relation to </span><span style="font-family:Garamond; font-size:12pt">antimicrobial resistance, are existing diagnostics tests used effectively across the NHS? If not, why not? Do you think t</span><span style="font-family:Garamond; font-size:12pt">hat the diagnostic tests used for</span><span style="font-family:Garamond; font-size:12pt"> looking into diseases are actually pertinent to what we are doing to dish out antibiotics</span><span style="font-family:Garamond; font-size:12pt">, or do you </span><span style="font-family:Garamond; font-size:12pt">think we are </span><span style="font-family:Garamond; font-size:12pt">not </span><span style="font-family:Garamond; font-size:12pt">doing a good enough job of the diagnostics in the first place?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">There are two elements of diagnostics. Once a sample gets to th</span><span style="font-family:Garamond; font-size:12pt">e microbiology department, </span><span style="font-family:Garamond; font-size:12pt">we can say that the microbiology departments are accredited to p</span><span style="font-family:Garamond; font-size:12pt">erform the microbiology tests. </span><span style="font-family:Garamond; font-size:12pt">They have minimum standards </span><span style="font-family:Garamond; font-size:12pt">so </span><span style="font-family:Garamond; font-size:12pt">that they can do it</span><span style="font-family:Garamond; font-size:12pt">. If they are unsure about the </span><span style="font-family:Garamond; font-size:12pt">resu</span><span style="font-family:Garamond; font-size:12pt">lt</span><span style="font-family:Garamond; font-size:12pt">, they can send it to a national reference laboratory. The question is if there is no sample</span><span style="font-family:Garamond; font-size:12pt"> sent; as we have heard</span><span style="font-family:Garamond; font-size:12pt"> already, 80% of prescribing happens in primary care where the majority of patients have no samples performed at all</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and actually even if they did have a sample sent it would have little impact on that patient</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s antibiotic prescription because the result would take three to five days to get back to the general practitioner. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">There needs to be new development of easier</span><span style="font-family:Garamond; font-size:12pt"> point</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">of</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">care</span><span style="font-family:Garamond; font-size:12pt"> testing—testing </span><span style="font-family:Garamond; font-size:12pt">that will give rapid results. Some of that is happening to diagnose viral infections. For example, we know that there are now tests that we can use</span><span style="font-family:Garamond; font-size:12pt"> where we </span><span style="font-family:Garamond; font-size:12pt">take a nose swab and see if someone has a virus</span><span style="font-family:Garamond; font-size:12pt">, and if they have a virus </span><span style="font-family:Garamond; font-size:12pt">you can say that they do not ne</span><span style="font-family:Garamond; font-size:12pt">ed an antibiotic. </span><span style="font-family:Garamond; font-size:12pt">We need to develop it such that the GP can do that quite easily</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> at a cheap cost that is not goin</span><span style="font-family:Garamond; font-size:12pt">g to massively influence health care costs across this country,</span><span style="font-family:Garamond; font-size:12pt"> and deliver that at a p</span><span style="font-family:Garamond; font-size:12pt">rimary care level. A lot of development work is required on that. F</span><span style="font-family:Garamond; font-size:12pt">rom a hospital level, once the sample gets into the laboratory, and it is an approved, accredited</span><span style="font-family:Garamond; font-size:12pt"> laboratory in a hospital, </span><span style="font-family:Garamond; font-size:12pt">we can be pretty sure that that laboratory is performing the right tests.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q73 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David Morris:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Is there a central database that these tests can be fed into</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> to give you a mapping of where and when antibiotics should be used, or certain treatments?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: A</span><span style="font-family:Garamond; font-size:12pt">ntibiotics are used according to the clini</span><span style="font-family:Garamond; font-size:12pt">cal syndrome about the patient—</span><span style="font-family:Garamond; font-size:12pt">when the patient presents</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> what signs and symptoms they have. The microbiology helps focus our treatments down to narrow treatments</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> or widen them as necessary, so it helps us in </span><span style="font-family:Garamond; font-size:12pt">“Start Smart—Then Fo</span><span style="font-family:Garamond; font-size:12pt">cus</span><span style="font-family:Garamond; font-size:12pt">,”</span><span style="font-family:Garamond; font-size:12pt"> but it does not change what</span><span style="font-family:Garamond; font-size:12pt"> happens to the patient and the</span><span style="font-family:Garamond; font-size:12pt"> patient</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">doctor</span><span style="font-family:Garamond; font-size:12pt"> interaction on the front line.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The issue about the point of care is not just one for primary care. With the centralisation of microbiology laboratories</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> it is becoming more and more important sometimes that we get the diagnosis at the point of care, particularly in intensive care. </span><span style="font-family:Garamond; font-size:12pt">P</span><span style="font-family:Garamond; font-size:12pt">oint of care is very important in acute care as well as primary care</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so that we can get the results fast, rapidly, where we are looki</span><span style="font-family:Garamond; font-size:12pt">ng after the patient. I</span><span style="font-family:Garamond; font-size:12pt">nvesting in research in this technology is absolutely critical. </span><span style="font-family:Garamond; font-size:12pt">It shapes how we treat patients and</span><span style="font-family:Garamond; font-size:12pt"> improves outcome</span><span style="font-family:Garamond; font-size:12pt">s,</span><span style="font-family:Garamond; font-size:12pt"> and there is a lot more we could do there. </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q74 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Mosley:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Most of the focus </span><span style="font-family:Garamond; font-size:12pt">so far has been on the clinical and</span><span style="font-family:Garamond; font-size:12pt"> on the professional side</span><span style="font-family:Garamond; font-size:12pt">, but Professor Holmes, you </span><span style="font-family:Garamond; font-size:12pt">mention</span><span style="font-family:Garamond; font-size:12pt">ed</span><span style="font-family:Garamond; font-size:12pt"> there was a need for public debate. Do you, as a panel, think that </span><span style="font-family:Garamond; font-size:12pt">UK</span><span style="font-family:Garamond; font-size:12pt"> patients understand the threat posed by antimicrobial resistance and how their own actions contribute towards it?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I think some of them do. </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e have touched on some of the issues</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and perhaps we need to consider the issue about heal</span><span style="font-family:Garamond; font-size:12pt">th literacy and be a little </span><span style="font-family:Garamond; font-size:12pt">more analytical about that in its broader sense, not just about the antimicrobial resistance issue. I mentioned before that there is a lot of work </span><span style="font-family:Garamond; font-size:12pt">a</span><span style="font-family:Garamond; font-size:12pt">round public engagement. We may need to look more critically at how we measure whether it is effective enough, but I also think we need to look at not just public engagement but engagement across everybody who is involved in delivering health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care. </span><span style="font-family:Garamond; font-size:12pt">We still need to work on </span><span style="font-family:Garamond; font-size:12pt">engagement within health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> as well as looking at</span><span style="font-family:Garamond; font-size:12pt"> public engagement. </span><span style="font-family:Garamond; font-size:12pt">I think we are looking more and more in</span><span style="font-family:Garamond; font-size:12pt">to</span><span style="font-family:Garamond; font-size:12pt"> aspects of qualitative research and social science</span><span style="font-family:Garamond; font-size:12pt"> and so on,</span><span style="font-family:Garamond; font-size:12pt"> to get the messages right and</span><span style="font-family:Garamond; font-size:12pt"> to calibrate them a little </span><span style="font-family:Garamond; font-size:12pt">more effectively</span><span style="font-family:Garamond; font-size:12pt">. T</span><span style="font-family:Garamond; font-size:12pt">hat is taking place now.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q75 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Mosley:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Whenever anyone says</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">We need to look at doing this,</span><span style="font-family:Garamond; font-size:12pt">” </span><span style="font-family:Garamond; font-size:12pt">I ask more spe</span><span style="font-family:Garamond; font-size:12pt">cifically what needs to be done.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor Holmes</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I will start with what I was saying about people within h</span><span style="font-family:Garamond; font-size:12pt">ealth care. We need to make sure as technical experts</span><span style="font-family:Garamond; font-size:12pt"> that we are not just talking to each other. We need to engage with our clinical </span><span style="font-family:Garamond; font-size:12pt">and</span><span style="font-family:Garamond; font-size:12pt"> professional colleag</span><span style="font-family:Garamond; font-size:12pt">ues. I</span><span style="font-family:Garamond; font-size:12pt">t is really important</span><span style="font-family:Garamond; font-size:12pt"> that we recognise the effect of</span><span style="font-family:Garamond; font-size:12pt"> the power of hierarchies within specialities, </span><span style="font-family:Garamond; font-size:12pt">and </span><span style="font-family:Garamond; font-size:12pt">work with leaders</span><span style="font-family:Garamond; font-size:12pt"> across a range of specialities and</span><span style="font-family:Garamond; font-size:12pt"> work with our professional bodies. We must include nurses here. There needs to be much more talk about the role of nurses in the delivery of antibiotic safety. There needs to be much more talk about the critical role of pharmacists</span><span style="font-family:Garamond; font-size:12pt">; </span><span style="font-family:Garamond; font-size:12pt">quite a bit of wo</span><span style="font-family:Garamond; font-size:12pt">rk has been done already with </span><span style="font-family:Garamond; font-size:12pt">the development of a </span><span style="font-family:Garamond; font-size:12pt">masters</span><span style="font-family:Garamond; font-size:12pt"> pro</span><span style="font-family:Garamond; font-size:12pt">gramme for pharmacists</span><span style="font-family:Garamond; font-size:12pt">. I think Anthony might be able to say a bit more about the work that is being done critically and academically looking at behavioural change strategies and</span><span style="font-family:Garamond; font-size:12pt"> getting the message right. T</span><span style="font-family:Garamond; font-size:12pt">here is investment in research to do this</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but there is also a programme of work that Public Health England is involved in.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q76 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Mosley:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">It is the public awareness side of things that I am particularly interested in.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I think the answer is yes</span><span style="font-family:Garamond; font-size:12pt">; in my view,</span><span style="font-family:Garamond; font-size:12pt"> there is a need for fur</span><span style="font-family:Garamond; font-size:12pt">ther </span><span style="font-family:Garamond; font-size:12pt">public engagement or public awareness. Again it is not straightforward</span><span style="font-family:Garamond; font-size:12pt">: how do you raise public awareness?</span><span style="font-family:Garamond; font-size:12pt"> One could say we will run an awareness</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">raising</span><span style="font-family:Garamond; font-size:12pt"> campaign</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but it is very important, in so doing, that you run something that is effe</span><span style="font-family:Garamond; font-size:12pt">ctive. They cost a lot of money and</span><span style="font-family:Garamond; font-size:12pt"> they take time. One does not want to do something that is not effective in terms of raising the public</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s knowledge, understanding</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> or even, most importantly, their behaviours in terms of going to a GP and asking for antibiotics. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">We in Public Health </span><span style="font-family:Garamond; font-size:12pt">England</span><span style="font-family:Garamond; font-size:12pt"> have from </span><span style="font-family:Garamond; font-size:12pt">1 </span><span style="font-family:Garamond; font-size:12pt">April this year taken from the Department of Health the team responsible for running those kinds of campaigns</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and I and my team have been asked to look at whether we can run a broader public health campaign around antimicrobial re</span><span style="font-family:Garamond; font-size:12pt">sistance in this country. W</span><span style="font-family:Garamond; font-size:12pt">e have started to look at how we can do that in a targeted way that is effective and cost</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">effective</span><span style="font-family:Garamond; font-size:12pt">. T</span><span style="font-family:Garamond; font-size:12pt">he research</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">draws on some of the work that the World Health </span><span style="font-family:Garamond; font-size:12pt">Organisation has done, called </span><span style="font-family:Garamond; font-size:12pt">TAB, which is about targeting app</span><span style="font-family:Garamond; font-size:12pt">ropriate antimicrobial resistance</span><span style="font-family:Garamond; font-size:12pt"> strategies around, first of all, doing some qualitative work to find out where such a ca</span><span style="font-family:Garamond; font-size:12pt">mpaign might be most effective—</span><span style="font-family:Garamond; font-size:12pt">which </span><span style="font-family:Garamond; font-size:12pt">groups, so it could be age groups;</span><span style="font-family:Garamond; font-size:12pt"> which sectors</span><span style="font-family:Garamond; font-size:12pt">, whether it is schools or </span><span style="font-family:Garamond; font-size:12pt">residential</span><span style="font-family:Garamond; font-size:12pt"> sectors, and those kind of things—</span><span style="font-family:Garamond; font-size:12pt">and then </span><span style="font-family:Garamond; font-size:12pt">running a tailored campaign accordingly. </span><span style="font-family:Garamond; font-size:12pt">You ask what should be looked at, and t</span><span style="font-family:Garamond; font-size:12pt">hat is something we are looking at</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> b</span><span style="font-family:Garamond; font-size:12pt">ut we have just started doing i</span><span style="font-family:Garamond; font-size:12pt">t</span><span style="font-family:Garamond; font-size:12pt">. T</span><span style="font-family:Garamond; font-size:12pt">hat is very much part of the s</span><span style="font-family:Garamond; font-size:12pt">trategy in terms of raising the</span><span style="font-family:Garamond; font-size:12pt"> level of discussion and debate. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: This is a</span><span style="font-family:Garamond; font-size:12pt">n important release, I think, to start us ha</span><span style="font-family:Garamond; font-size:12pt">ving those conversations</span><span style="font-family:Garamond; font-size:12pt">. </span><span style="font-family:Garamond; font-size:12pt">Eurobarometer</span><span style="font-family:Garamond; font-size:12pt">, which is a European</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">wide</span><span style="font-family:Garamond; font-size:12pt"> survey, has just released the results of the 2013 survey</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which focused on antimicrobial resistance because obviously this is a big attent</span><span style="font-family:Garamond; font-size:12pt">ion area throughout Europe. That survey </span><span style="font-family:Garamond; font-size:12pt">showed that one in three people in the UK, and roughly the same across Europe, had an awareness of some antibiotic cam</span><span style="font-family:Garamond; font-size:12pt">paign in the previous year. T</span><span style="font-family:Garamond; font-size:12pt">here are campaigns out there that people are becoming aware of. Interestingly, one in two people in the </span><span style="font-family:Garamond; font-size:12pt">UK</span><span style="font-family:Garamond; font-size:12pt"> knew that antibiotic</span><span style="font-family:Garamond; font-size:12pt">s were not right for colds, flu</span><span style="font-family:Garamond; font-size:12pt"> and viruses</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but that means 50% do not, so we still have a lot of work </span><span style="font-family:Garamond; font-size:12pt">to do </span><span style="font-family:Garamond; font-size:12pt">out there to convince people that viruses do not need antibiotics. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">hat I thought was really important in those results was to know t</span><span style="font-family:Garamond; font-size:12pt">hat actually the main place where</span><span style="font-family:Garamond; font-size:12pt"> people seek advice and where they will get advice that they believe in is from health professionals. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hat comes back to the engagement of health professionals</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and look</span><span style="font-family:Garamond; font-size:12pt">ing</span><span style="font-family:Garamond; font-size:12pt"> at health professional strategies rather than just looking at all</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">encompassing</span><span style="font-family:Garamond; font-size:12pt"> campaigns. </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">hen people are ill and seek health advice</span><span style="font-family:Garamond; font-size:12pt">, that</span><span style="font-family:Garamond; font-size:12pt"> is the moment whe</span><span style="font-family:Garamond; font-size:12pt">n </span><span style="font-family:Garamond; font-size:12pt">they will listen to the important piece of advice that can change their behaviour, not only for this episode but potentially for the next episode and the one thereafter. </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">t is about resources</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> education campaigns and interventions that can be rolled out across GP practices that can change those behaviours in the future, not just for now.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q77 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Mosley:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">We </span><span style="font-family:Garamond; font-size:12pt">have </span><span style="font-family:Garamond; font-size:12pt">focused on the prescribing of medicines. It is also important that once a member of the </span><span style="font-family:Garamond; font-size:12pt">public has these medicines </span><span style="font-family:Garamond; font-size:12pt">the</span><span style="font-family:Garamond; font-size:12pt">y complete the course and use them</span><span style="font-family:Garamond; font-size:12pt"> properly. How can medical p</span><span style="font-family:Garamond; font-size:12pt">rofessionals make sure that </span><span style="font-family:Garamond; font-size:12pt">patients actually complete the course they are given</span><span style="font-family:Garamond; font-size:12pt">? People go to the doctor</span><span style="font-family:Garamond; font-size:12pt">, get given the antibiotics and then that is the end of the story as far as that connection with the GP is concerned. How can you make sure t</span><span style="font-family:Garamond; font-size:12pt">hat the link continues and </span><span style="font-family:Garamond; font-size:12pt">they complete the course?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">There are two things that are quite important. The first thing is that a lot of the research about the length of course happened a long time ago</span><span style="font-family:Garamond; font-size:12pt">; </span><span style="font-family:Garamond; font-size:12pt">often </span><span style="font-family:Garamond; font-size:12pt">it </span><span style="font-family:Garamond; font-size:12pt">w</span><span style="font-family:Garamond; font-size:12pt">as</span><span style="font-family:Garamond; font-size:12pt"> predefined 30, 40 or 50 years ago. Actually we need research about what i</span><span style="font-family:Garamond; font-size:12pt">s the shortest length of course.</span><span style="font-family:Garamond; font-size:12pt"> Can we let the courses be shorter so that people do not take antibiotics on day 7 when they are better</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because they do not need them? </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">We also know that</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> if people do not have an infection in the first place</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> they do not need antibi</span><span style="font-family:Garamond; font-size:12pt">otics. If they were in hospital,</span><span style="font-family:Garamond; font-size:12pt"> they would have stopped antibiotics on day 2 when we decided they did not have an infection, so perhaps we need to reinvent this a bit and get better at understanding when patients do not need them</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hat is about stopping the prescriptions in the first place</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but it is als</span><span style="font-family:Garamond; font-size:12pt">o about trying to see if </span><span style="font-family:Garamond; font-size:12pt">we </span><span style="font-family:Garamond; font-size:12pt">can </span><span style="font-family:Garamond; font-size:12pt">come up with a way that we can shorten the durations of courses so that they do not take them</span><span style="font-family:Garamond; font-size:12pt"> for such a long time. I</span><span style="font-family:Garamond; font-size:12pt">f they are feeling</span><span style="font-family:Garamond; font-size:12pt"> better after two days, and it wa</span><span style="font-family:Garamond; font-size:12pt">s thought </span><span style="font-family:Garamond; font-size:12pt">to</span><span style="font-family:Garamond; font-size:12pt"> be a virus at the beginning </span><span style="font-family:Garamond; font-size:12pt">but</span><span style="font-family:Garamond; font-size:12pt"> it was a delayed prescription, perhaps they should stop it at that point. I would like to turn that on its head a bit</span><span style="font-family:Garamond; font-size:12pt">; </span><span style="font-family:Garamond; font-size:12pt">we need to look at that in the future in a different way</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because the more antibiotics people tak</span><span style="font-family:Garamond; font-size:12pt">e, the more the microbiology </span><span style="font-family:Garamond; font-size:12pt">inside their body will change.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: I</span><span style="font-family:Garamond; font-size:12pt">f a patient ultimately decides when they have a five</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">day treatment that they are feeling better after three or four days and they want to throw the rest in the bin or not continue, it is quite </span><span style="font-family:Garamond; font-size:12pt">hard</span><span style="font-family:Garamond; font-size:12pt"> to influence that</span><span style="font-family:Garamond; font-size:12pt">. The way we do i</span><span style="font-family:Garamond; font-size:12pt">t is by awareness raising, public debate</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> discussion with the public</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but also with professionals about how they convey the importance of those messages. I</span><span style="font-family:Garamond; font-size:12pt"> was just </span><span style="font-family:Garamond; font-size:12pt">reminded by a note about a very good educational material called e</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">Bug</span><span style="font-family:Garamond; font-size:12pt">, electronic bug, which is an online tool that we developed in the Health Protection Agency</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">now Public Health England</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">which has</span><span style="font-family:Garamond; font-size:12pt"> won awards and is used multiply</span><span style="font-family:Garamond; font-size:12pt"> in schools across this country</span><span style="font-family:Garamond; font-size:12pt">. I</span><span style="font-family:Garamond; font-size:12pt">ndeed</span><span style="font-family:Garamond; font-size:12pt">, it</span><span style="font-family:Garamond; font-size:12pt"> has been used in a number of countries overseas, having been tran</span><span style="font-family:Garamond; font-size:12pt">slated into different languages.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">t covers areas pertaining to that understanding</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">which bugs respond to antibiotics, why antibiotics should be used and for what duration and so forth.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q78 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Jim Dowd:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I think all of you have made reference during the course of the morning to the </span><span style="font-family:Garamond; font-size:12pt">differences and </span><span style="font-family:Garamond; font-size:12pt">discrepancies</span><span style="font-family:Garamond; font-size:12pt">, or </span><span style="font-family:Garamond; font-size:12pt">the different ways matters are treated in</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">secondary as opposed to primary care. I want to look briefl</span><span style="font-family:Garamond; font-size:12pt">y at the antimicrobial resistance</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">strategy, the five</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">year plan for 2013-</span><span style="font-family:Garamond; font-size:12pt">18. It has been criticised from a number of quarters for being far too concerned with the cl</span><span style="font-family:Garamond; font-size:12pt">inical environment, principally</span><span style="font-family:Garamond; font-size:12pt"> the secondary acute sector, at the expense </span><span style="font-family:Garamond; font-size:12pt">of </span><span style="font-family:Garamond; font-size:12pt">primary care</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and</span><span style="font-family:Garamond; font-size:12pt"> not mentioning </span><span style="font-family:Garamond; font-size:12pt">t</span><span style="font-family:Garamond; font-size:12pt">he environment in nursing homes</span><span style="font-family:Garamond; font-size:12pt"> at all. I wo</span><span style="font-family:Garamond; font-size:12pt">nder </span><span style="font-family:Garamond; font-size:12pt">if any of yo</span><span style="font-family:Garamond; font-size:12pt">u would care to respond to that.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I can talk to that. I have recently done some work looking at antibiotic prescribing in nursing homes</span><span style="font-family:Garamond; font-size:12pt">; it</span><span style="font-family:Garamond; font-size:12pt"> is not yet published</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but it shows that if you take into</span><span style="font-family:Garamond; font-size:12pt"> account the other co</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">morbidities</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">the othe</span><span style="font-family:Garamond; font-size:12pt">r illnesses that people have—</span><span style="font-family:Garamond; font-size:12pt">the rate of antibiotic prescribing in nursing homes is around double what you would expect for that population. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">here is a problem with antibiotic prescribing in nursing homes and it is, I think, often misdirected</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">his </span><span style="font-family:Garamond; font-size:12pt">is </span><span style="font-family:Garamond; font-size:12pt">a high</span><span style="font-family:Garamond; font-size:12pt">-</span><span style="font-family:Garamond; font-size:12pt">risk population</span><span style="font-family:Garamond; font-size:12pt">;</span><span style="font-family:Garamond; font-size:12pt"> these are very frail, elderly people usually</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> who are at high risk of bacterial infections and serious infections</span><span style="font-family:Garamond; font-size:12pt">. M</span><span style="font-family:Garamond; font-size:12pt">anaging that risk in primary care is difficult because you are worried that people may h</span><span style="font-family:Garamond; font-size:12pt">ave more serious infections, b</span><span style="font-family:Garamond; font-size:12pt">ut there is still overtreatment</span><span style="font-family:Garamond; font-size:12pt">.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">M</span><span style="font-family:Garamond; font-size:12pt">y particular focus has been on urinary infections</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">t is very common for people in nursing homes to carry bacteria in their urine. Probably about a third of people, if you do a random sample, would have bacteria in their urine</span><span style="font-family:Garamond; font-size:12pt">;</span><span style="font-family:Garamond; font-size:12pt"> there is a kind of a paradigm</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> where somebody becomes more unwell and then somebody </span><span style="font-family:Garamond; font-size:12pt">else </span><span style="font-family:Garamond; font-size:12pt">will dip their urine and show that there is protein and blood in it</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which suggests an infection</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and then they will get an antibiotic, but actually the link between the bacteria in the urine and the illness is very tenuous</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hat is one of the driver</span><span style="font-family:Garamond; font-size:12pt">s of antibiotic prescribing, so i</span><span style="font-family:Garamond; font-size:12pt">t is an area that I have been looking at and will be focusing on to try and intervene and get better targeting. Again, it is about identifying the people that really need the antibiotics</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but we are talking about a high</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">risk environment with the frail elderly.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q79 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Jim Dowd:</span><span style="font-family:Garamond; font-size:12pt"> Y</span><span style="font-family:Garamond; font-size:12pt">our </span><span style="font-family:Garamond; font-size:12pt">view would be that the resistance</span><span style="font-family:Garamond; font-size:12pt"> strategy is seriously deficient in this area.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Moore</span><span style="font-family:Garamond; font-size:12pt">: I</span><span style="font-family:Garamond; font-size:12pt">t is an area which warrants more attention</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and I thi</span><span style="font-family:Garamond; font-size:12pt">nk it has not been an area that</span><span style="font-family:Garamond; font-size:12pt"> has been looked at. There are high levels of prescribing, probably greater than you would expect even for the frail elderly population who are in there</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and I think more work needs to be done, yes.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Kessel</span><span style="font-family:Garamond; font-size:12pt">: A</span><span style="font-family:Garamond; font-size:12pt">s I mentioned earlier, I think this is an amb</span><span style="font-family:Garamond; font-size:12pt">itious and important strategy; i</span><span style="font-family:Garamond; font-size:12pt">t </span><span style="font-family:Garamond; font-size:12pt">is an overarching strategy. W</span><span style="font-family:Garamond; font-size:12pt">e talked earlier about the enormity of the challenge and the fact that implementation at ground</span><span style="font-family:Garamond; font-size:12pt"> level has other elements, </span><span style="font-family:Garamond; font-size:12pt">which cannot be, and would not be, covered in an overarching strategy. The issue around community settings is vitally important for all the reasons that have been mentioned. I cannot recall whether that i</span><span style="font-family:Garamond; font-size:12pt">s specifically mentioned,</span><span style="font-family:Garamond; font-size:12pt"> but I can be absolutely sure that it does not stop Public Health England, as part of our work on surveillance and our r</span><span style="font-family:Garamond; font-size:12pt">oles and responsibilities there—</span><span style="font-family:Garamond; font-size:12pt">roles on sur</span><span style="font-family:Garamond; font-size:12pt">veillance, education and practice—</span><span style="font-family:Garamond; font-size:12pt">from attending to co</span><span style="font-family:Garamond; font-size:12pt">mmunity settings, nursing homes and</span><span style="font-family:Garamond; font-size:12pt"> residential homes. In fact only last year</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">Dr Hopkins might correct me if I get the date wrong, but I think it was last year or the year before</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">we produced an important pack </span><span style="font-family:Garamond; font-size:12pt">on </span><span style="font-family:Garamond; font-size:12pt">community nursing home</span><span style="font-family:Garamond; font-size:12pt">s</span><span style="font-family:Garamond; font-size:12pt">, residential care settings and advice for practitioners on health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">associated</span><span style="font-family:Garamond; font-size:12pt"> infections an</span><span style="font-family:Garamond; font-size:12pt">d antimicrobial resistance. I</span><span style="font-family:Garamond; font-size:12pt">t is an area that is already being addressed.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q80 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Jim Dowd:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">But the huge increase in recent years in </span><span style="font-family:Garamond; font-size:12pt">resistance, and attention</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">given to </span><span style="font-family:Garamond; font-size:12pt">resistance</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> has been in the community rather than in clinical environments. The position in hospitals, </span><span style="font-family:Garamond; font-size:12pt">in </span><span style="font-family:Garamond; font-size:12pt">the acute sector, has not really changed that much over</span><span style="font-family:Garamond; font-size:12pt"> time. </span><span style="font-family:Garamond; font-size:12pt">Infection levels are effectively under control and now reducing, but the huge explosion in this has taken place in the community sector. Should that not be where the attention is being placed?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr Hopkins</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">We can say that we have seen a rise</span><span style="font-family:Garamond; font-size:12pt"> in </span><span style="font-family:Garamond; font-size:12pt">E.coli</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">bacter</span><span style="font-family:Garamond; font-size:12pt">a</span><span style="font-family:Garamond; font-size:12pt">emia across the country. We know that you are more likely to have resistance if you have had a health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care setting intervention in</span><span style="font-family:Garamond; font-size:12pt"> the previous three months. T</span><span style="font-family:Garamond; font-size:12pt">he infection may start in the community</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but it is more likely to have been related to your previous health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care event. </span><span style="font-family:Garamond; font-size:12pt">N</span><span style="font-family:Garamond; font-size:12pt">ursing homes are really important. There are more than 30,000 nursing and residential homes across England</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and they have a very vulnerable population. I do not think they are excluded from the strategy</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because the strategy encompasses the whole health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care economy and primary and secondary care</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and nursing home residents are involved</span><span style="font-family:Garamond; font-size:12pt">. T</span><span style="font-family:Garamond; font-size:12pt">he delivery of their care </span><span style="font-family:Garamond; font-size:12pt">is </span><span style="font-family:Garamond; font-size:12pt">via primary care</span><span style="font-family:Garamond; font-size:12pt">, so </span><span style="font-family:Garamond; font-size:12pt">thei</span><span style="font-family:Garamond; font-size:12pt">r prescriptions that we gather—</span><span style="font-family:Garamond; font-size:12pt">the resistance that we g</span><span style="font-family:Garamond; font-size:12pt">ather—are</span><span style="font-family:Garamond; font-size:12pt"> being gathered by the same mechanisms a</span><span style="font-family:Garamond; font-size:12pt">s everything else. A</span><span style="font-family:Garamond; font-size:12pt">s something that could be strengthened</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> explicitly stating what is requir</span><span style="font-family:Garamond; font-size:12pt">ed in long</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">term care facilities would be beneficial. L</span><span style="font-family:Garamond; font-size:12pt">ong</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">term facilities are also covered by the Health and Social Care Act. They are also regulated by </span><span style="font-family:Garamond; font-size:12pt">the </span><span style="font-family:Garamond; font-size:12pt">CQC. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hey fall under everything else that we have talked about in primary and secondary care as well, so they are not excluded by any means by what it says in the strategy, though it does not, I agree, explicitly state</span><span style="font-family:Garamond; font-size:12pt">, “This applies to long</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">term care,” but </span><span style="font-family:Garamond; font-size:12pt">primary and secondary care physicians and nurses</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">are the same people who deliver care in long</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">term care facilities.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> That was</span><span style="font-family:Garamond; font-size:12pt"> an extremely informative session. We are extremely grateful for the contributions you have made. I realise there will be one</span><span style="font-family:Garamond; font-size:12pt"> or two follow</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">up documents—</span><span style="font-family:Garamond; font-size:12pt">the ones yo</span><span style="font-family:Garamond; font-size:12pt">u referred to, Professor </span><span style="font-family:Garamond; font-size:12pt">Kessel</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> Dr Moore, if you are able to flesh out a little more about the paper you are about to publish</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">I recognise the sensitivity of that in the science environment</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">that would be helpful</span><span style="font-family:Garamond; font-size:12pt">, and a</span><span style="font-family:Garamond; font-size:12pt">lso</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">if there are any further bits of information the rest of you would like to add as well. Thank you very much for your attendance this morning.</span></p><p style="margin:0pt 0pt 12pt; text-align:center"><span style="font-family:Garamond; font-size:12pt; font-weight:bold">Examination of Witnesses</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">Witnesses: </span><span style="font-family:Garamond; font-size:12pt; font-weight:bold">John </span><span style="font-family:Garamond; font-size:12pt; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">, Chief Executive Officer, </span><span style="font-family:Garamond; font-size:12pt">Novolytics</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt; font-weight:bold">Dr David McIntosh</span><span style="font-family:Garamond; font-size:12pt">, Global Scientific Affairs Senior Expert, Novartis, </span><span style="font-family:Garamond; font-size:12pt; font-weight:bold">Professor George </span><span style="font-family:Garamond; font-size:12pt; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">, Professor of Health </span><span style="font-family:Garamond; font-size:12pt">Research, University of Southampton Medical School, and </span><span style="font-family:Garamond; font-size:12pt; font-weight:bold">Doris-Ann Williams</span><span style="font-family:Garamond; font-size:12pt">, Chief Executive, British In Vitro Diagnostics Asso</span><span style="font-family:Garamond; font-size:12pt">ciation</span><span style="font-family:Garamond; font-size:12pt">, gave evide</span><span style="font-family:Garamond; font-size:12pt">nce.</span></p><p style="line-height:13.35pt; margin:0pt; orphans:0; widows:0"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q81 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Thank you very much for attending this morning. It would be helpful if you could introduce yourselves.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Doris-Ann Williams</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I am Doris</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">Ann</span><span style="font-family:Garamond; font-size:12pt"> Williams. I am chief executive of the British In Vitro Diagnostics Association, the industry association representing manufacturers and distributors of diagnostic products in the </span><span style="font-family:Garamond; font-size:12pt">UK</span><span style="font-family:Garamond; font-size:12pt">.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I am George </span><span style="font-family:Garamond; font-size:12pt">Lewith</span><span style="font-family:Garamond; font-size:12pt">. I am a professor in the department of primary care. I work very closely with Mike Moore on a number of studies</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which David </span><span style="font-family:Garamond; font-size:12pt">Tredinnick</span><span style="font-family:Garamond; font-size:12pt"> just mentioned. I am a GP and a consultant physician. I have 30 years of experience in researching herbal medicines and hold a variety of roles. One of the things I have been involved with</span><span style="font-family:Garamond; font-size:12pt"> very recently is getting the </span><span style="font-family:Garamond; font-size:12pt">National Sc</span><span style="font-family:Garamond; font-size:12pt">hool for Primary Care Research—part of the NIHR—</span><span style="font-family:Garamond; font-size:12pt">to develop a really powerful working group looking at alternatives to antibiotic prescribing both in care homes and in primary care</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> using a variety of nutritional and herbal approaches, particularly in relation to urinary and lower respiratory tract infections. I do not re</span><span style="font-family:Garamond; font-size:12pt">present anybody other than the U</span><span style="font-family:Garamond; font-size:12pt">niversity of Southampton and the NIHR.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I am David McIntosh. I am a paediatric infectious disease specialist. I am also an honorary clinic</span><span style="font-family:Garamond; font-size:12pt">al senior lecturer at Imperial C</span><span style="font-family:Garamond; font-size:12pt">ollege in London. I act as the global scienti</span><span style="font-family:Garamond; font-size:12pt">fic affairs senior expert for Novartis V</span><span style="font-family:Garamond; font-size:12pt">accines</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and I teach at a number of universities around the world.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I am John </span><span style="font-family:Garamond; font-size:12pt">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">. I am the chief executive of </span><span style="font-family:Garamond; font-size:12pt">Novolytics</span><span style="font-family:Garamond; font-size:12pt">, which is a</span><span style="font-family:Garamond; font-size:12pt">n SME company in </span><span style="font-family:Garamond; font-size:12pt">Daresbury</span><span style="font-family:Garamond; font-size:12pt">; </span><span style="font-family:Garamond; font-size:12pt">we research into </span><span style="font-family:Garamond; font-size:12pt">bacteriophage</span><span style="font-family:Garamond; font-size:12pt"> therapeutics. Prior to that, most of my career has been spent in the venture capital industry.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q82 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">In different ways</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> you all propose alternatives to antibiotics. Could you each </span><span style="font-family:Garamond; font-size:12pt">outline what your approach is? </span><span style="font-family:Garamond; font-size:12pt">Let us go down the line again.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Doris-Ann Williams</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The diagnostics industry sees the tools that our products produce as a way of appropriately differentiating patients</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt"> treatment. </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">n primary care the</span><span style="font-family:Garamond; font-size:12pt">re are simple tests, as we </span><span style="font-family:Garamond; font-size:12pt">heard in the last session, which are in common use in the Nordic countries, Germany and Switzerland and also in the USA, to differentiate between viral and bacterial infections</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and allow a debate or a discussion between the primary care physician and the patient as to whether an antibiotic is appropriate</span><span style="font-family:Garamond; font-size:12pt"> for that condition or not. I</span><span style="font-family:Garamond; font-size:12pt">n secondary care</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> it is a way of targeting antibiotic therapy to make sure that the correct antibiotic is used for the correct infection. Increasingly, there are products available </span><span style="font-family:Garamond; font-size:12pt">that</span><span style="font-family:Garamond; font-size:12pt"> will look at more than one parameter in one sample type</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and </span><span style="font-family:Garamond; font-size:12pt">they </span><span style="font-family:Garamond; font-size:12pt">are reducing the length of time to get the results. </span><span style="font-family:Garamond; font-size:12pt">In</span><span style="font-family:Garamond; font-size:12pt"> the trad</span><span style="font-family:Garamond; font-size:12pt">itional microbiology lab, </span><span style="font-family:Garamond; font-size:12pt">it would take five to 14 day</span><span style="font-family:Garamond; font-size:12pt">s to culture up micro</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">organisms;</span><span style="font-family:Garamond; font-size:12pt"> you can now </span><span style="font-family:Garamond; font-size:12pt">do it within five hours using </span><span style="font-family:Garamond; font-size:12pt">molecular technology.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">My background is as a clinician, a GP, so I can add to some of the comments made by Dr Moore and I can certainly expand any that may be relevant to this part of the meeting. As a primary care physician, you a</span><span style="font-family:Garamond; font-size:12pt">re in a very difficult position;</span><span style="font-family:Garamond; font-size:12pt"> you are in a one</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">to</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">one situation with a patient who may </span><span style="font-family:Garamond; font-size:12pt">want or demand</span><span style="font-family:Garamond; font-size:12pt"> an antibiotic. Education works </span><span style="font-family:Garamond; font-size:12pt">to a point</span><span style="font-family:Garamond; font-size:12pt">, and we </span><span style="font-family:Garamond; font-size:12pt">discussed the strategies in the previous part of the meeting, but GPs very much feel they need alternatives. The evidence we have from the research is that they would look at things like herbal and nutritional medicines if they were t</span><span style="font-family:Garamond; font-size:12pt">houghtfully evidence based. W</span><span style="font-family:Garamond; font-size:12pt">ithin the EU, particularly in Germany, 20</span><span style="font-family:Garamond; font-size:12pt">% of the </span><span style="font-family:Garamond; font-size:12pt">OTC prescriptions are for herbal medicines. There is a real good track record of herbal medicines </span><span style="font-family:Garamond; font-size:12pt">being</span><span style="font-family:Garamond; font-size:12pt"> better produced and us getting better quality herbal medicines in the </span><span style="font-family:Garamond; font-size:12pt">UK</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and better herbal practitioners, particularly since the 2001 House of Lords report. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">My main approach would be to try and see how we can use these kinds of approaches</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> looking at good science but perhaps understanding that we are not after a magic single chemical. Herbals work differently. They work synergistically and often through several different </span><span style="font-family:Garamond; font-size:12pt">i</span><span style="font-family:Garamond; font-size:12pt">mmuno</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">modifying</span><span style="font-family:Garamond; font-size:12pt"> mechanisms. O</span><span style="font-family:Garamond; font-size:12pt">ne herbal, which may have 40 or 50 different biologically active chemicals, may be working through several different systems</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and nutritionals may be as well. They modify many different systems in the body, so it is a different kind of approach</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which requires a slightly different understanding of science. I think we can use those approaches to manage symptoms and mitigate antibiotic prescribing in primary care very effectively when we know that there is good preliminary evidence and we do not need to make many of the antibiotic prescriptions that we are making. </span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Thank you. We are go</span><span style="font-family:Garamond; font-size:12pt">ing to pursue that a little </span><span style="font-family:Garamond; font-size:12pt">further later on.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Antibiotics are used for treatment generally</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and vaccines are used for prevention. We have had a golden age of antibiotic development</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and I believe that golden age is coming to an end. I believe we are at the beginning of a golden age of vaccination and discovery of vaccines. Vaccination has the potential to prevent patients </span><span style="font-family:Garamond; font-size:12pt">from </span><span style="font-family:Garamond; font-size:12pt">being admitted to hospital, thereby preventing their exposure to organisms in the hospital. Vaccination also has the potential to preven</span><span style="font-family:Garamond; font-size:12pt">t disease in the community; </span><span style="font-family:Garamond; font-size:12pt">in fact</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> vaccination can prevent large epidemics. Vaccination can prevent the long</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">term consequences and </span><span style="font-family:Garamond; font-size:12pt">sequelae</span><span style="font-family:Garamond; font-size:12pt"> of infections. I believe that vaccination is now the best approach for looking at organisms, both resistant and multi</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">resistant</span><span style="font-family:Garamond; font-size:12pt"> and susceptible in that fashion, by targeting multiple targets on these organisms. Antibiotics just target one aspect of the organism. Vaccines have the potential to target multiple targets on the organism. I also believe that with effective vaccines against community and healthcare</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">associated</span><span style="font-family:Garamond; font-size:12pt"> pathogens, </span><span style="font-family:Garamond; font-size:12pt">and </span><span style="font-family:Garamond; font-size:12pt">effective implementation, we have the potential to reduce antibiotic resistance by up to 50%.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">We are trying to develop </span><span style="font-family:Garamond; font-size:12pt">bacteriophage</span><span style="font-family:Garamond; font-size:12pt"> therapeutics. </span><span style="font-family:Garamond; font-size:12pt">Phages</span><span style="font-family:Garamond; font-size:12pt"> are viruses that kill bacteria</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and you will be drinking them as you drink your water. They have been around for longer than bacteria. They are used regularly in the eastern bloc</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but they are not used here yet because we have not done clinical trials that are to western standards. Our belief is that they will form a complementary approach to the use of antibiotics</span><span style="font-family:Garamond; font-size:12pt">. T</span><span style="font-family:Garamond; font-size:12pt">hey are very narrow spectrum. Typically, any one phage will only kill a number of strains withi</span><span style="font-family:Garamond; font-size:12pt">n a bacterial species, s</span><span style="font-family:Garamond; font-size:12pt">o you need to know what bug you are dealing with before they are effective.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q83 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">That response, from your point of view, answers one o</span><span style="font-family:Garamond; font-size:12pt">f my next questions: a</span><span style="font-family:Garamond; font-size:12pt">re other countries ahead in your particular fields and are the procedures for adopting alternatives in the NHS easy ones to deal with?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">With vaccination</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> the United Kingdom has set an extraordinary example over many years of introducing new, innovative vaccines. We </span><span style="font-family:Garamond; font-size:12pt">have now </span><span style="font-family:Garamond; font-size:12pt">not completely </span><span style="font-family:Garamond; font-size:12pt">conquered, </span><span style="font-family:Garamond; font-size:12pt">but are getting towards conquering</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> the great killers of the 20th century</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and before that. We now face somewhat rarer infections in the community</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> such as meningococcal infecti</span><span style="font-family:Garamond; font-size:12pt">on, and in the hospital, such as S</span><span style="font-family:Garamond; font-size:12pt">taph and </span><span style="font-family:Garamond; font-size:12pt">E.coli</span><span style="font-family:Garamond; font-size:12pt">. With </span><span style="font-family:Garamond; font-size:12pt">its</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">extraordinary </span><span style="font-family:Garamond; font-size:12pt">track record of vaccinati</span><span style="font-family:Garamond; font-size:12pt">on, </span><span style="font-family:Garamond; font-size:12pt">the United Kingdom is in fact right at the sharp end of being able to develop new vaccines. Of course, other countries are using variou</span><span style="font-family:Garamond; font-size:12pt">s vaccines, and t</span><span style="font-family:Garamond; font-size:12pt">he United Kingdom is using those and other vaccines, so it does depend somewhat, but my point is that the United Kingdom is really very advanced with the implementation of most vaccines.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: My response</span><span style="font-family:Garamond; font-size:12pt"> is that you need all of us in a co</span><span style="font-family:Garamond; font-size:12pt">-</span><span style="font-family:Garamond; font-size:12pt">ordinated way. You need </span><span style="font-family:Garamond; font-size:12pt">phages</span><span style="font-family:Garamond; font-size:12pt"> when you have rea</span><span style="font-family:Garamond; font-size:12pt">lly bad infections in hospital. You need </span><span style="font-family:Garamond; font-size:12pt">vaccinations for prevention</span><span style="font-family:Garamond; font-size:12pt">. You need </span><span style="font-family:Garamond; font-size:12pt">simple primary care approaches that stop over</span><span style="font-family:Garamond; font-size:12pt">-</span><span style="font-family:Garamond; font-size:12pt">prescription and you need near</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">patient</span><span style="font-family:Garamond; font-size:12pt"> testing</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so you need the technology. You need to implement the near</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">patient</span><span style="font-family:Garamond; font-size:12pt"> testing by making private contractors in general practice do it so that it is feasible</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">they do not lose money. At the moment</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> they would be paying for the tests themselves out of their own wages. You need better research for symptom</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">relieving</span><span style="font-family:Garamond; font-size:12pt"> remedies</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and we need a better structure to manage that research within the NIHR. We need the vaccinations prevent</span><span style="font-family:Garamond; font-size:12pt">at</span><span style="font-family:Garamond; font-size:12pt">ively</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and we need better strategies when we have serious overwhelming infections in secondary and tertiary care environments. </span><span style="font-family:Garamond; font-size:12pt">Y</span><span style="font-family:Garamond; font-size:12pt">ou cannot have one of us without the other. I am sorry I am in the middle. I am the GP, you see, </span><span style="font-family:Garamond; font-size:12pt">and </span><span style="font-family:Garamond; font-size:12pt">I am always in the middle.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Doris-Ann Williams</span><span style="font-family:Garamond; font-size:12pt">: I </span><span style="font-family:Garamond; font-size:12pt">agree that we are not talking about one of our approaches against all of them. There is room for everything to fit into the health</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">care pictu</span><span style="font-family:Garamond; font-size:12pt">re. One of the problems, </span><span style="font-family:Garamond; font-size:12pt">which George just alluded to</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> was the cost of doing testing in primary care. It is an added cost, but there are ways around it. Outside of antimicrobial infection, GPs have started doing simple tests</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which stop referring to secondary care</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and the money is recouped in other ways. Companies are quite innovative at doing risk</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">sharing</span><span style="font-family:Garamond; font-size:12pt"> projects on costing</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so I do not think that is beyond the wit of us to do. Much </span><span style="font-family:Garamond; font-size:12pt">more important, I think, is </span><span style="font-family:Garamond; font-size:12pt">awareness among GPs of what tests</span><span style="font-family:Garamond; font-size:12pt"> are available commonly and</span><span style="font-family:Garamond; font-size:12pt"> are being used in northern Europe and in the US.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q84 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Mosley:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I wanted to discuss vaccinati</span><span style="font-family:Garamond; font-size:12pt">ons in particular, so I guess this</span><span style="font-family:Garamond; font-size:12pt"> is </span><span style="font-family:Garamond; font-size:12pt">mainly aimed at Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">, but if anyone has any comments, please add in. In your initial answer</span><span style="font-family:Garamond; font-size:12pt">, you </span><span style="font-family:Garamond; font-size:12pt">cover</span><span style="font-family:Garamond; font-size:12pt">ed the broad areas and</span><span style="font-family:Garamond; font-size:12pt"> I want to be a bit more specific. We </span><span style="font-family:Garamond; font-size:12pt">have had recent news </span><span style="font-family:Garamond; font-size:12pt">in the London press abo</span><span style="font-family:Garamond; font-size:12pt">ut TB and the incidence, or </span><span style="font-family:Garamond; font-size:12pt">rates</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> of TB in London in particular. The current TB vaccinations that we all ha</span><span style="font-family:Garamond; font-size:12pt">d</span><span style="font-family:Garamond; font-size:12pt"> as teenagers are 70 years old now. I think you said that we are entering a golden age of vaccination. How can that be so when the vaccines are so old?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Of course, we have had an unfortunate failure of the developmen</span><span style="font-family:Garamond; font-size:12pt">t of a new tuberculosis vaccine</span><span style="font-family:Garamond; font-size:12pt"> from the Jenner Institute</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and this was sad because we do need to replace the BCG vaccine for tuberculosis. The approach that has been used for</span><span style="font-family:Garamond; font-size:12pt"> the </span><span style="font-family:Garamond; font-size:12pt">Bexsero</span><span style="font-family:Garamond; font-size:12pt"> meningococcal </span><span style="font-family:Garamond; font-size:12pt">sero</span><span style="font-family:Garamond; font-size:12pt">group</span><span style="font-family:Garamond; font-size:12pt"> B vaccine is called reverse </span><span style="font-family:Garamond; font-size:12pt">vaccinology</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and this is what I mean by a new golden age of vaccine development. By looking at the genetics of the organism</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> we now have the pot</span><span style="font-family:Garamond; font-size:12pt">ential to identify targets that</span><span style="font-family:Garamond; font-size:12pt"> ca</span><span style="font-family:Garamond; font-size:12pt">n be used for vaccine. The </span><span style="font-family:Garamond; font-size:12pt">serogroup</span><span style="font-family:Garamond; font-size:12pt"> B meningococcal vaccine—the Novartis </span><span style="font-family:Garamond; font-size:12pt">Bexsero</span><span style="font-family:Garamond; font-size:12pt"> vaccine—</span><span style="font-family:Garamond; font-size:12pt">was developed along those lines. For the </span><span style="font-family:Garamond; font-size:12pt">nosocomi</span><span style="font-family:Garamond; font-size:12pt">al</span><span style="font-family:Garamond; font-size:12pt"> infections—to be specific, S</span><span style="font-family:Garamond; font-size:12pt">taphylococcus </span><span style="font-family:Garamond; font-size:12pt">aureu</span><span style="font-family:Garamond; font-size:12pt">s</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">t</span><span style="font-family:Garamond; font-size:12pt">here has also been a failure, or two failures, of vaccines.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">E.coli</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt">Acinetobacter</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt">Enteroba</span><span style="font-family:Garamond; font-size:12pt">cteriaceae</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt">Klebsiella</span><span style="font-family:Garamond; font-size:12pt"> and so on:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">w</span><span style="font-family:Garamond; font-size:12pt">e need to use this new sort of technology to</span><span style="font-family:Garamond; font-size:12pt"> develop specific vaccines for Staph, </span><span style="font-family:Garamond; font-size:12pt">E.coli</span><span style="font-family:Garamond; font-size:12pt">, Staph </span><span style="font-family:Garamond; font-size:12pt">epi</span><span style="font-family:Garamond; font-size:12pt"> and so on. W</span><span style="font-family:Garamond; font-size:12pt">hen I </span><span style="font-family:Garamond; font-size:12pt">say </span><span style="font-family:Garamond; font-size:12pt">golden age, we are going to have great difficulties in developing new antibiotics unless the</span><span style="font-family:Garamond; font-size:12pt">re are some miracles. But we </span><span style="font-family:Garamond; font-size:12pt">have the potential now to </span><span style="font-family:Garamond; font-size:12pt">use genetics, looking at these very resistant organisms, to develop vaccines, not necessarily to use them throughout the whole community</span><span style="font-family:Garamond; font-size:12pt"> for </span><span style="font-family:Garamond; font-size:12pt">everyone, like we generally do</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt">but </span><span style="font-family:Garamond; font-size:12pt">to use these new vaccines </span><span style="font-family:Garamond; font-size:12pt">in a more targeted approach, especially </span><span style="font-family:Garamond; font-size:12pt">for </span><span style="font-family:Garamond; font-size:12pt">people going into hospitals, people who are at risk of these serious infections.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q85 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Mosley:</span><span style="font-family:Garamond; font-size:12pt"> Is one of the problems </span><span style="font-family:Garamond; font-size:12pt">y</span><span style="font-family:Garamond; font-size:12pt">ou face—going back to the BCG—</span><span style="font-family:Garamond; font-size:12pt">that it only protects against certain </span><span style="font-family:Garamond; font-size:12pt">strains of the TB virus, or </span><span style="font-family:Garamond; font-size:12pt">bacteria? Is there a problem that</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> if you are just vaccinati</span><span style="font-family:Garamond; font-size:12pt">ng against certain strains, </span><span style="font-family:Garamond; font-size:12pt">actually you can encourage the other strains to develop?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The beauty of this new approach is that one can attack or prevent as many potential strains as possible, and again I refer to the meningococcal </span><span style="font-family:Garamond; font-size:12pt">serogroup</span><span style="font-family:Garamond; font-size:12pt"> B. Until</span><span style="font-family:Garamond; font-size:12pt"> now we have had a vaccine in </span><span style="font-family:Garamond; font-size:12pt">C</span><span style="font-family:Garamond; font-size:12pt">ó</span><span style="font-family:Garamond; font-size:12pt">rdoba, a vaccine in Normandy</span><span style="font-family:Garamond; font-size:12pt"> and</span><span style="font-family:Garamond; font-size:12pt"> a vaccine in New Zealand</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">because that is where there have</span><span style="font-family:Garamond; font-size:12pt"> been particular strain</span><span style="font-family:Garamond; font-size:12pt">s</span><span style="font-family:Garamond; font-size:12pt"> of this organism. But in fact there are hundreds of different strains of this organism around the world, the meningococcal B, and now we have the potential to have a vaccine which can cover the majority of</span><span style="font-family:Garamond; font-size:12pt"> those strains. Similarly with S</span><span style="font-family:Garamond; font-size:12pt">taph, similarly with tuberculosis</span><span style="font-family:Garamond; font-size:12pt">; </span><span style="font-family:Garamond; font-size:12pt">in fact</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> what I would also like to mention</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">this might come as a surprise to you</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">is the role of viral vaccines in preventing antibiotic consumption and antibiotic resistance. For example, influenza may result in secondary super</span><span style="font-family:Garamond; font-size:12pt">-</span><span style="font-family:Garamond; font-size:12pt">infection, bacterial infection, and this is why the influenza vaccine has the potential to prevent antibiot</span><span style="font-family:Garamond; font-size:12pt">ic usage. </span><span style="font-family:Garamond; font-size:12pt">I think we should be talking about bacterial vaccines</span><span style="font-family:Garamond; font-size:12pt"> and</span><span style="font-family:Garamond; font-size:12pt"> about viral vaccines as well.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q86 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Mosley:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Why is vaccine development so much behind an</span><span style="font-family:Garamond; font-size:12pt">tibiotic development? Again with TB, </span><span style="font-family:Garamond; font-size:12pt">it is 70 years since it was developed. There must be some sort of failure in the system.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: With </span><span style="font-family:Garamond; font-size:12pt">vaccine devel</span><span style="font-family:Garamond; font-size:12pt">opment we have been using, let’s call them,</span><span style="font-family:Garamond; font-size:12pt"> old</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">fashioned approaches, </span><span style="font-family:Garamond; font-size:12pt">mushing</span><span style="font-family:Garamond; font-size:12pt"> up the organism or breaking up the organism, using bits of the organism</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> intuitively trying them out. Now we have the potential to look at the genetics of the organism, do various tests after that</span><span style="font-family:Garamond; font-size:12pt">, using bio</span><span style="font-family:Garamond; font-size:12pt">info</span><span style="font-family:Garamond; font-size:12pt">r</span><span style="font-family:Garamond; font-size:12pt">matics and computer systems</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and reall</span><span style="font-family:Garamond; font-size:12pt">y identify the targets that </span><span style="font-family:Garamond; font-size:12pt">will be successful vaccine targets. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q87 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Mosley:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Why has</span><span style="font-family:Garamond; font-size:12pt">n’t that </span><span style="font-family:Garamond; font-size:12pt">come along in the past? Is it a technology thing or is it because of the market situation</span><span style="font-family:Garamond; font-size:12pt">?</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">D</span><span style="font-family:Garamond; font-size:12pt">rugs companies have a vaccine on the market, it does 90% of the job</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so, hey, it is not really worth the</span><span style="font-family:Garamond; font-size:12pt">ir</span><span style="font-family:Garamond; font-size:12pt"> econom</span><span style="font-family:Garamond; font-size:12pt">ically developing a new vaccine.</span><span style="font-family:Garamond; font-size:12pt"> Is that the case</span><span style="font-family:Garamond; font-size:12pt">?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">No.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q88 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Mosley:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Why has it taken 70 years?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">It is a long process to develop a new antibiotic. It is also a long process to develop a new vaccine. It is very expensive. Once you have done that particular process of discovery of an antibiotic or a vaccine, then you have to run it through human clinical trials, </span><span style="font-family:Garamond; font-size:12pt">you </span><span style="font-family:Garamond; font-size:12pt">h</span><span style="font-family:Garamond; font-size:12pt">ave to get it approved and so on</span><span style="font-family:Garamond; font-size:12pt">, so it is very costly. I think that the process of reverse </span><span style="font-family:Garamond; font-size:12pt">vaccinology</span><span style="font-family:Garamond; font-size:12pt"> will reduce the costs of developing new vaccines. I do not see any new techniques available for developing new antibiotics. I think the discovery process there is fixed. </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e now have a flexible, new approach to developing n</span><span style="font-family:Garamond; font-size:12pt">ew vaccines.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q89 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David Morris:</span><span style="font-family:Garamond; font-size:12pt"> M</span><span style="font-family:Garamond; font-size:12pt">s Williams, you said you wanted Government action to ensure existing diagnoses were taken up more widely in the NHS. Is there ready evidence that this would be cost</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">effective?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Doris-Ann Williams</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">There is some</span><span style="font-family:Garamond; font-size:12pt"> evidence. T</span><span style="font-family:Garamond; font-size:12pt">here ar</span><span style="font-family:Garamond; font-size:12pt">e studies done on certain tests. There are international audits;</span><span style="font-family:Garamond; font-size:12pt"> there is an audit on a C</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">reactive</span><span style="font-family:Garamond; font-size:12pt"> protein, which is a test to show </span><span style="font-family:Garamond; font-size:12pt">rise in infection. T</span><span style="font-family:Garamond; font-size:12pt">here are some studies</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> with co</span><span style="font-family:Garamond; font-size:12pt">st</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">effectiveness</span><span style="font-family:Garamond; font-size:12pt"> related,</span><span style="font-family:Garamond; font-size:12pt"> ava</span><span style="font-family:Garamond; font-size:12pt">ilable from a global study</span><span style="font-family:Garamond; font-size:12pt">. Cost savings within the NHS are hard. There is never a bag of cas</span><span style="font-family:Garamond; font-size:12pt">h that is released. W</span><span style="font-family:Garamond; font-size:12pt">ith diagnostics, </span><span style="font-family:Garamond; font-size:12pt">it is more </span><span style="font-family:Garamond; font-size:12pt">that you are shifting resources to be used elsewhere</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> or releasing capacity</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> much more than actually turning up with money at the chief executive</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s door</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and it is quite hard to track that through the s</span><span style="font-family:Garamond; font-size:12pt">ystem. It is not quite as clear; it is not as simple </span><span style="font-family:Garamond; font-size:12pt">as taking a pill and someone gets better</span><span style="font-family:Garamond; font-size:12pt">, or they don’t,</span><span style="font-family:Garamond; font-size:12pt"> and they release a bed. Diagnostic tests produce information which is used</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but it is</span><span style="font-family:Garamond; font-size:12pt"> only one step in the pathway. I</span><span style="font-family:Garamond; font-size:12pt">t is quite complex. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">If we use a CRP, which is C</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">r</span><span style="font-family:Garamond; font-size:12pt">eactive</span><span style="font-family:Garamond; font-size:12pt"> protein, you can use i</span><span style="font-family:Garamond; font-size:12pt">t as a near</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">bedside</span><span style="font-family:Garamond; font-size:12pt"> test. That is what GPs can use. It is reasonably effective at differentiating between viruses and bacteria. It is something that is used outside the </span><span style="font-family:Garamond; font-size:12pt">UK</span><span style="font-family:Garamond; font-size:12pt"> quite widely. We do not use it here, as I </span><span style="font-family:Garamond; font-size:12pt">said, because it costs the GPs three </span><span style="font-family:Garamond; font-size:12pt">quid each time they do it</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and t</span><span style="font-family:Garamond; font-size:12pt">hey might be spending a lot of three </span><span style="font-family:Garamond; font-size:12pt">quids</span><span style="font-family:Garamond; font-size:12pt"> in a</span><span style="font-family:Garamond; font-size:12pt"> winter. We are about to pilot a large study in Southampton</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">Mike Moore is running that</span><span style="font-family:Garamond; font-size:12pt">. It will be piloted through our </span><span style="font-family:Garamond; font-size:12pt">clerk and we will look at the cost</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">effectiveness</span><span style="font-family:Garamond; font-size:12pt"> of offering that remuneratio</span><span style="font-family:Garamond; font-size:12pt">n within primary care. T</span><span style="font-family:Garamond; font-size:12pt">hat is a process that is in the planning stages at the moment. It is a very good question</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and it is one we need to answer for the NHS</span><span style="font-family:Garamond; font-size:12pt">, but w</span><span style="font-family:Garamond; font-size:12pt">e need rigorous evidence</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which we do not have yet.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: T</span><span style="font-family:Garamond; font-size:12pt">her</span><span style="font-family:Garamond; font-size:12pt">e is </span><span style="font-family:Garamond; font-size:12pt">great potential for synergy between diagnostics and vaccination</span><span style="font-family:Garamond; font-size:12pt">. I </span><span style="font-family:Garamond; font-size:12pt">refer to the previous session in terms of the fear of medical practitioners that the patient could have some underlying serious infection</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and therefore </span><span style="font-family:Garamond; font-size:12pt">the wish</span><span style="font-family:Garamond; font-size:12pt"> to prescribe antibiotics. With diagnostics and successful vaccination</span><span style="font-family:Garamond; font-size:12pt">, we can reduce the fear level—</span><span style="font-family:Garamond; font-size:12pt">not only in the medical practitioners b</span><span style="font-family:Garamond; font-size:12pt">ut also in the public—that the</span><span style="font-family:Garamond; font-size:12pt"> patient w</span><span style="font-family:Garamond; font-size:12pt">ill have a severe infection. </span><span style="font-family:Garamond; font-size:12pt">I think there is a great potential for synergy between diagnostics and vaccination. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">We </span><span style="font-family:Garamond; font-size:12pt">mentioned influenza diagnostics. We should mention the great success of the pneumococcal conjugate vaccine</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which has really reduced the fear of people having pneumonia</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because it has reduced pneumococcal pneumonia</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and the great success obviously of measles, mumps </span><span style="font-family:Garamond; font-size:12pt">and </span><span style="font-family:Garamond; font-size:12pt">rubella, measles being associated with pneumonia as well. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">he synergy between effective diagnostics and effective vaccination can certainly impact on compliance, </span><span style="font-family:Garamond; font-size:12pt">the </span><span style="font-family:Garamond; font-size:12pt">number of prescriptions, </span><span style="font-family:Garamond; font-size:12pt">the </span><span style="font-family:Garamond; font-size:12pt">fear of patients that there is a serious infection and also </span><span style="font-family:Garamond; font-size:12pt">on</span><span style="font-family:Garamond; font-size:12pt"> this public debate about whether or not antibiotics should be used.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">David, I agree with you that it could impact, but it is not</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because it is not getting into primary care. It is not happening. The science is right, but the dissemination and the activity </span><span style="font-family:Garamond; font-size:12pt">are</span><span style="font-family:Garamond; font-size:12pt"> not happening from the GP</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s seat. </span><span style="font-family:Garamond; font-size:12pt">We have real issues—</span><span style="font-family:Garamond; font-size:12pt">Mike Moore and some of the ot</span><span style="font-family:Garamond; font-size:12pt">her guys were talking about it this morning—</span><span style="font-family:Garamond; font-size:12pt">about a co</span><span style="font-family:Garamond; font-size:12pt">-</span><span style="font-family:Garamond; font-size:12pt">ordinated process of making this happen in primary care where the prescriptions are happening.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q90 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David Morris:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Presumably information on the incidence of infection and resistance would be useful to companies producing diagnostic tools. Should these companies be doing more to facilitate gathering the information</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> to aid their product</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s production?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Doris-Ann Williams</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Access to that sort of information is quite tricky. As an industry</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> we are small with limited resources</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and it is a bit of a vicious circle to drive production of a product when you have limited resources to pay for the data and the information. But companies are quite happy to work in combination with the NHS wherever possible to produce that sort of data.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q91 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Tredinnick</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">:</span><span style="font-family:Garamond; font-size:12pt"> T</span><span style="font-family:Garamond; font-size:12pt">his is really to Mr </span><span style="font-family:Garamond; font-size:12pt">Hardcastle</span><span style="font-family:Garamond; font-size:12pt"> and Professor </span><span style="font-family:Garamond; font-size:12pt">Lewith</span><span style="font-family:Garamond; font-size:12pt"> first and foremost</span><span style="font-family:Garamond; font-size:12pt">. What advantages </span><span style="font-family:Garamond; font-size:12pt">do your approaches have over other tradit</span><span style="font-family:Garamond; font-size:12pt">ional antimicrobials</span><span style="font-family:Garamond; font-size:12pt">?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The thing that gets me about this discussion is </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">there is lots of talk about </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">potential</span><span style="font-family:Garamond; font-size:12pt">”,</span><span style="font-family:Garamond; font-size:12pt"> and the thing that Dame Sally Davies keeps emphasising is that we are running out of time. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">he critical thing for us i</span><span style="font-family:Garamond; font-size:12pt">s that we know that </span><span style="font-family:Garamond; font-size:12pt">phages</span><span style="font-family:Garamond; font-size:12pt"> work; i</span><span style="font-family:Garamond; font-size:12pt">t is just that we cannot make them available in this country. The reason we cannot make them available in this country is </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">we have more rigorous regulatory standards. </span><span style="font-family:Garamond; font-size:12pt">First, </span><span style="font-family:Garamond; font-size:12pt">we know </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">there is evidence that they work. </span><span style="font-family:Garamond; font-size:12pt">S</span><span style="font-family:Garamond; font-size:12pt">econd</span><span style="font-family:Garamond; font-size:12pt">ly,</span><span style="font-family:Garamond; font-size:12pt"> they are harml</span><span style="font-family:Garamond; font-size:12pt">ess in man and they are inert; t</span><span style="font-family:Garamond; font-size:12pt">herefore, the rate at which you can bring them through the regulatory regime should be quicker. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hird</span><span style="font-family:Garamond; font-size:12pt">ly,</span><span style="font-family:Garamond; font-size:12pt"> there are lots of them. One of the issues that the antibiotic development arena has is that there are lots of possible candidates and very few of them actually get thro</span><span style="font-family:Garamond; font-size:12pt">ugh to being useful drugs. F</span><span style="font-family:Garamond; font-size:12pt">rom our perspective, we have a lot of good putative candidates already.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I think that the nutritional and herbal approaches have some preliminary eviden</span><span style="font-family:Garamond; font-size:12pt">ce behind them. We need </span><span style="font-family:Garamond; font-size:12pt">some further investment in research, so we need some harder studies to demonstrate that they really do control symptoms, </span><span style="font-family:Garamond; font-size:12pt">and </span><span style="font-family:Garamond; font-size:12pt">that they can be prescribed by GPs</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> or over the counter and made available by pharmacists, so that the GPs can feel they are doing something. It is very difficult when somebody comes to ask you for help</span><span style="font-family:Garamond; font-size:12pt"> to say,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">Go away and put up with it for five days.</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt"> We do not have that kind of culture.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">We need to be able to do something that is safe and does not actually load up antimicrobial resistance for the future. There is huge potential with herbal remedies, but I think we need to move away a little bit from the drug</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">mining</span><span style="font-family:Garamond; font-size:12pt"> element of herbal remedies, where we are looking for the wonderful chemical in the way they lo</span><span style="font-family:Garamond; font-size:12pt">oked for the new malarial with A</span><span style="font-family:Garamond; font-size:12pt">rtemisia. We need to see them in a slightly different context</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> as more complex mixtures of chemicals. We need to understand much more about herbal safety, because herbs generally are much safer than conventional medicines</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">the evidence is pretty overwhelming around that</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">and we need to have thoughtful levels of regulation with t</span><span style="font-family:Garamond; font-size:12pt">he MHRA. </span><span style="font-family:Garamond; font-size:12pt">I share with John that we need a better process within our regulatory and safety processes</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> to take account of things which are not standard pharmaceutical agents</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and a process which allows us to have</span><span style="font-family:Garamond; font-size:12pt"> good, critical and </span><span style="font-family:Garamond; font-size:12pt">thoughtful scientific review </span><span style="font-family:Garamond; font-size:12pt">that</span><span style="font-family:Garamond; font-size:12pt"> is relevant to the disciplines</span><span style="font-family:Garamond; font-size:12pt">, so</span><span style="font-family:Garamond; font-size:12pt"> that these new and old medications may be reviewed properly and scientifically.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Our dealings with the MHRA have been pretty good</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> as far as I am aware, we are the only company on the planet that has regulatory approval in the way we make our product</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and that is where most of</span><span style="font-family:Garamond; font-size:12pt"> our money has gone to date. I</span><span style="font-family:Garamond; font-size:12pt">t is not that the </span><span style="font-family:Garamond; font-size:12pt">MHRA are difficult</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> or the FDA or any of the rest of them for that matter, but the mentality makes it very difficult to bring new antimicrobials through quickly.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q92 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Tredinnick</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">The UK Five Year Antimicrobial Resistance St</span><span style="font-family:Garamond; font-size:12pt">rategy 2013 to 2018 states that </span><span style="font-family:Garamond; font-size:12pt">the development of novel therapies is an important element of the mult</span><span style="font-family:Garamond; font-size:12pt">ifaceted approach to tackling </span><span style="font-family:Garamond; font-size:12pt">AR</span><span style="font-family:Garamond; font-size:12pt">M</span><span style="font-family:Garamond; font-size:12pt">. Do you then feel that more resources should be dedicated to your work</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and that this falls into the category so described here?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">It certainly falls into that category. I get very nervous about suggesting that more money from Government should be placed behind our company or our initiative, but what you should think about is changing the landscape so that both big </span><span style="font-family:Garamond; font-size:12pt">pharma</span><span style="font-family:Garamond; font-size:12pt"> and the venture capital community will put private money behind potential new antimicrobials.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The answer to that, I would add, </span><span style="font-family:Garamond; font-size:12pt">is </span><span style="font-family:Garamond; font-size:12pt">that t</span><span style="font-family:Garamond; font-size:12pt">he MHRA has been really helpful,</span><span style="font-family:Garamond; font-size:12pt"> but they are surroun</span><span style="font-family:Garamond; font-size:12pt">ded by a regulatory system that</span><span style="font-family:Garamond; font-size:12pt"> makes it sometimes difficult for them. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">he situation with herbals is very difficult because herbals are not easily patentable</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and </span><span style="font-family:Garamond; font-size:12pt">also </span><span style="font-family:Garamond; font-size:12pt">many nutritionals, which may equally be effective</span><span style="font-family:Garamond; font-size:12pt">. W</span><span style="font-family:Garamond; font-size:12pt">e have a big trial that is in debate at the moment about using nu</span><span style="font-family:Garamond; font-size:12pt">tritionals in care homes—</span><span style="font-family:Garamond; font-size:12pt">vitamin D and </span><span style="font-family:Garamond; font-size:12pt">probiotics</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">to diminish or cause antibiotic prescribing. </span><span style="font-family:Garamond; font-size:12pt">Y</span><span style="font-family:Garamond; font-size:12pt">ou have talked about care homes</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and </span><span style="font-family:Garamond; font-size:12pt">i</span><span style="font-family:Garamond; font-size:12pt">t could have a big impact if we could </span><span style="font-family:Garamond; font-size:12pt">do </span><span style="font-family:Garamond; font-size:12pt">that. They </span><span style="font-family:Garamond; font-size:12pt">are </span><span style="font-family:Garamond; font-size:12pt">very simple, cheap supplements, but they are not</span><span style="font-family:Garamond; font-size:12pt"> patentable, so it is very difficult for us to </span><span style="font-family:Garamond; font-size:12pt">combine with industry to do that</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e need to do that with Government</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">funded</span><span style="font-family:Garamond; font-size:12pt"> research boards</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and that is difficult with the present structure.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q93 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Tredinnick</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">:</span><span style="font-family:Garamond; font-size:12pt"> D</span><span style="font-family:Garamond; font-size:12pt">eveloping this theme for a second, accor</span><span style="font-family:Garamond; font-size:12pt">ding to a submission from the Chinese Medical Institute, </span><span style="font-family:Garamond; font-size:12pt">research in China tells us that the </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">immunomodulatory</span><span style="font-family:Garamond; font-size:12pt"> actions of </span><span style="font-family:Garamond; font-size:12pt">traditional Chinese medicine formulations have a stimulatory effect on immune cells, immune organs,</span><span style="font-family:Garamond; font-size:12pt"> cytokine production</span><span style="font-family:Garamond; font-size:12pt"> as well as inhibitory effect on in</span><span style="font-family:Garamond; font-size:12pt">flammations, allergies and auto</span><span style="font-family:Garamond; font-size:12pt">immune diseases. Studies on acupuncture have shown that this treatment can increas</span><span style="font-family:Garamond; font-size:12pt">e the release of endogen </span><span style="font-family:Garamond; font-size:12pt">opioid</span><span style="font-family:Garamond; font-size:12pt"> peptides—”</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: Endog</span><span style="font-family:Garamond; font-size:12pt">e</span><span style="font-family:Garamond; font-size:12pt">n</span><span style="font-family:Garamond; font-size:12pt">ous opiates.</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Tredinnick</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">:</span><span style="font-family:Garamond; font-size:12pt"> Thank you, Professor. “—t</span><span style="font-family:Garamond; font-size:12pt">hat affect the immune system. Indeed, acupuncture can strengthen the immune system</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">he effect can </span><span style="font-family:Garamond; font-size:12pt">be </span><span style="font-family:Garamond; font-size:12pt">further enhanced with acupuncture when combined with Chinese herbal medicine</span><span style="font-family:Garamond; font-size:12pt">”—and w</span><span style="font-family:Garamond; font-size:12pt">estern medicine.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Is this not something that we should be looking at more carefully? They have a body of knowledge there that has been developed over thousands of years. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">We are. First, we are looking at it. Secondly, that is a bit of a claim, and I will just leave it at that. Thirdly, you are unlikely to go to your GP in </span><span style="font-family:Garamond; font-size:12pt">London</span><span style="font-family:Garamond; font-size:12pt"> and get acupuncture for your chest infection. That is not going to be cost</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">effective. That is not a reasonable thing to expect the NHS to pay for. But, for instance, we are currently doing a study in </span><span style="font-family:Garamond; font-size:12pt">Southampton</span><span style="font-family:Garamond; font-size:12pt"> on recurrent urinary tract infections in older women</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which is a big problem for a significant minority of older women</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> in which we are using Chinese herbal medicines instead of antibiotics. We think that they act in several ways. Interestingly, they act to block the cell membrane pumping the antibiotic out</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">O</span><span style="font-family:Garamond; font-size:12pt">ne of the ways that the body becomes resistant to antibiotics is that </span><span style="font-family:Garamond; font-size:12pt">it</span><span style="font-family:Garamond; font-size:12pt"> get</span><span style="font-family:Garamond; font-size:12pt">s</span><span style="font-family:Garamond; font-size:12pt"> rid of </span><span style="font-family:Garamond; font-size:12pt">them</span><span style="font-family:Garamond; font-size:12pt"> from the bacterial cells very quickly</span><span style="font-family:Garamond; font-size:12pt">; </span><span style="font-family:Garamond; font-size:12pt">synergistically</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> the herbs appear to stop that membrane transport pump</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so the antibiotics can stay in the cells for longer. </span><span style="font-family:Garamond; font-size:12pt">O</span><span style="font-family:Garamond; font-size:12pt">ne of the actions of the particular concoction of herbal medicines we are using does that. It also has direct </span><span style="font-family:Garamond; font-size:12pt">antibacterial effects. The whole point of this process is </span><span style="font-family:Garamond; font-size:12pt">that we can do this, </span><span style="font-family:Garamond; font-size:12pt">and </span><span style="font-family:Garamond; font-size:12pt">we can do it very scientifically</span><span style="font-family:Garamond; font-size:12pt"> and very thoughtfully, b</span><span style="font-family:Garamond; font-size:12pt">ut we cannot do it in an easily patentable way</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and commercialisation is difficult.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: O</span><span style="font-family:Garamond; font-size:12pt">ne needs to remember that there is an overwhelming body of scientific evidence in favour of immunisation and vaccination</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and that immunisa</span><span style="font-family:Garamond; font-size:12pt">tion and vaccination is preventa</span><span style="font-family:Garamond; font-size:12pt">tive. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">o crystallise your point, do you want to go down the path of treatment or do you want to go down the path of prevention? I think prevention is, ultimately, in the short term and the long term</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> going to be the way to combat antibiotic resistance.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I am a big fan of vaccines, but all I would point out again is the time line. Traditionally, vaccines work better against viruses than bacteria</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and I am not sure it makes commercial sense to develop vaccines against all bacteria that cause problems, simply because not everyone gets infected.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q94 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Tredinnick</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">:</span><span style="font-family:Garamond; font-size:12pt"> I have j</span><span style="font-family:Garamond; font-size:12pt">ust one more question. I think I am right in saying that none of you a</span><span style="font-family:Garamond; font-size:12pt">re qualified as homeopaths, but,</span><span style="font-family:Garamond; font-size:12pt"> Professor </span><span style="font-family:Garamond; font-size:12pt">Lewith</span><span style="font-family:Garamond; font-size:12pt">, </span><span style="font-family:Garamond; font-size:12pt">I think </span><span style="font-family:Garamond; font-size:12pt">your submissi</span><span style="font-family:Garamond; font-size:12pt">on was in conjunction with Dr Peter Fisher</span><span style="font-family:Garamond; font-size:12pt">, who is the Queen</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s physician</span><span style="font-family:Garamond; font-size:12pt">.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">He is.</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">David </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Tredinnick</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">:</span><span style="font-family:Garamond; font-size:12pt"> He</span><span style="font-family:Garamond; font-size:12pt"> also runs the </span><span style="font-family:Garamond; font-size:12pt">London h</span><span style="font-family:Garamond; font-size:12pt">ospital for integrated </span><span style="font-family:Garamond; font-size:12pt">medicine</span><span style="font-family:Garamond; font-size:12pt">. He draws attention in your submission</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">I assume it is him</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">to a health technology a</span><span style="font-family:Garamond; font-size:12pt">ssessment commissioned by the Swiss Federal G</span><span style="font-family:Garamond; font-size:12pt">overnment which found that </span><span style="font-family:Garamond; font-size:12pt">“29 clinical trials of hom</span><span style="font-family:Garamond; font-size:12pt">eopathy for upper respiratory tract</span><span style="font-family:Garamond; font-size:12pt"> infection or allergies found 29 clinical studies</span><span style="font-family:Garamond; font-size:12pt"> of which 24 were positive for</span><span style="font-family:Garamond; font-size:12pt"> hom</span><span style="font-family:Garamond; font-size:12pt">eopathy.</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt"> He also refers to a study supported by the Indian Minis</span><span style="font-family:Garamond; font-size:12pt">try of Health, which “involved </span><span style="font-family:Garamond; font-size:12pt">collaboration between conventional ear, nose and throat specialists and homeopathic doctors in a randomised control</span><span style="font-family:Garamond; font-size:12pt">led trial of hom</span><span style="font-family:Garamond; font-size:12pt">eopathy versus conventional treatment in acute </span><span style="font-family:Garamond; font-size:12pt">otitis</span><span style="font-family:Garamond; font-size:12pt"> media</span><span style="font-family:Garamond; font-size:12pt">.”</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">t suggests that the numbers of antibiotic presc</span><span style="font-family:Garamond; font-size:12pt">riptions in the </span><span style="font-family:Garamond; font-size:12pt">homeopathically</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">treated group were much lower. Although this is not particularly your field, would it not be sensible for us to make further investigations in this field to establish whether its usage is effective?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">There are two things. First, I agree that vaccinations are very important preventatively</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but you are not going to stop every virus or bacteria with vaccinations. We need some interventions. Secondly, as far as homeopathy is concerned, this Committee has been around the corner very publicly with homeopathy previously and I do not want to get involved in that. The biggest impact a general practitioner has in a consultation is the consultation</span><span style="font-family:Garamond; font-size:12pt">. W</span><span style="font-family:Garamond; font-size:12pt">hen you consider that we </span><span style="font-family:Garamond; font-size:12pt">have</span><span style="font-family:Garamond; font-size:12pt"> an ageing population with multi</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">morbidity</span><span style="font-family:Garamond; font-size:12pt">, pain, arthritis, hypertension, irritable bowel, headaches and all sorts of things, </span><span style="font-family:Garamond; font-size:12pt">for </span><span style="font-family:Garamond; font-size:12pt">the vast majority of those chronic illnesses, except perhaps hypertension, the biggest response is </span><span style="font-family:Garamond; font-size:12pt">to </span><span style="font-family:Garamond; font-size:12pt">the consultation, not the medicine. If you go to a GP and get a homeopathic medicine, it may well be a placebo</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but you may go away without using your antibiotics. That happens quite a lot in </span><span style="font-family:Garamond; font-size:12pt">France</span><span style="font-family:Garamond; font-size:12pt"> and it seems to be quite an effective way of minimising antibiotic prescribing. If you wanted to know whether homeopathy really worked for these infections, then you would need to do more clinical trials</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because the trials are promising but small. T</span><span style="font-family:Garamond; font-size:12pt">here are about 80,000 medically qualified hom</span><span style="font-family:Garamond; font-size:12pt">eopaths, mainly in France and Germany, who use homeopathy </span><span style="font-family:Garamond; font-size:12pt">in this situation quite regularly</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and the evidence is that they use many fewer antibiotics. Whether that is all placebo or real effect, we do not know yet.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q95 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> B</span><span style="font-family:Garamond; font-size:12pt">efore we move on, to help my understanding, could micro</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">organisms develop resistance to either the </span><span style="font-family:Garamond; font-size:12pt">bacteriophage</span><span style="font-family:Garamond; font-size:12pt"> approach or indeed the herbal approach?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Resistance in micro</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">organisms is very interesting. If you go back to the genome of the micro</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">organism</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> you note that they evolved with fungi. Most of our antibiotics a</span><span style="font-family:Garamond; font-size:12pt">re fungi. There is </span><span style="font-family:Garamond; font-size:12pt">an interesting theory that quite a lot of the current antimicrobial resistance is the reawakening of old evolutionary genes</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">f you remember Fleming</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s experiment </span><span style="font-family:Garamond; font-size:12pt">in </span><span style="font-family:Garamond; font-size:12pt">St Mary</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s, the fungi flew in from the window, sat on his plate and the penicillin </span><span style="font-family:Garamond; font-size:12pt">fungus killed the bacteria. O</span><span style="font-family:Garamond; font-size:12pt">ur antibiotics largely come from fungi </span><span style="font-family:Garamond; font-size:12pt">that</span><span style="font-family:Garamond; font-size:12pt"> have co</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">evolved</span><span style="font-family:Garamond; font-size:12pt"> with bacteria.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q96 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">So the answer to my question is yes.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Yes. The argument here around vaccination and stimulating the immune system becomes ve</span><span style="font-family:Garamond; font-size:12pt">ry powerfully preventative</span><span style="font-family:Garamond; font-size:12pt"> if you look at the evolutionary context of antimicrobial resistance.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Just for a bit of background, </span><span style="font-family:Garamond; font-size:12pt">phages</span><span style="font-family:Garamond; font-size:12pt"> have been around for about 3 billion years an</span><span style="font-family:Garamond; font-size:12pt">d bacteria just afterwards. T</span><span style="font-family:Garamond; font-size:12pt">here has been, for want of a better expression, an arms race going on between the pair of them for a long time. Every day about a quarter of all bact</span><span style="font-family:Garamond; font-size:12pt">eria are killed by </span><span style="font-family:Garamond; font-size:12pt">phages</span><span style="font-family:Garamond; font-size:12pt"> world</span><span style="font-family:Garamond; font-size:12pt">wide. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">o be clear, the way they apply them is as a cocktail</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so that you do not get that concern practically.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q97 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Further research seems to be key to finding future developments. Who should be the main funders</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> or who are the main funders of the various types of research that are going on?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">his is obviously relevant to a</span><span style="font-family:Garamond; font-size:12pt"> big question for vaccination</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because vaccine</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">developing</span><span style="font-family:Garamond; font-size:12pt"> companies invest hundreds of millions of dollars and pounds in developing new vaccines.</span><span style="font-family:Garamond; font-size:12pt"> Universities and </span><span style="font-family:Garamond; font-size:12pt">biotechs</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">are </span><span style="font-family:Garamond; font-size:12pt">often involved</span><span style="font-family:Garamond; font-size:12pt"> at very early stages</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but then you get to the very expensive part of doing the big clinical trials, which we have all referred to</span><span style="font-family:Garamond; font-size:12pt">. T</span><span style="font-family:Garamond; font-size:12pt">o get these products approved one has to do clinical trials. The question then comes on to the val</span><span style="font-family:Garamond; font-size:12pt">ue that the particular product—</span><span style="font-family:Garamond; font-size:12pt">the phage</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">the </span><span style="font-family:Garamond; font-size:12pt">homeopathic</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">the </span><span style="font-family:Garamond; font-size:12pt">vaccine</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> obviously, or </span><span style="font-family:Garamond; font-size:12pt">the antibiotic for that matter—</span><span style="font-family:Garamond; font-size:12pt">will have to the NHS in reducing cost. The balance is the amount of i</span><span style="font-family:Garamond; font-size:12pt">nvestment being put in and the cost-benefit to the national health service that will come out—</span><span style="font-family:Garamond; font-size:12pt">the reduction in antibiotic prescriptions, the reduction in antibiotic resistance. My quick answer really is that in appraising vaccines</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">I am not going </span><span style="font-family:Garamond; font-size:12pt">to comment on the </span><span style="font-family:Garamond; font-size:12pt">phages</span><span style="font-family:Garamond; font-size:12pt"> or hom</span><span style="font-family:Garamond; font-size:12pt">eopathy</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">we now need new ways of appraising using health technology assessment to assess the cost</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">effectiveness</span><span style="font-family:Garamond; font-size:12pt"> of vaccines, not only in the community but also within the hospital setting.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Stephen, did you mean as in who should be picking up the tab for the development of new antimicrobials?</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">No, non</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">chemical</span><span style="font-family:Garamond; font-size:12pt"> antibiotics. Who is funding the research that is going on at the moment?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I would say that any antimicrobial</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">it does not really matter whether it is a vaccine, a phage or a new drug</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">for the most part should be funded by the private sector. The reason I say that is that you need to ensure that everyone is appropriately incentivised. The reason there are few new antibiotics coming along is that it is not worth big </span><span style="font-family:Garamond; font-size:12pt">pharma</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s</span><span style="font-family:Garamond; font-size:12pt"> while to put their effort there. That is why</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> if you look at the top selling drugs, they are antidepressants, cholesterol reducers and the like. </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">hat you need to do is change the landscape to encourage those with very deep pockets to take advantage of the good work that is done in academic centres already. It is not an issue about a lack of good ideas. The real issue is when it gets expensive and you have to make it </span><span style="font-family:Garamond; font-size:12pt">worth</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">while</span><span style="font-family:Garamond; font-size:12pt"> for those with deep pockets to make a turn.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: I </span><span style="font-family:Garamond; font-size:12pt">agree with that completely.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q98 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I was just going to use you as an example of why you may not agree with that.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: Thank you. W</span><span style="font-family:Garamond; font-size:12pt">e can always turn the arguments round the other way. I think what John is saying is </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">we need different kind</span><span style="font-family:Garamond; font-size:12pt">s</span><span style="font-family:Garamond; font-size:12pt"> of processes to incentivise companies. There are </span><span style="font-family:Garamond; font-size:12pt">lots of </span><span style="font-family:Garamond; font-size:12pt">big herbal companies</span><span style="font-family:Garamond; font-size:12pt"> in Europe—</span><span style="font-family:Garamond; font-size:12pt">unfortunately not in this country because we seem to be in the process of destroyi</span><span style="font-family:Garamond; font-size:12pt">ng that industry at the moment—that</span><span style="font-family:Garamond; font-size:12pt"> produce very good quality products and want to work with us</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and we need to make that easier and more feasible</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e need to understand tha</span><span style="font-family:Garamond; font-size:12pt">t if they are going to invest </span><span style="font-family:Garamond; font-size:12pt">£1 million in a clinical trial they need to have something out of that</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hat then comes back to the process of patenting and how we manage that insti</span><span style="font-family:Garamond; font-size:12pt">tutionally. People are willing; </span><span style="font-family:Garamond; font-size:12pt">we </span><span style="font-family:Garamond; font-size:12pt">just </span><span style="font-family:Garamond; font-size:12pt">need to create the right environment for that to happen.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q99 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">That was my point. You were saying how difficult it was to patent herbs. </span><span style="font-family:Garamond; font-size:12pt">C</span><span style="font-family:Garamond; font-size:12pt">an you give us some direction that we should go in</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> to try and resolve this</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> rather than saying </span><span style="font-family:Garamond; font-size:12pt">“This is the problem”</span><span style="font-family:Garamond; font-size:12pt">? We can all see that. What is the resolution to that problem?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The resolution is to have commitment from both public and private joint ventures</span><span style="font-family:Garamond; font-size:12pt"> that </span><span style="font-family:Garamond; font-size:12pt">wo</span><span style="font-family:Garamond; font-size:12pt">rk well, because if you incentivise</span><span style="font-family:Garamond; font-size:12pt"> people they work harder and they do not sit on their bums and expect the Government to pay. I think that is really important. The other thing is </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">we </span><span style="font-family:Garamond; font-size:12pt">can </span><span style="font-family:Garamond; font-size:12pt">create</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">patented remedies around two or three herbals </span><span style="font-family:Garamond; font-size:12pt">that</span><span style="font-family:Garamond; font-size:12pt"> might do this</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and they might be very effective mechanisms of symptom control</span><span style="font-family:Garamond; font-size:12pt">; </span><span style="font-family:Garamond; font-size:12pt">some of the big Chinese companie</span><span style="font-family:Garamond; font-size:12pt">s are really interested in this</span><span style="font-family:Garamond; font-size:12pt">. </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e need to reach out to them</span><span style="font-family:Garamond; font-size:12pt"> and</span><span style="font-family:Garamond; font-size:12pt"> get our MHRA inspectors going </span><span style="font-family:Garamond; font-size:12pt">in</span><span style="font-family:Garamond; font-size:12pt">to </span><span style="font-family:Garamond; font-size:12pt">China</span><span style="font-family:Garamond; font-size:12pt"> to make sure that these products are produced to good manufacturing practice. We need to be more open in our universities and incentivise </span><span style="font-family:Garamond; font-size:12pt">them</span><span style="font-family:Garamond; font-size:12pt"> to set up joint ventures</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and </span><span style="font-family:Garamond; font-size:12pt">we need </span><span style="font-family:Garamond; font-size:12pt">to have facilities within the MHRA so that they</span><span style="font-family:Garamond; font-size:12pt"> can understand and facilitate—not drop standards—</span><span style="font-family:Garamond; font-size:12pt">and bring in the skilled people who understand these processes and can let us work. I think if we can do that</span><span style="font-family:Garamond; font-size:12pt">, it is not expensive: it needs legislation </span><span style="font-family:Garamond; font-size:12pt">and a few people.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Could I give you a concrete example of why big </span><span style="font-family:Garamond; font-size:12pt">pharma</span><span style="font-family:Garamond; font-size:12pt"> might not want to invest in antibiotics or vaccines? The concrete example is the vaccine I referred to before, </span><span style="font-family:Garamond; font-size:12pt">Bexsero</span><span style="font-family:Garamond; font-size:12pt">, the meningococcal B vaccine</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which has had a huge amount of investment and approval in </span><span style="font-family:Garamond; font-size:12pt">Europe</span><span style="font-family:Garamond; font-size:12pt"> but rec</span><span style="font-family:Garamond; font-size:12pt">ently got knocked back by the </span><span style="font-family:Garamond; font-size:12pt">JCBI. Now of course the JCBI is reviewing that decision and putting some new inputs into their model, but for big </span><span style="font-family:Garamond; font-size:12pt">pharma</span><span style="font-family:Garamond; font-size:12pt">, let us say, the investment that one has to make in a vaccine such as </span><span style="font-family:Garamond; font-size:12pt">Bexsero</span><span style="font-family:Garamond; font-size:12pt">, or a vaccine for S</span><span style="font-family:Garamond; font-size:12pt">taphylococcus </span><span style="font-family:Garamond; font-size:12pt">aureus</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">E.coli</span><span style="font-family:Garamond; font-size:12pt"> or </span><span style="font-family:Garamond; font-size:12pt">Acinetobacter</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> is huge</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and the tools we have for measuring the potential benefit for the NHS and the health system in general are not the best tools</span><span style="font-family:Garamond; font-size:12pt">. That is a concrete example</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">where I think </span><span style="font-family:Garamond; font-size:12pt">a big </span><span style="font-family:Garamond; font-size:12pt">pharma</span><span style="font-family:Garamond; font-size:12pt"> company may think twice about investing huge amounts of money in any intervention if there is not more of an as</span><span style="font-family:Garamond; font-size:12pt">surance of it being recommended—</span><span style="font-family:Garamond; font-size:12pt">whether it be a phage, homeopathy or a vaccine such as </span><span style="font-family:Garamond; font-size:12pt">Bexsero</span><span style="font-family:Garamond; font-size:12pt">, which is now available to prevent the most common cause of childh</span><span style="font-family:Garamond; font-size:12pt">ood infectious death in the UK</span><span style="font-family:Garamond; font-size:12pt">. </span><span style="font-family:Garamond; font-size:12pt">O</span><span style="font-family:Garamond; font-size:12pt">ne thinks</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">“T</span><span style="font-family:Garamond; font-size:12pt">his is a huge investment, but is this product or vaccine going to be recommended?</span><span style="font-family:Garamond; font-size:12pt">”</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q100 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> It strikes me that</span><span style="font-family:Garamond; font-size:12pt"> barriers to the resear</span><span style="font-family:Garamond; font-size:12pt">ch are the regulatory framework and</span><span style="font-family:Garamond; font-size:12pt"> the tools that are used to work out that cost</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">benefit</span><span style="font-family:Garamond; font-size:12pt"> analysis. Funding is an issue because of some of that. Are there any other barriers to people investing? The will? Is there a will to research?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">There may not be a will to research certain things </span><span style="font-family:Garamond; font-size:12pt">like </span><span style="font-family:Garamond; font-size:12pt">phages</span><span style="font-family:Garamond; font-size:12pt"> or herbal medicines; t</span><span style="font-family:Garamond; font-size:12pt">here may not be enough investme</span><span style="font-family:Garamond; font-size:12pt">nt academically to do that. S</span><span style="font-family:Garamond; font-size:12pt">etting up one or two centres of excellence would be really helpful and can be done relatively cheaply in joint ventures with specific universities </span><span style="font-family:Garamond; font-size:12pt">that</span><span style="font-family:Garamond; font-size:12pt"> express interest. </span><span style="font-family:Garamond; font-size:12pt">S</span><span style="font-family:Garamond; font-size:12pt">mall amounts of money can be used to seed things. </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">f you get the academic interest and get people on side</span><span style="font-family:Garamond; font-size:12pt">, in</span><span style="font-family:Garamond; font-size:12pt"> the clinical professions, you can begin to make things change.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: My experience on this has been that</span><span style="font-family:Garamond; font-size:12pt"> we have had to go outside the UK to tie up with centres of excellence in our business, but really there are three things you need to think about. </span><span style="font-family:Garamond; font-size:12pt">First, you </span><span style="font-family:Garamond; font-size:12pt">need to think about changing when the patent time starts ticking</span><span style="font-family:Garamond; font-size:12pt">. R</span><span style="font-family:Garamond; font-size:12pt">ather than </span><span style="font-family:Garamond; font-size:12pt">it being </span><span style="font-family:Garamond; font-size:12pt">when you apply for a patent, you need to tie it to whe</span><span style="font-family:Garamond; font-size:12pt">n you can sell the medicine. S</span><span style="font-family:Garamond; font-size:12pt">econd</span><span style="font-family:Garamond; font-size:12pt">ly,</span><span style="font-family:Garamond; font-size:12pt"> you need to think about why </span><span style="font-family:Garamond; font-size:12pt">it </span><span style="font-family:Garamond; font-size:12pt">is that those folk who set the drug tariffs believe it is worse to die of cancer</span><span style="font-family:Garamond; font-size:12pt"> than it is to die of pneumonia,</span><span style="font-family:Garamond; font-size:12pt"> because right now you can get a heck of a lot more mon</span><span style="font-family:Garamond; font-size:12pt">ey for a new drug against, let’</span><span style="font-family:Garamond; font-size:12pt">s say, bowel cancer than you can against a new antibiotic or antimicrobial. </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">hird</span><span style="font-family:Garamond; font-size:12pt">ly,</span><span style="font-family:Garamond; font-size:12pt"> you might think about supercharging </span><span style="font-family:Garamond; font-size:12pt">E</span><span style="font-family:Garamond; font-size:12pt">IS relief</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which should be relatively straightforward. You are not going to be able to pick winners</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so what you should be thinking about is saying </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">those folk who are prepared to back companies in our situation need to be encouraged to divert more of their spare cash </span><span style="font-family:Garamond; font-size:12pt">away from, let’s say, a bricks and </span><span style="font-family:Garamond; font-size:12pt">mortar deal or a software development company into antimicrobials.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q101 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Thank </span><span style="font-family:Garamond; font-size:12pt">you. There is a proposal for a D</span><span style="font-family:Garamond; font-size:12pt">iagno</span><span style="font-family:Garamond; font-size:12pt">stics and Stratified Medicine Catapult C</span><span style="font-family:Garamond; font-size:12pt">entre. Do you think that is the right approach</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> or do you think we should have one that specialises in antibiotics research and things associated with that</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">diagnostics?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Doris-Ann Williams</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">We were delighted in the diagnostics industry that the TSB recogni</span><span style="font-family:Garamond; font-size:12pt">sed the importance of having a C</span><span style="font-family:Garamond; font-size:12pt">atapult to get diagnostics used</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and</span><span style="font-family:Garamond; font-size:12pt"> that</span><span style="font-family:Garamond; font-size:12pt"> stratified medicine is </span><span style="font-family:Garamond; font-size:12pt">across the whole heal</span><span style="font-family:Garamond; font-size:12pt">th care continuum, </span><span style="font-family:Garamond; font-size:12pt">diagnosing, ruling out, monitoring and managing disease as well. I would be highly in favour of that continuing along the plans that they have got going at the moment.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q102 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Stephen Metcalfe:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Does anyone else have a comment on that?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">It would probably be no bad thing to align those </span><span style="font-family:Garamond; font-size:12pt">kinds of initiatives with the </span><span style="font-family:Garamond; font-size:12pt">import </span><span style="font-family:Garamond; font-size:12pt">that Dame Sally gives, b</span><span style="font-family:Garamond; font-size:12pt">ut I would say </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">the diagnostic aspect is absolutely critical.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q103 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Pamela Nash:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">You have covered quite extensively the barriers to research in the UK. Could you tell us a bit more about barriers to introducing new techniques to the market</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> apart from research?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">First, I will make a broad comment,</span><span style="font-family:Garamond; font-size:12pt"> not necessarily about vaccines.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e do value more, I think, interventions for the elderly end</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">of</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">life</span><span style="font-family:Garamond; font-size:12pt"> type of approaches which may extend life perhaps by a few months or improve quality of life in older people and the elderly</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and there is nothing wrong with that at all.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q104 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Pamela Nash:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I am sorry, Dr McIntosh, when you say </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">we</span><span style="font-family:Garamond; font-size:12pt">”,</span><span style="font-family:Garamond; font-size:12pt"> who are you referring to?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I am saying </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">broadly speaking</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt">.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Are you making a comment about the age of politicians now?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I am speaking as a paediatrician</span><span style="font-family:Garamond; font-size:12pt">;</span><span style="font-family:Garamond; font-size:12pt"> we could spend more investment and resources at the beginning</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> in</span><span style="font-family:Garamond; font-size:12pt"> childhood, in paediatrics. </span><span style="font-family:Garamond; font-size:12pt">I am speaking, I guess, as a paediatrician more than anything, again not devaluing what is done for elderly </span><span style="font-family:Garamond; font-size:12pt">people </span><span style="font-family:Garamond; font-size:12pt">and </span><span style="font-family:Garamond; font-size:12pt">older people, but </span><span style="font-family:Garamond; font-size:12pt">I think we could perhaps start to transfer the focus to earlier times i</span><span style="font-family:Garamond; font-size:12pt">n life, childhood, paediatrics and </span><span style="font-family:Garamond; font-size:12pt">even neonato</span><span style="font-family:Garamond; font-size:12pt">logy, with vaccines coming in for</span><span style="font-family:Garamond; font-size:12pt"> that area as well</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> where we can really improve not only the quality of life but the length of life by preventing childhood infections. Secondly, preventing childho</span><span style="font-family:Garamond; font-size:12pt">od infections with vaccines has</span><span style="font-family:Garamond; font-size:12pt"> been shown to have a benefit for adult and elderly population</span><span style="font-family:Garamond; font-size:12pt">s as well;</span><span style="font-family:Garamond; font-size:12pt"> the pneumococcal and influenza vaccination programmes are cases in point where an intervention in childhood has an extreme benefit in the a</span><span style="font-family:Garamond; font-size:12pt">dult and elderly population. </span><span style="font-family:Garamond; font-size:12pt">I think we can start to link up a little bit the beginning</span><span style="font-family:Garamond; font-size:12pt"> of life</span><span style="font-family:Garamond; font-size:12pt"> and </span><span style="font-family:Garamond; font-size:12pt">the </span><span style="font-family:Garamond; font-size:12pt">end of life.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q105 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Pamela Nash:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I would be quite interes</span><span style="font-family:Garamond; font-size:12pt">ted to hear, M</span><span style="font-family:Garamond; font-size:12pt">s Williams, about the barriers that BIVDA feel are prevalent in the </span><span style="font-family:Garamond; font-size:12pt">UK</span><span style="font-family:Garamond; font-size:12pt">, particularly within the NHS.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Doris-Ann Williams</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">One of the barriers is the financial flows around the NHS systems in both </span><span style="font-family:Garamond; font-size:12pt">England</span><span style="font-family:Garamond; font-size:12pt"> and the developed nations. Pathology generally has a budget to provide the testing </span><span style="font-family:Garamond; font-size:12pt">for all of the hospital care and </span><span style="font-family:Garamond; font-size:12pt">local community care as well</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and that means that there is a restriction on the amount of testing that can be done.</span><span style="font-family:Garamond; font-size:12pt"> O</span><span style="font-family:Garamond; font-size:12pt">ne of the things we would like to see</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> wherever tests ar</span><span style="font-family:Garamond; font-size:12pt">e specific to a patient pathway, is</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">the relevant department actually </span><span style="font-family:Garamond; font-size:12pt">picks up the costs of that</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because, as we have said, the cost of a diagnostic test is relatively cheap on the whole and the value it provides is much higher. But if you</span><span style="font-family:Garamond; font-size:12pt"> have a restricted silo budget for </span><span style="font-family:Garamond; font-size:12pt">numerous tests on respiratory infections</span><span style="font-family:Garamond; font-size:12pt">—</span><span style="font-family:Garamond; font-size:12pt">respiratory infections are the second of the main </span><span style="font-family:Garamond; font-size:12pt">causes of admission to hospital—and </span><span style="font-family:Garamond; font-size:12pt">if you have an old</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">fashioned microbiology lab</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">which</span><span style="font-family:Garamond; font-size:12pt"> will very effectively pick</span><span style="font-family:Garamond; font-size:12pt"> up the cause of the infection but </span><span style="font-family:Garamond; font-size:12pt">will take t</span><span style="font-family:Garamond; font-size:12pt">ime to culture those plates up,</span><span style="font-family:Garamond; font-size:12pt"> it is very difficult to </span><span style="font-family:Garamond; font-size:12pt">introduce a new technology that</span><span style="font-family:Garamond; font-size:12pt"> will be slightly more expensive</span><span style="font-family:Garamond; font-size:12pt"> but </span><span style="font-family:Garamond; font-size:12pt">means that the patient could get the right antibiotic therapy within five hours of being admitted.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q106 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Pamela Nash:</span><span style="font-family:Garamond; font-size:12pt"> I know we are running short of</span><span style="font-family:Garamond; font-size:12pt"> time, but I am interested in everyone</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s view </span><span style="font-family:Garamond; font-size:12pt">on this, particularly yours:</span><span style="font-family:Garamond; font-size:12pt"> do you think that the new structure</span><span style="font-family:Garamond; font-size:12pt">s within NHS England are</span><span style="font-family:Garamond; font-size:12pt"> going to be a help or a hindrance to getting new techniques through?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Doris-Ann Williams</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">At the moment</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> it does not look like the situation for us has changed significantly. Maybe it will and commissioning may help in that, but one of our problems is the lack of awareness as well</span><span style="font-family:Garamond; font-size:12pt">;</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">we need </span><span style="font-family:Garamond; font-size:12pt">to make physicians aware </span><span style="font-family:Garamond; font-size:12pt">of the tests that are available.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e have talked about CRP, but there are simple swab tests that could be used in primary care </span><span style="font-family:Garamond; font-size:12pt">that</span><span style="font-family:Garamond; font-size:12pt"> are routinely used el</span><span style="font-family:Garamond; font-size:12pt">sewhere, which just give a colour-</span><span style="font-family:Garamond; font-size:12pt">change reaction in the same </span><span style="font-family:Garamond; font-size:12pt">way</span><span style="font-family:Garamond; font-size:12pt"> as a pre</span><span style="font-family:Garamond; font-size:12pt">gnancy kit. They take seconds to do and </span><span style="font-family:Garamond; font-size:12pt">co</span><span style="font-family:Garamond; font-size:12pt">st</span><span style="font-family:Garamond; font-size:12pt"> maybe £1 or £2</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">W</span><span style="font-family:Garamond; font-size:12pt">e have to find a way of financing that, but it is </span><span style="font-family:Garamond; font-size:12pt">about </span><span style="font-family:Garamond; font-size:12pt">educating GPs. I even thought that having a biomedical scientist working in the c</span><span style="font-family:Garamond; font-size:12pt">ommunity would be a way to support </span><span style="font-family:Garamond; font-size:12pt">GP</span><span style="font-family:Garamond; font-size:12pt">s’ workload</span><span style="font-family:Garamond; font-size:12pt"> for that sort of point</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">of</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">care</span><span style="font-family:Garamond; font-size:12pt"> testing.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">We have a uniquely refined primary care research structure in the UK which is probably the best in the world</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and it is really well funded. It has not been dramatically affected by the NHS changes</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> becaus</span><span style="font-family:Garamond; font-size:12pt">e it is mainly an academic and</span><span style="font-family:Garamond; font-size:12pt"> NIHR</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">funded</span><span style="font-family:Garamond; font-size:12pt"> structure</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">T</span><span style="font-family:Garamond; font-size:12pt">here is a huge amoun</span><span style="font-family:Garamond; font-size:12pt">t that we could do if we took </span><span style="font-family:Garamond; font-size:12pt">co</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">ordinated and</span><span style="font-family:Garamond; font-size:12pt"> thoughtful action on this. I</span><span style="font-family:Garamond; font-size:12pt">t is very attractive to large </span><span style="font-family:Garamond; font-size:12pt">pharma</span><span style="font-family:Garamond; font-size:12pt"> to do that kind of work in the UK</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because they know it will be hig</span><span style="font-family:Garamond; font-size:12pt">h quality. W</span><span style="font-family:Garamond; font-size:12pt">e could do a lot of these things here</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> within the community</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> very ef</span><span style="font-family:Garamond; font-size:12pt">fectively and earn money from them</span><span style="font-family:Garamond; font-size:12pt">.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">You asked about the barriers</span><span style="font-family:Garamond; font-size:12pt">, a</span><span style="font-family:Garamond; font-size:12pt">s I understood it, in relation to the NHS. The issue for us is cultural. There is a real familiarity with using antibiotics to sort out infectious disease</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and it is not necessarily easy for cli</span><span style="font-family:Garamond; font-size:12pt">nicians to have to deal with a</span><span style="font-family:Garamond; font-size:12pt"> number of different approaches to killing a troublesome bug</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> so there is going to be a cultural issue.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q107 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Pamela Nash:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">When you say a </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">cultural issue</span><span style="font-family:Garamond; font-size:12pt">”</span><span style="font-family:Garamond; font-size:12pt">, who is this affecting? </span><span style="font-family:Garamond; font-size:12pt">I</span><span style="font-family:Garamond; font-size:12pt">t is the same with what you </span><span style="font-family:Garamond; font-size:12pt">were saying about </span><span style="font-family:Garamond; font-size:12pt">BIVDA</span><span style="font-family:Garamond; font-size:12pt">; </span><span style="font-family:Garamond; font-size:12pt">there is a high recognition within this place, for </span><span style="font-family:Garamond; font-size:12pt">instance, about what BIVDA does.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Say, for example, </span><span style="font-family:Garamond; font-size:12pt">that </span><span style="font-family:Garamond; font-size:12pt">someone comes in and they have an infection, the typical response would be a broad spectrum antibiotic, initially. If you have rapid diagnostics and you know exactly which version of a bug is causing you difficulty, you could apply a narrow spectrum treatment</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which would give you a better outcome</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> but it would require a different approach by the clinicians treating the patient.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The medical culture, not the culture in the House of Commons.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q108 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Can we pin this down a bit more? There is a UK antim</span><span style="font-family:Garamond; font-size:12pt">icrobial resistance strategy </span><span style="font-family:Garamond; font-size:12pt">2013</span><span style="font-family:Garamond; font-size:12pt">&#x2011;</span><span style="font-family:Garamond; font-size:12pt">18. Does that strategy encompass fully the approaches that each of you </span><span style="font-family:Garamond; font-size:12pt">is</span><span style="font-family:Garamond; font-size:12pt"> adopting? If not, what amendments would you recommend</span><span style="font-family:Garamond; font-size:12pt">?</span><span style="font-family:Garamond; font-size:12pt"> I will just go down the table and ask that.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I know </span><span style="font-family:Garamond; font-size:12pt">phages</span><span style="font-family:Garamond; font-size:12pt"> are mentioned on page 18, so yes is the short answer. The key issue is the funding.</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Dr McIntosh? </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Dr McIntosh</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">The strategy is a good document but it does not explicitly or implicitly state that vaccination has had a role in reducing </span><span style="font-family:Garamond; font-size:12pt">antibiotic </span><span style="font-family:Garamond; font-size:12pt">c</span><span style="font-family:Garamond; font-size:12pt">onsumption or</span><span style="font-family:Garamond; font-size:12pt"> antibiotic resistance</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and does not implicitly or explicitly state that in the future vaccination has a role in reducing antibiotic resistance.</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Can we leave Professor </span><span style="font-family:Garamond; font-size:12pt">Lewith</span><span style="font-family:Garamond; font-size:12pt"> till last</span><span style="font-family:Garamond; font-size:12pt">?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Doris-Ann Williams</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">I think the strategy is excellent. It does mention diagnostics. I was quite surprised in the earlier session to hear that GPs are not considering prescription of antibiotics. When you think that must be the most common prescription they write, you would think they would look for a tool and that that would still be at the forefront of their mind.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q109 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">The reason I left you </span><span style="font-family:Garamond; font-size:12pt">till</span><span style="font-family:Garamond; font-size:12pt"> last, Professor </span><span style="font-family:Garamond; font-size:12pt">Lewith</span><span style="font-family:Garamond; font-size:12pt">, is that I want to split the answer in two from you, one in respect of what you said about herbal and the other in response to David </span><span style="font-family:Garamond; font-size:12pt">Tredinnick</span><span style="font-family:Garamond; font-size:12pt">’</span><span style="font-family:Garamond; font-size:12pt">s</span><span style="font-family:Garamond; font-size:12pt"> question, your response on hom</span><span style="font-family:Garamond; font-size:12pt">eopathy</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> because I guess there mu</span><span style="font-family:Garamond; font-size:12pt">st be two separate answers</span><span style="font-family:Garamond; font-size:12pt">.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">Yes, there are.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q110 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">Professor Davies is on record to this Committee and talking to the Lords as saying that </span><span style="font-family:Garamond; font-size:12pt">“</span><span style="font-family:Garamond; font-size:12pt">outwith</span><span style="font-family:Garamond; font-size:12pt"> the placebo effect</span><span style="font-family:Garamond; font-size:12pt">, hom</span><span style="font-family:Garamond; font-size:12pt">eopathy has no impact</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> I am very concerned when homeopathic practitioners try </span><span style="font-family:Garamond; font-size:12pt">and</span><span style="font-family:Garamond; font-size:12pt"> peddle this way of life to prevent malaria or other infectious diseases. I am quite clear </span><span style="font-family:Garamond; font-size:12pt">about where </span><span style="font-family:Garamond; font-size:12pt">I believe the evidence is.</span><span style="font-family:Garamond; font-size:12pt">” </span><span style="font-family:Garamond; font-size:12pt">I am presuming you might have two separate answers.</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Professor </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Lewith</span><span style="font-family:Garamond; font-size:12pt">: Let’</span><span style="font-family:Garamond; font-size:12pt">s answer the difficult one first. I do not t</span><span style="font-family:Garamond; font-size:12pt">hink you should be using hom</span><span style="font-family:Garamond; font-size:12pt">eopathy with malaria; I think that is outrageous. In dealing with acute infections, the actual evidence, if you look at it, is unclear </span><span style="font-family:Garamond; font-size:12pt">as to </span><span style="font-family:Garamond; font-size:12pt">whether it is a placebo or not. With the greatest respect, I do not think Dame Sally Davies has perhaps studied that evidence in any detail, but I think the jury is very much out on that. I do not think it is conclusive. I would support that by saying that you can look at </span><span style="font-family:Garamond; font-size:12pt">the same data in two separate </span><span style="font-family:Garamond; font-size:12pt; font-style:italic">Lancet</span><span style="font-family:Garamond; font-size:12pt"> systematic reviews about hom</span><span style="font-family:Garamond; font-size:12pt">eopathy and come to entirely opposing conclusions</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> which, to me, me</span><span style="font-family:Garamond; font-size:12pt">ans there is not enough data. </span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">As to t</span><span style="font-family:Garamond; font-size:12pt">he second</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> in terms of herbal medicine, I agree that the policy is a great policy. I have read it and I think it covers most of the issues. I think that the issues around herbal medicine are around regulatory issues and facilitating expertise in the </span><span style="font-family:Garamond; font-size:12pt">UK</span><span style="font-family:Garamond; font-size:12pt">,</span><span style="font-family:Garamond; font-size:12pt"> and within that context, with </span><span style="font-family:Garamond; font-size:12pt">very small changes, we could do some quite interesting things in the same way as they are doing in continental </span><span style="font-family:Garamond; font-size:12pt">Europe</span><span style="font-family:Garamond; font-size:12pt">.</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I thank the panel for their presentations this morning</span><span style="font-family:Garamond; font-size:12pt">.</span><span style="font-family:Garamond; font-size:12pt"> It has been a very interesting morning all round. If you have any additional information you would like to submit, please feel free.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Garamond; font-size:12pt">&#xa0;</span></p><p style="margin:0pt 0pt 10pt; text-align:justify; text-indent:0pt"><span style="font-family:Garamond; font-size:12pt; font-style:normal; font-weight:bold">Q111 </span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Jim Dowd:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">I have one brief question, if I may, Chair. If </span><span style="font-family:Garamond; font-size:12pt">phages</span><span style="font-family:Garamond; font-size:12pt"> are killing a quarter of all the bacteria in the world every day, how come there is still so much of it about?</span></p><p style="margin:0pt 0pt 10pt 14.2pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">John </span><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">Hardcastle</span><span style="font-family:Garamond; font-size:12pt">: </span><span style="font-family:Garamond; font-size:12pt">It is those pesky bacteria</span><span style="font-family:Garamond; font-size:12pt"> that go and</span><span style="font-family:Garamond; font-size:12pt"> breed the next day.</span></p><p style="margin:0pt 0pt 12pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Chair:</span><span style="font-family:Garamond; font-size:12pt"> </span><span style="font-family:Garamond; font-size:12pt">On that point, thank you very much for your attendance. </span></p><p style="line-height:28pt; margin:14pt 0pt 9pt"><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:10pt">              </span><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:10pt">Oral evidence: Antimicrobial resistance</span><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:10pt">, HC </span><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:10pt">848</span><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:10pt">              </span><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:10pt">              </span><span style="color:#005232; font-family:'Frutiger LT Std 55 Roman'; font-size:10pt">37</span></p></div></body></html>